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ABSTRACT 
 
Protein folding is the reversible transition by which an unordered polypeptide chain 
attains its functional 3-D native structure.  A detailed understanding of the principles 
which govern the protein folding process, such as how sequence codes for structure, 
remains elusive.  Achieving a complete picture of the folding process requires 
information regarding structural preferences in the unfolded state.  Moreover, 
understanding the principles which govern protein aggregation is of significant 
biomedical and biotechnological importance.  Herein, short alanine-based peptides are 
used as model systems for studying both the structural preferences in the unfolded state 
as well as protein aggregation in relation to human disease, and exploitation of the self-
assembly process for various biotechnological applications.     
It is now a central dogma of protein science that the unfolded state is not 
conformationally random, as was originally believed, but that, instead, residual structure 
exists.  Here, we elucidate the conformational propensities of alanine in the unfolded 
state using short alanine-rich peptides as model systems.  The intrinsic conformational 
propensities of alanine, as well as nearest neighbor effects are illuminated using various 
vibrational spectroscopic methods, combined with NMR results.  
 Protein and peptide aggregation is affiliated with various seemingly unrelated 
diseases, including several neurodegenerative diseases and the systemic amyloidoses.  It 
is of current belief that aggregation is a general feature of the protein energy landscape, 
suggesting that the various unrelated human pathologies linked to protein aggregation are 
linked by common principles.  Herein, fibril formation of a short alanine-based peptide 
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with no known disease affiliation is probed by vibrational circular dichroism (VCD) 
spectroscopy.  In particular, it is demonstrated that peptide fibrils give rise to VCD 
intensity enhancement, illustrating the use of the technique as a novel means to probe 
aggregation kinetics. 
In addition to the biomedical relevance, protein and peptide self-assembly can be 
exploited as a means of constructing biomaterials with inherent biofunctionality.  In this 
regard, oligopeptide-based hydrogels have shown potential as drug delivery systems and 
tissue engineering scaffolds.  Herein, the unique properties of a novel class of self-
assembling alanine-rich oligoopeptides are presented.  In particular, it is demonstrated 
that conformational instability can be exploited to tune the physicochemical properties of 
hydrogels formed by such systems, for the potential use in various biotechnological 
applications.  
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CHAPTER 1 
Intrinsic Conformational Propensities in the Unfolded State 
 
 
1.1 Synopsis 
 
A complete understanding of the unfolded state of proteins and polypeptides requires the 
systematic investigation of the conformational propensities of amino acids in unfolded 
chains.  Herein, the combined use of FTIR, VCD, Raman, and NMR spectroscopic 
methods is employed to determine the intrinsic conformational propensities of alanine in  
short alanine-based peptides.  To this end, an excitonic coupling model is employed to 
simulate the amide I’ band profile of various short alanine-rich peptides.  These 
simulations are constrained using 3JCαHNH coupling constants obtained from NMR 
experiments.   
Results from this study affirm that alanine has a clear propensity to adopt  
polyproline II (PPII)-like conformations in the unfolded state, at odds with the random 
coil model commonly used to describe unfolded proteins.  Lysine, on the other hand, was 
found to behave like a statistical coil in an alanine context, in contrast to polylysine 
peptides of varying lengths which are known to adopt local segments of PPII-like 
conformations.  Moreover, the PPII propensity of alanine is found to be modified by 
neighboring charged residues, e.g. lysine, which results in a decreased sampling of PPII 
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for alanine.  This result emphasizes that nearest neighbor interactions play a crucial role 
in individual amino acid propensities.      
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1.2 Background Information 
 
1.2.1 Protein Folding  
 
Protein folding is the reversible transition by which an unordered polypeptide chain 
attains its fully functioning 3-D native structure, as depicted in Figure 1.  Many questions 
regarding the principles which govern the folding process, including a detailed 
understanding of how the amino acid sequence codes for the 3-D native structure, remain 
elusive.   From a thermodynamic viewpoint, protein folding is the simple two-state 
reaction between the unfolded (U) and folded (F) states of a polypeptide chain, e.g. U ↔ 
F.  Owing to the size of typical proteins, however, the folding reaction tends to be much 
more complex.  Ways in which the protein folding field is emerging is comparable to the 
progress made on small molecule chemical reactions, where knowledge of basic potential 
energy surfaces between reactants (unfolded peptides) and products (folded protein) is a 
priority (1).  Owing to the interplay between the large entropic and enthalpic 
contributions to the free energy of the protein system during folding, the free energy of 
the native state tends to be only slightly lower than that of the unfolded state, so that the 
protein folding reactions are much more complex than typical chemical reactions of small 
molecules (1).  
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Figure 1:  Typical schematic of protein folding depicting the reversible transition between the unfolded (left) and 
folded state (right). 
 
 
In vivo, the primary amino acid sequence of any protein is encoded by DNA in the 
cell nucleus (2).  This genetic information is transcribed from DNA to RNA, where the 
information is then translated into a polypeptide chain from the corresponding nucleotide 
sequence.  Some proteins begin to fold while still attached to the ribosome, i.e. co-
translationally, while others fold only after they have left the ribosome.  In vivo, proteins 
fold with the aid of numerous chaperones, some of which interact with the nascent 
polypeptide chain as it emerges from the ribosome, while others guide the newly 
synthesized chains to other locations for folding at later stages (3).   Thus, in the same 
way that biochemical reactions are catalyzed by enzymes, protein folding is ‘catalyzed’ 
by molecular chaperones in vivo (4).   
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1.2.2 Thermodynamic Hypothesis of Protein Folding 
 
In vitro protein folding studies can yield fundamental mechanistic insight into the folding 
process without needing to consider contributing factors from the often highly crowded 
biological environment.  The history of protein folding studies in vitro dates back to the 
early 1960’s, when Charles Anfinsen and associates first demonstrated that chemically 
denatured ribonuclease can restore itself back to its native fold when re-exposed to 
conditions which favor the native state (5).  Anfinsen reasoned that proteins fold in such a 
way so as to ultimately yield a structure with a minimum Gibbs energy (∆G).  Thus, in 
Anfinsen’s “thermodynamic hypothesis” of protein folding, the native fold is that which 
attains a minimum free energy.  From these early experiments, Anfinsen concluded that 
the native conformation is encoded by the protein’s amino acid sequence.  Although 
methods of secondary structure prediction have been around since the early 1970’s, the 
most famous being the Chou and Fasman method (6-7), a complete and detailed 
understanding of how a protein’s native fold is encoded in the primary amino acid 
sequence remains a mystery of the biological sciences (8).   
 
1.2.3 Levinthal Paradox 
 
A contradiction to the thermodynamic hypothesis of protein folding was put forth by 
Cyrus Levinthal in 1968.  Levinthal reasoned that even if each residue in a sequence 
containing 100 amino acid residues can sample only two distinct conformations, so that 
the total # of conformations is 2100 = 1030, and that if it is assumed that each conformation 
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can be sampled in 1 picosecond (a somewhat conservative assumption), then it would 
take > 1010 years to fold, that is, close to the lifetime of the universe (9).  In contrast to 
Levinthal’s estimate, proteins typically fold in the microsecond to second regime.  In 
particular, α-helical segments and β-turns can form in µs or less (10-11), and simple 
proteins have even been shown to fold from their unfolded state in these short times (12-
13).  Based on his thought experiment, Levinthal suggested the possibility of protein 
folding pathways which dominate the “classical view” of protein folding (14).  In this 
view, proteins fold kinetically, that is via a series of sequential steps, to ultimately attain 
their native 3-D structure with a minimum free energy, ∆G.   
 
1.2.4 The ‘New View’ of Protein Folding: Energy Landscapes and Folding Funnels 
 
Recently, the concepts of energy landscapes and folding funnels have been introduced to 
help visualize the protein folding process.  In this ‘new view’ of protein folding, a typical 
protein energy landscape consists of a multidimensional funnel in which various minima 
exist along this energy funnel, with the native state residing at the global energy 
minimum.  In particular, the unfolded state and folded states reside at the top and bottom 
of an energy funnel, respectively (15-17).   
During folding, an unfolded polypeptide chain undergoes a stochastic search of 
the many accessible conformations as it advances down the energy funnel.  Since native-
contacts are more energetically favorable and thus more persistent than non-native ones, 
the conformational search is greatly reduced, and the polypeptide ultimately attains its 
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global free energy minimum, i.e. the native state, (See Figure 1) (1, 3-4, 16).  While two 
state transitions have been documented between the unfolded (U) and folded (F) states, 
e.g. U ↔ F,  the folding process is much more complex, especially for larger systems 
(more than 100 amino acid residues), where one or more kinetic intermediates are often 
populated (3, 18).  Various techniques are available which can provide information about 
residues involved in folding intermediates and transition states (3, 19) and their 
respective stabilities.  The more well-known of these techniques include pulsed hydrogen 
exchange NMR (18) and the protein engineering method (20), where the latter attempts to 
identify specific amino acids involved in native-like contacts in the transition or 
intermediate states by introducing point mutations and probing the subsequent effects on 
the folding rate (19).  
The conversion of natively folded proteins into well-ordered aggregates is a 
common phenomenon of the protein folding process, and is affiliated with various 
debilitating human pathologies.  Recently, the funnel concept of protein folding has been 
modified to include protein aggregation, which is now considered a generic feature of all 
proteins and peptides.  This extension of the protein energy landscape to include the 
aggregated state will be addressed in Chapter 2.  
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Figure 2:  Energy Landscape of a typical protein, where the native state resides at the free energy minimum of the 
funnel.  This figure was adapted from ref(21). 
 
 
1.2.5 Protein secondary structure 
 
The polypeptide backbone consists of three degrees of freedom resulting from the three 
dihedral angles, ω, φ, and ψ, defined by rotation about the Cα-C’-N-Cα, C’-N-Cα-C’, and 
N-Cα-C’-N backbone atoms, respectively (2).  Owing to its partial double bond character, 
the peptide group (H-N-C’-O) tends to be very rigid, making the four atoms nearly co-
planar.  Aside from proline, polypeptides formed from the other naturally occurring L-
amino acids prefer the formation of peptide groups with a trans- conformation, so that ω 
is constrained to 180°.  As such, the secondary structure of the polypeptide chain is 
usually governed only by the dihedral angles φ and ψ, as depicted in Figure 3. 
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Figure 3:  Polypeptide backbone, showing the dihedral angles (φ, ψ).  Figure was adapted from ref(2). 
 
 Due to steric restrictions, however, not all possible combinations of φ and ψ are 
allowed.  A convenient way to view the allowed conformations of a protein is via a 
Ramachandran map, developed by G.N. Ramachandran in the early 1960’s (22).  Figure 
4 shows the Ramachandran map for proteins, illustrating the allowed regions, as well as 
pointing out the locations of various common elements of secondary structure.   
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Figure 4:  Ramachandran map showing the sterically allowed regions (blue).  The locations of various secondary 
structures are also indicated.  This figure was adapted from ref(2). 
 
 
The simplest method of qualitatively deducing the elements of secondary 
structure present in a particular polypeptide is ultraviolet circular dichroism (UV-CD) 
spectroscopy (23-26).  UV-CD measures the differential absorption of right and left-
circularly polarized light, in the regime of electronic transitions associated with the 
peptide group.  The distinct basins of the Ramachandran map are indicative of well-
defined polypeptide secondary structures, such as α-helices and β-sheets.  Each of these 
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major secondary structures exhibits a distinct UV-CD spectrum, as depicted in Figure 5 
for the α-helix, β-sheet, β-turn, and PPII conformations. 
 
 
Figure 5:  Far-UV circular dichroism (CD) spectra of various secondary structures.  Taken from ref(23) and modified. 
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1.2.6 The Unfolded State 
 
Determining the structure of folded proteins is somewhat of a routine endeavor, at least 
for non-membrane proteins.  As crystallization is often required for structure 
determination, membrane proteins present a challenge owing to the requirement of 
surfactants and/or denaturants required for their solubility, which can interfere with 
crystallization (27).  High-resolution techniques such as X-ray crystallography and 
nuclear magnetic resonance (NMR) spectroscopy can provide atomic resolution of even 
large proteins.  Approximately 62,000 protein crystal structures have been solved to date 
(28).  Due to these high resolution methods a great deal is known about the structure and 
dynamics of the folded state.  The unfolded state of proteins, on the other hand, has 
eluded such a detailed structural and energetic characterization.  This is due to the 
inherent heterogeneity of the unfolded state and complex dynamics (8).   
In spite of the elusive nature of the unfolded species, a complete understanding of 
the mechanistic principles which govern the protein folding process requires a detailed 
thermodynamic characterization of the unfolded state, including both structure and 
dynamics (8).  Classic textbook wisdom dictates that the unfolded state is purely random, 
such that all amino acid residues, with the exceptions of glycine and proline, can sample 
the entire sterically allowed Ramachandran space, thus suggesting that structural studies 
of the unfolded state are futile.  The presence of residual structure in the unfolded state, 
however, has significant implications for protein folding theories, as the number of 
conformations needed to be sampled by a polypeptide chain would be greatly reduced 
(29).   
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1.2.7 Unfolded Proteins and the Random-Coil Model 
 
The structure of unfolded proteins was first pioneered by Tanford using chemical 
denaturants to unfold native proteins (30).  Tanford observed that denatured proteins 
behave like polymers in a good solvent (30-32), in contrast to folded proteins globules 
which behave like polymer chains in poor solvents  (30).  This pioneering work led the 
foundation for treating unfolded proteins with a statistical model from polymer theory, 
now known as the random- or statistical-coil model, developed by Paul J. Flory (33).  
Due to implicit steric restrictions of the peptide backbone, the term statistical coil is 
preferred to random coil (34-35).   
In the statistical-coil model, the length of an unfolded polypeptide chain length 
and radius of gyration are related by the following power-law (36-37):  
 
𝑅𝑔 = 𝑅𝑜𝑁𝜈                            (1) 
 
where N is the number of amino acid residues, 𝑅𝑜 is measure of the excluded volume of 
the polymer chain (which allows for favorable solvent interactions), and 𝜈 is an 
exponential scaling factor which depends on the quality of the solvent, where 𝜈 = 0.33 
for a poor solvent,  𝜈 = 0.5 for an ideal solvent, and 𝜈 = 0.6 for a good solvent (37-38).  
Typically, 𝜈 = 0.6 and  𝑅𝑜 = 1.93 ± .001 are used in the treatment of unfolded and 
denatured polypeptides (36).  Such a random-coil scaling of the radius of gyration 
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suggests that the unfolded polypeptide does not depend on the amino acid composition of 
the peptide chain. 
The statistical-coil theory of unfolded polypeptides is based on the assumption 
that each pair of (φ,ψ) dihedral angles is independent of neighboring pairs.  This is 
known as the isolated pair hypothesis (IPH).  The IPH hypothesis suggests that the total 
number of possible conformations which can be adopted by a polypeptide can be 
determined as the product of the number of conformations sampled by each amino acid 
residue.  The isolated pair hypothesis may be formulated mathematically as (39): 
 
𝑆𝑛 ≤ 𝑛𝑆𝑛,𝑖                             (2) 
 
where 𝑆𝑛 is the entropy of a polypeptide with 𝑛 residues, and 𝑆𝑛,𝑖 is the entropy of 
residue 𝑖.  The isolated pair hypothesis is valid when the equality holds.       
 
1.2.8 The Tiffany and Krimm Hypothesis (TK Hypothesis) 
 
Homopolypeptides of charged amino acid residues, e.g. lysine, glutamic acid, etc., adopt 
different secondary structures depending on the protonation state of the side chains.  In 
particular, poly-L-lysine (PLK) can adopt an α-helical structure in water at pH values 
above the pKa of the lysine side chain.  Below the pKa, however, PLK was believed to 
adopt a more ‘random-coil’ structure due to electrostatic repulsion between the positively 
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charged lysine residues.  In 1968, Tiffany and Krimm showed that the UV-CD spectra of 
poly-L-glutamic acid (PGA) and PLK, at pH values where the side chains were charged, 
resemble the UV-CD spectrum of trans-poly-L-proline (PLP), which was known to adopt 
an extended left-handed helix, known as poly-L-proline II (PPII) (40-41).  Thus, the 
Tiffany and Krimm hypothesis (TK hypothesis) dictates that unfolded peptides actually 
exhibit a significant amount of PPII-like structure.  Tiffany and Krimm suggested that 
segments of local order exist in polypeptides which were thought to adopt the so-called 
‘random-coil’ structure, with admixtures from conformational sampling of the sterically 
allowed regions of the Ramachandran map obtained for the alanine dipeptide (22, 42). 
 
 
1.2.9 Model Systems for Studying the Unfolded State 
 
Following the findings of Tiffany and Krimm in the late 1960’s and early 1970’s, little 
attention was drawn to their conclusions.  In recent years, however, the TK hypothesis 
has been revived based on the results of numerous experimental studies of short peptides 
(43-58).  This rekindling of the TK hypothesis is due to the vibrational circular dichroism 
(VCD) studies of Dukor and Keiderling on proline oligomers in the early 1990’s (59).  
Since then, various experimental studies on short peptides suggest that they significantly 
sample the PPII conformation in water (43-58).  Such peptides, which are too short to 
adopt any stable elements of secondary structure such as α-helices, β-sheets, and β-
strands, are continually being used as models for probing the unfolded state of peptides 
and proteins.  
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In addition to short peptides, various other model systems have been employed 
over the years to better characterize the unfolded state of peptides and proteins.  These 
include the charged homopolypeptides such as PLK and PGA studied by Tiffany and 
Krimm in their seminal work (40-42), as well as denatured proteins, natively unfolded 
proteins, and coil libraries.   
Studies of denatured proteins are usually carried out using chemical denaturants, 
such as guanadinium chloride (GndCl) or Urea (8), but such chemically denatured 
species might not reflect the true unfolded state of polypeptides.  In this regard, natively 
unfolded proteins, such as synuclein, which is linked with Parkinson’s disease, are better 
suited for studies of the unfolded state of longer polypeptides (60).  A coil library is 
essentially a catalog of (φ, ψ) dihedral angles sampled by a particular amino acid 
obtained by analyzing the various protein structures archived within the Protein Data 
Bank (28, 61).  It is thought that all contextual dependencies will be eliminated, such that 
coil libraries are representative of the intrinsic conformational propensities of a particular 
amino acid.  Recently, Serrano (61) used a less-restricted coil library, where those pairs 
of dihedral angles which correspond to elements of major secondary structure, e.g. α-
helix, β-strand, β-sheet, etc., were removed, to yield new conformational distributions.  
Such an approach is more representative of intrinsic conformational propensities (62).  
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1.2.10 Polyproline II (PPII) Conformation 
 
The conformation adopted by trans-PLP obtained from the crystal structure of Cowan et 
al. (63) is found to be an extended left-handed helix, known poly-L-proline II (PPII), as 
shown in Figure 1(a.).  The canonical dihedral angles of PPII are (φ, ψ) = (-78°, 145°), 
so that it is located in the upper-left quadrant of the Ramachandran map (see Section 
1.2.5).  PPII is a 31, helix, containing three amino acid residues per helical turn, and 
therefore exhibits three-fold rotational symmetry, as shown by the axial view in Figure 
1(b.). 
 
 
Figure 6:  Illustration of deca-alanine (A10) in the polyproline II (PPII) conformation.  (a.)  Side view showing the 
extended left-handed helical conformation and (b.) a view down the axis of the polypeptide chain, illustrating the 
3-fold rotational symmetry of PPII. 
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1.2.11 Alanine-Based Peptides  
 
Short alanine-Based peptides have been the subject of intense research activities since the 
late 1980’s.  This interest stemmed from the discovery by Marqusee et al. that short 
alanine-based peptides with at least 12 amino acid residues could adopt stable α-helices 
in aqueous solution if doped with a limited number of charged residues (64-65).  The 
addition of charged residues increases the solubility of the peptide in aqueous solution.  
Such short alanine-rich sequences also serve as convenient model systems for studying 
helix ↔ coil transitions of proteins (66-67).  Short alanine-based peptides have been used 
extensively in recent years as convenient model systems to study the unfolded state of 
peptides and proteins (45, 68).  This mostly stems from the fact that they are too short to 
form any stable elements of secondary structure.  They are, in essence, intrinsically 
unfolded, so that they can be used to study the unfolded state under physiological 
conditions.  Moreover, recent experimental and theoretical studies suggest that the 
unfolded state of short alanine-based peptides cannot be described by Tanford (30) and 
Flory’s (33) statistical coil model (36, 43, 48, 69).   
 
 
1.2.12 The Reconciliation Problem 
 
Despite numerous theoretical and experimental studies which suggest that conformational 
preferences exist in the unfolded state, such unfolded polypeptides typically exhibit radii 
of gyration that scale with random-coil behavior (see Section 1.2.7).  The reconciliation 
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problem concerns the question of how one can reconcile the obvious local structure 
observed for unfolded and denatured peptides and proteins, with the fact that their radii of 
gyration appear independent of the identity of the amino acid sequence, and suggest 
rather that they behave more like random or statistical coils (32, 36-37).   
 For example, Tran et al. (36) simulated ensembles of conformations which are 
accessible to peptide and proteins, and showed that, in the limit of excluded volume, a 
tug-o-war exists between steric overlap, which promotes chain stretching, and 
conformational entropy, which opposes chain stretching.  Minimization of steric overlap 
in a polypeptide chain results in the formation of local structure, consistent with 
experimental studies, which indicate a PPII-preference in the unfolded state.  
Conformational entropy, on the other hand, opposes the formation of long, locally 
ordered segments, resulting in short persistence lengths and random-coil scaling 
behavior. 
 Fitzkee and Rose (38) introduced a counterexample to show that polypeptides 
with rigid segments of native protein structure exhibit random coil statistics when they 
are interconnected by various flexible hinge residues.  These studies clearly indicate that 
polypeptides with local order can still exhibit random-coil characteristics, and that other 
criteria are necessary to suggest complete randomness of a polypeptide chain, as was 
originally pointed out by Tanford (30).   
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1.2.13 Violation of the Isolated Pair Hypothesis 
 
The isolated pair hypothesis (IPH) is a pillar of protein folding (70) and helix-coil 
theories (71-73).  Recent studies, however, have provided results which clearly violate 
the IPH (74-77).  These include studies from the Rose and Sosnick groups.  Pappu et al., 
for example, divided the Ramachandran map into so-called mesostates, and used an all-
atom representation to enumerate all of the possible sterically allowed conformations for 
short alanine-rich peptides (77).  These authors showed that steric effects can extend 
beyond nearest-neighbor residues, at least for residues which adopt conformations 
residing in the lower left quadrant of the Ramachandran map, such as α-helices.  Pappu et 
al. demonstrated that while the IPH holds for residues in the upper left quadrant of the 
Ramachandran map (PPII and β-strand), that mixtures of residues adopting PPII and/or β-
conformations, with residues adopting α-helical conformations, also violates the IPH.  
Based on their results, these authors suggested that the entropy of the unfolded state is 
much less than expected based on a random- or statistical-coil model.  A more recent 
study by this group provides further support for this notion (78).    
The results of Pappu et al., however, were challenged by Ohkubo et al., who 
argued that the non-nearest-neighbor clashes that occur in the short peptides studied by 
Pappu et al. are due to end effects, and are expected to be absent in longer peptides (39).  
In particular, Ohkubo et al. demonstrated that the conformational entropy of polyalanines 
containing 3 – 20 amino acid residues is proportional to the chain length, and thus 
support the validity of the IPH (39).   
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1.3 Intrinsic Conformational Propensity of Alanine in the Unfolded State 
 
1.3.1 Introduction 
 
The unfolded state of peptides and proteins has been the subject of an increasing number 
of experimental and theoretical studies (8, 36, 43, 48, 51, 79-82).  This is due to the 
discovery of naturally disordered, yet biologically functioning proteins and peptides (82), 
as well as the general relevance for a thorough understanding of the protein folding 
process.  In this context, the possible existence of local residue structure would certainly 
affect the initial phase of the folding process (83).  The existence of such locally ordered 
segments was first proposed by Tiffany and Krimm (see Section 1.2.8) based on UV-
circular dichroism (UV-CD) measurements on PLP, PLK, and PGA (41).  The authors 
concluded that charged polypeptides assume, at least locally, a rather ordered PPII 
conformation. This notion was later confirmed by vibrational circular dichroism (VCD) 
studies on a variety of unfolded polypeptides and proteins (47, 59).    
More recently, the interest of the protein/peptide folding community has focused 
on the unfolded state of alanine based peptides, after theoretical and experimental results 
suggested that it cannot be described by the classical statistical coil model of Flory (33).  
In particular, tri- (43, 49) and tetra-alanine (69) have recently been suggested to adopt 
predominant fractions of PPII-like conformations in aqueous solution.  Thus, alanine has 
emerged as a paradigm for the breakdown of the statistical coil model.   
Moreover, the solution structure of the hepta-alanine polypeptide Ac-X2A7O2-
NH2 (XAO, X and O denote diaminobutyric acid and ornithine, respectively) has been a 
matter of controversy in the current literature.  Shi et al., for instance, used NMR and 
P a g e  | 22 
 
UV-CD measurements to study the structure of XAO, and interpreted their results as 
indicating that the individual residues predominantly adopt a PPII conformation at room 
temperature, with a < 20% population of β conformations at room temperature (45).  The 
results of Shi et al. have been corroborated by numerous experimental and theoretical 
studies on short peptides, all of which revealed a substantial PPII propensity for alanine 
(36, 43, 48, 51, 79, 81).  Here the word propensity is used to indicate a quantified mole 
fraction or probability to adopt a specific conformation.   This notion is also in perfect 
agreement with distributions which Serrano (61) and Jha et al. (80) inferred from coil 
libraries, but at variance with a less restricted library investigated by Dobson and 
associates (84).  The results of MD simulations are force field dependent, and generally 
do not reproduce a PPII propensity of alanine without force-field modifications (85).   
Zagrovic et al. investigated XAO by small angle x-ray scattering (SAXS) 
experiments and obtained a radius of gyration of 7.4 Å (86).  If one assumes the ‘random 
walk scaling’ between radius of gyration and end to end distance, this value corresponds 
to an average end-to-end distance of 18.1 Å, which is significantly shorter than what one 
would expect for a pure PPII structure (radius of gyration = 13.1 Å, end to end distance = 
32.04 Å).  Zagrovic et al. also performed several molecular dynamics simulations with 
six variants of the Amber and Gromos force fields (86). The simulations reproduced 
neither the extended, PPII dominated structure, nor the very short radius of gyration 
obtained from the SAXS data.  Makowska et al. combined UV-CD and NMR 
measurements of XAO (involving the measurement of 3JCαHNH coupling constants, 
NOE’s, and chemical shifts) with MD simulations performed with the AMBER 99 force 
field (87).  The results lead the authors to conclude that PPII is only one of many 
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conformations sampled by alanine, along with multiple β-turn structures.  Additionally, 
the residues of XAO were found to sample multiple β-turn structures, without leading to 
the formation of stable structures with intra-peptide hydrogen bonding.  This is a 
surprising result since alanine is not known for its propensity for turn structures (7).  
Altogether, the results of Makowska et al. reemphasize the validity of the classical 
statistical coil model, though their Ramachandran plot looks somewhat different from the 
random coil distribution of alanine (84, 88-89).  
Molecular Dynamics (MD) simulations of the alanine dipeptide and polyalanines 
of varying lengths have increased the confusion in that different force fields yield rather 
different Ramachandran plots for the very same peptide.  Some of these simulations 
support the high PPII propensity of alanine (90-91), while others do not even yield a 
substantial population of this conformation (85, 92).  Distributions derived from coil 
libraries seem to support a PPII preference of alanine, but this depends on how the data 
set is chosen (61).  Even those simulations supporting the PPII propensity of alanine 
indicate an additional sampling of helix-like conformations, which is generally not 
considered in the analysis of experimental data (48, 69). 
Recently, Jun et al. used electron spin resonance distance measurements to probe 
the distance of two spin labels attached to an alanine based peptide in the folded and 
(thermally) unfolded state, and found the respective value for the latter to be too short for 
a pure PPII state of the peptide (93).  Analogously, Tucker et al. used an intrinsic 
fluorescence resonance energy transfer (FRET) pair to deduce that the supposedly 
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disordered mastoparan X peptide actually exists in aqueous solution as an ensemble of 
compact conformations (94).  
One might try to resolve the above discussed conflicting results by arguing that 
the PPII propensity of alanine solely applies to very short peptides, i.e. tri- and tetra-
peptides, whereas it behaves like a statistical coil in longer ones (48, 69, 95), which 
would violate the IPH.  A clarification of this issue has a high bearing on the 
understanding of both the unfolded state of peptides and proteins, as well as the protein 
unfolding process, in view of the abundance of alanine in nature, and its high propensity 
for helix formation (65).   
In what follows, we combine the use of FTIR, polarized Raman, VCD 
(vibrational circular dichroism), UV-CD and NMR data to explore the conformations 
sampled by short alanine-based peptides, in particular the unblocked cationic tetrapeptide  
H-AAKA-OH (AAKA), and the controversial XAO peptide, containing a hepta-alanine 
segment.  An excitonic coupling model is employed to simulate the amide I’ band, where 
the backbone φ angle for each residue is constrained using the 3JCαHNH NMR coupling 
constants reported in the literature along with a modified Karplus equation.   
 AAKA was chosen for two reasons.  First, obtaining the conformational 
propensity of lysine as a guest residue in an alanine host system is necessary to reconcile 
the contextual dependence reported for lysine, since polylysine peptides of varying 
lengths have been reported to prefer PPII conformations (41, 50), while the PPII 
propensity of the central lysine residue in the tripeptide AKA was found to depend on the 
C-terminal protonation state (48).  These contrasting results raise the question of whether 
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lysine itself has a high PPII propensity, which is of relevance for the understanding of 
naturally unfolded proteins in which lysine residues occur much more frequently than in 
folded proteins (96).  Also, lysine is one of the residues used in helix forming alanine 
based peptides, because it increases the overall helix stability, most likely by dehydrating 
the adjacent part of the backbone (97).   
We performed a structure analysis of AAKA and XAO by exploiting the excitonic 
coupling between the amide I’ modes of the peptide groups, which produces 
conformationally sensitive IR, Raman and VCD band profiles.  For the simulation of the 
profiles, we used a more extended approach than that employed for tri- and tetrapeptides 
in previous studies by explicitly considering coexisting conformations for the individual 
residues (48, 69).  The statistical modeling was constrained by the 3JCαHNH coupling 
constants of the residues obtained from 1H NMR experiments.  For XAO, which remains 
at the center of the debate, results from SAXS experiments were also used as constraints.   
Subsequently, we utilized the same approach to reanalyze earlier published amide 
I’ band profiles of tetra- and trialanine, in conjunction with corresponding NMR data.  
For short alanine peptides (AAA, AAAA, and AAKA), the results led us to conclude a 
modified view about the conformational propensity of alanine, which is in excellent 
agreement with MD simulations of Gnanakaran and Garcia (90).  With respect to lysine, 
our results show that it exhibits a reduced PPII propensity in an alanine context, e.g. 
AAKA.   
The conformational manifold of XAO on the other hand was found to be quite 
heterogeneous.  The best reproduction of the experimental data could only be achieved by 
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assuming an ensemble of conformations, which contains various β-turn conformations 
(~26%), in addition to β-strand (~23%) and PPII (~50%) conformations. PPII is the 
dominant conformation in segments not involved in turn formations. Most of the residues 
were found to sample the bridge region connecting the PPII and right-handed helix 
troughs in the Ramachandran plot, which is part of the very heterogeneous ensemble of 
conformations generally termed as type IV β-turn.  Technically, the current study shows 
that the combination of NMR and vibrational spectroscopy provides a powerful tool to 
explore the conformational landscape of peptides.   
 
1.3.2 Vibrational Spectroscopy as a Tool to Probe Residual Structure in the Unfolded 
State  
 
Protein structure determination remains as one of the most important endeavors in 
molecular biology and biochemistry.  In this regard, x-ray crystallography and nuclear 
magnetic resonance (NMR) spectroscopy are the most common techniques used to 
determine the structure of a protein, representing ~87% and ~ 12% of the ~62,000 solved 
protein crystals, respectively (28).  Intrinsically disordered/unfolded peptides and 
proteins typically adopt an ensemble of conformations in solution, so that even if 
crystallization can be achieved on such a dynamic system, the resulting structure may 
only represent one of many conformations occurring in the solution ensemble (98). 
Owing to the ensemble of conformations sampled, complementary techniques are often 
required to gain a clear picture of the structural properties of intrinsically disordered and 
unfolded polypetides in solution.  In this regard, vibrational spectroscopic techniques 
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such as Fourier transform infrared (FTIR), vibrational circular dichroism (VCD), and 
Raman spectroscopies can be coupled to quantify distinct elements of secondary structure 
that contribute to a protein’s overall structure (99-101).  Owing to the larger time 
windows ( > 10-12 s) made available by Raman and IR spectroscopies, such methods are 
particularly well-suited for exploring fast dynamic processes such as conformational 
fluctuations (102).   
 
 
1.3.3 Amide I Normal Mode 
 
The normal modes of polypeptides have been well-documented (99, 103).  The most 
structurally sensitive vibrational mode is the amide I mode, which results predominantly 
from backbone carbonyl stretching (CO s), with some contributions from N-H in plane 
bending (NH ip b), CN stretching (CN s), and CH bending (CH b) (104-107).  The 
structural sensitivity of amide I arises from the ability of the backbone carbonyl oxygen 
to participate in hydrogen bonding with other peptide groups as well as the solvent (e.g. 
water).  In deuterated solvents, the amide I downshifts due to a result of decoupling of the 
NH s, and is denoted as amide I’ (102).  The position and intensity of the amide I’ have 
been shown to be dependent on the type of amino acid (108).  
In addition to the sensitivity of amide I due to hydrogen bonding and amino acid 
type, the major structural sensitivity of the amide I mode arises from delocalization along 
the polypeptide backbone, which results predominately from transition dipole coupling 
(TDC) and through-bond coupling (109-110).  These delocalized excited vibrational 
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states are termed excitonic states, and can be described using a coupled oscillator model.  
The following section will introduce the excitonic coupling model, which can be used to 
simulate the vibrational spectra (e.g. infrared (IR), Raman, and vibrational circular 
dichroism (VCD)) of short polypeptides.   
 
 
1.3.4 Theory of Excitonic Coupling Model to Describe Delocalization of Amide I 
 
Excitonic coupling of the amide I mode has previously been successfully described by 
using a coupled quantum mechanical oscillator model (69, 79, 111-113).  Each 
vibrationally excited amide I oscillator in a polypeptide containing n amide I oscillators 
gives rise to a manifold of n excited vibrational states, termed excitonic states.  These 
excitonic states can be written as a linear combination of local excited amide I oscillators, 
such as: 
 
𝜒′𝑖 = ∑ 𝑎𝑖𝑗𝜒𝑗𝑛𝑖=1                  (3) 
 
where 𝜒′𝑖 is wavefunction of the ith excitonic state, 𝜒𝑗 is the local uncoupled excited state 
wavefunction of the jth oscillator, and 𝑎𝑖𝑗 are the mixing coefficients, which reflect the 
contribution of the local excited state wavefunctions to the ith excitonic state. 
The Schrödinger equation for a peptide with n residues can be written as: 
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 �𝐻�𝑜 + 𝐻�𝑒𝑥�� 𝜒′〉 =  𝐸|  𝜒′〉 (4) 
            
where 𝐻�𝑜 and 𝐻�𝑒𝑥 are the Hamiltonian operators for the unperturbed local amide I 
oscillators and excitonic coupling, respectively, 𝐸 is the set of n eigenenergies, and  |  𝜒′〉 
is a state vector comprising the n  excitonic amide I’ states (114).   
 The total Hamiltonian, 𝐻�𝑇 = 𝐻�𝑜 +  𝐻�𝑒𝑥, therefore contains the interactions 
between the oscillator of the 𝑗th residue and its neighboring residues, i.e. 𝑗±1, 𝑗±2, 𝑗±3, 
and 𝑗±4, namely: 
 
𝐻�𝑇 =
⎣
⎢
⎢
⎢
⎢
⎢
⎢
⎢
⎢
⎢
⎡
𝜈�1 Δ12 𝛿13 𝛿14 𝛿15 . . . . 0
Δ21 𝜈�2 Δ23 𝛿24 𝛿25 𝛿26 . . . 0
𝛿31 Δ32 𝜈�3 Δ34 𝛿35 𝛿36 𝛿37 . . 0
𝛿41 𝛿42 Δ43 𝜈�4 Δ45 𝛿46 𝛿47 𝛿48 . 0
𝛿51 𝛿52 𝛿53 Δ54 . . . . . .. 𝛿62 𝛿63 𝛿64 . . . . . .. . . . . . . . . .. . . . . . . . . 𝛿𝑛−2,𝑛0 . . . . . . . 𝜈�𝑛−1 Δ𝑛−1,𝑛0 0 0 0 . . . 𝛿𝑛,𝑛−2 Δ𝑛,𝑛−1 𝜈�𝑛 ⎦⎥⎥
⎥
⎥
⎥
⎥
⎥
⎥
⎥
⎤
        (5) 
 
Here, the term ‘residue’ is defined as a peptide group and the amino acid side 
chain.  For amide I oscillators which are more than 4 residues apart, the coupling between 
them can be considered as negligible except in the case of intermolecular coupling, e.g. in 
β-sheets.  In the matrix representation of the total Hamiltonian above, 𝜈�𝑗 is the energy of 
the unperturbed local oscillators, j, ∆𝑗,𝑗±1 represents nearest-neighbor interactions, while 
𝛿𝑗,𝑗′(𝑗′ = 𝑗 ± 2, 𝑗 ± 3, 𝑗 ± 4) accounts for the coupling between non-nearest-neighbors.  
The latter is assumed to result solely from through-space interactions, i.e. transition 
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dipole coupling (TDC), while the former  involves both through-bond and through-space 
coupling (109).  TDC can be calculated by utilizing the following equation (103): 
 
𝛿𝑗𝑗′ = 𝜉 �𝜇��⃗ 𝑗∙𝜇��⃗ 𝑗′
�𝑇�⃗ 𝑗𝑗′�
3 − 3 �𝜇��⃗ 𝑗∙𝑇�⃗ 𝑗𝑗′��𝜇��⃗ 𝑗′∙𝑇�⃗ 𝑗𝑗′�
�𝑇�⃗ 𝑗𝑗′�
5 �                                                                               (6) 
 
where ?⃗?𝑗 and ?⃗?𝑗′  are the vibrational transisiton dipole moments of the 𝑗th and 𝑗′th 
residues, respectively, and 𝑇�⃗ 𝑗𝑗′  is the distance vector connecting the centers of the 𝑗th and 
𝑗′th dipole moments.  𝜉 is a constant which depends on the units used to express the 
transition dipole moments and distance vector (103).  In electrostatic units (esu), it is 
equal to 9.047 x 1015 esu-1(115). 
Diagonalization of the above Hamiltonian yields eigenfunctions and thus the 
mixing coefficients, 𝑎𝑖𝑗, which can be used to calculate the Raman tensor and the 
transition dipole moment of the ith excitonic state: 
 
𝛼�𝑖
′ = ∑ 𝑎𝑖𝑗𝑛𝑗=1 𝛼�𝑗                 (7) 
 
?⃗?𝑖
′ = ∑ 𝑎𝑖𝑗𝑛𝑗=1 ?⃗?𝑗                 (8) 
 
Here, the Raman tensors and transition dipole moments for the local modes, j, are written 
as (116):  
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𝛼�𝑗 = 𝛼� = �𝑎∗ 𝑐∗ 0𝑐∗ 1 00 0 𝑑�                (9) 
 
?⃗?𝑗 = ?⃗? = �𝜇𝑜 ∙ 𝑐𝑜𝑠𝜗𝜇𝑜 ∙ 𝑠𝑖𝑛𝜗0 �              (10) 
 
Where µo is the magnitude of the transition dipole moment of the amide I mode, 𝜗 is its 
angle with respect to the x-axis of the coordinate system.  The tensor elements and dipole 
strengths of the local amide I’ oscillators were obtained from a previous study on AX and 
XA dipeptides (X signifies one of the 20 naturally occurring amino acid residues) (108).  
The elements, 𝑎∗, 𝑐∗, and 𝑑, are expressed in units of αyy, which is set to 1.  Eq. 7 
describes the Raman tensor of the molecular frame depicted in Figure 7 (117).  In this 
frame, the respective nitrogen atom is at the origin of the coordinate system, and the x-
axis is chosen to be co-linear with the NCα bond.  The rotational axis of x is therefore the 
rotational axis associated with the dihedral angle φ.  The y-axis is (nearly) coplanar with 
the peptide group, and the z is the out-of-plane coordinate.  The small deviation from 
coplanarity (~1.1°) results from the fact that the NCα bond is not exactly coplanar with 
the peptide group (117).  
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Figure 7:  Local coordinate systems for expressing the transition dipole, Raman tensor, and distance vectors shown 
for the model system tetraalanine.  The peptide is depicted as adopting a completely extended β-sheet structure 
with (φ, ψ) = (180°, 180°).  For clarity, the z-axes are not shown.     
 
  
To utilize eqs. 5 - 8 for determination of the Raman tensors and transition dipole 
moments of the excitonic states, all local Raman tensors and dipole moments must first 
be transformed into a common reference system.  We arbitrarily choose the coordinate 
system of the C-terminal residue as the reference system.  Namely, Raman tensors and 
transition dipole moment vectors in the jth coordinate system have to be rotated (n - 1) – j 
times (for an unblocked peptide) in order to have their elements expressed in the basis of 
the chosen C-terminal reference system (116).  As an example, the respective 
transformation of the Raman tensor of the 1st residue in coordinate system S1(x1, y1, z1) to 
the coordinate system S2(x2, y2, z2) of the 2nd residue, can be  written as follows (116): 
 
𝛼�1(𝑆2) = 𝑅𝑇(𝜔) �𝑅𝑇(𝜓)��𝑅𝑇(𝜉)[𝑅𝑇(𝜙′)𝛼�1(𝑆1)𝑅(𝜙′)]𝑅(𝜉)��𝑅(𝜓)� 𝑅(𝜔)               (11) 
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 In particular, S1 is first rotated by an angle 𝜙′ = 𝜙 − 𝜋, followed by a rotation by 
an angle 𝜉 in the xy plane, to result in the y coordinate coinciding with the CαC bond, 
which is then the rotational axis for y.  Here, 𝜉 is the angle formed by the y1 axis and the 
CαC bond.  Next, the system is rotated by the dihedral angle 𝜓.   The fourth step involves 
the rotation by an angle 𝜔 formed by the CαC bond and the y2 axis.  This causes the x-
axis to coincide with the NCα bond.  The angles 𝜔 and   𝜉 have been obtained from 
textbooks on peptide structure, and are given as 96° and 20°, respectively (2).         
The Raman tensor, 𝛼�𝑖, of the ith excitonic state is thus calculated by first rotating 
all of the local amide I’ Raman tensors into the coordinate system of the C-terminal 
residue, in combination with eq. 5.  It can then be used to calculate the isotropic and 
anisotropic Raman intensity via the respective tensor invariants, 𝛽𝑠,𝑖′2  and 𝛾𝑎𝑛𝑖𝑠𝑜,𝑖′2 , via the 
following equations (118):  
 
𝛽𝑠,𝑖′2 = 19 (𝑇𝑟 𝛼�𝑖′)2               (12) 
 
𝛾𝑎𝑛𝑖𝑠𝑜,𝑖′2 = 12 ��𝛼�𝑥𝑥,𝑖′ − 𝛼�𝑦𝑦,𝑖′ �2 + �𝛼�𝑦𝑦,𝑖′ − 𝛼�𝑧𝑧,𝑖′ �2 + �𝛼�𝑧𝑧,𝑖′ − 𝛼�𝑥𝑥,𝑖′ �2�+ 34 ��𝛼�𝑥𝑦,𝑖′ − 𝛼�𝑦𝑥,𝑖′ �2 + �𝛼�𝑦𝑧,𝑖′ − 𝛼�𝑧𝑦,𝑖′ �2 + �𝛼�𝑧𝑥,𝑖′ − 𝛼�𝑥𝑧,𝑖′ �2� 
                    (13) 
 
IR absorption intensity is proportional to the square of the transition dipole moment 
associated with the respective vibrational transition, so that the IR intensity of the ith 
excitonic mode is calculated as: 
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𝐼𝑖
𝐼𝑅 = 𝜈�𝑜 𝜇𝚤����⃗ ∙𝜇𝚤����⃗𝜁                 (14) 
 
where 𝜁 is a constant that depends on the units of 𝜇𝑖 and 𝜈�𝑜, which is the first moment of 
the entire amide I band profile  In electrostatic units, 𝜁 is equal to 9.2 x 10-39 esu (119). 
 The IR and Raman amide I profiles can be calculated as a superposition of 
Gaussian bands representing the respective bands of the excitonic modes. 
 
 
𝐼𝑖𝑠𝑜(Ω) = ∑ �45 ∙ 𝛽𝑠,𝑖2 ∙ 𝑓𝑖(Ω,Ω𝑜)�𝑛−1𝑖=1              (15) 
 
𝐼𝑎𝑛𝑖𝑠𝑜(Ω) = ∑ [7 ∙ 𝛾𝑖2 ∙ 𝑓𝑖(Ω,Ω𝑜)]𝑛−1𝑖=1  (16) 
         
𝐼𝐼𝑅(Ω) = ∑ [𝐼𝑖𝐼𝑅 ∙ 𝑓𝑖(Ω,Ω𝑜)]𝑛−1𝑖=1            (17) 
            
where: 
 
𝑓𝑖(Ω,Ω𝑜) = 1𝜎𝑖√2𝜋 𝑒𝑥𝑝 �− (Ω−Ω𝑖)22𝜎𝑖2 �             (18) 
 
Here, Ω𝑖 denotes the eigenenergy of the ith excitonic mode in units of cm-1 and 𝜎𝑖 is full 
width at half maximum (FWHM) of the respective band.  It should be mentioned here 
that the choice of Gaussian profiles for the individual excitonic transitions is one of 
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convenience, and in accord with common practice.  The real bands, in fact, exhibit a 
Voigtian profile, with a Lorentzian half-width of ~ 11 cm-1 (104, 120).   
If multiple representative conformations are considered, each configuration of a 
peptide gives rise to an individual band profile.  The total amide I intensity of a peptide 
ensemble thus calculated as a superposition of intensity profiles of co-existing 
conformations, which are weighted with their respective Boltzmann terms according to 
the following equation: 
 
𝐼(Ω) = ∑ ∑ �𝐼𝑖𝑗1𝑗2…𝑗𝑛(Ω)𝑒−�∑ 𝐺𝑗𝑘𝑛𝑘=1 �/𝑅𝑇�𝑛𝑐1 ,𝑛𝑐2…𝑛𝑐𝑛𝑗1,𝑗2…𝑗𝑛=1𝑛𝑖=1
𝑍
             (19) 
 
where 𝐼𝑖𝑗1𝑗2…𝑗𝑛(Ω) is the respective IR or Raman intensity profile of the configuration 
{𝑗1, 𝑗2, … , 𝑗𝑛} calculated from eqs. 15 - 17, Gjk is the Gibbs energy of residue k in the jth 
conformation, and i denotes the respective excitonic state.  R is the gas constant, T the 
absolute temperature, Z is the partition sum of the ensemble, and 𝑛𝑐𝑘  are the number of 
conformations considered for residue k.  The conformation of the C-terminal residue does 
not affect the amide I’ band profiles.  Hence, n excitonic states depend on the 
conformation of n - 1 residues. 
 Vibrational circular dichroism (VCD) intensity is proportional to the rotational 
strength of the ith excitonic state which is the imaginary part of the scalar product 
between the transition dipole and transition magnetic moments of the respective excitonic 
state (121-122): 
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𝑅𝑖 = 𝐼𝑚[?⃗?𝑖 ∙ 𝑚��⃗ 𝑖]               (20) 
 
The generalized equation for the rotational strength of the ith excitonic state for a 
polypeptide containing n – 1 residues is given as (114):  
 
𝑅𝑖 = 𝐼𝑚 �∑ 𝑎𝑖𝑗?⃗?𝑗 �∑ 𝑎𝑖𝑗𝑚��⃗ 𝑗 − 𝑖𝜋2𝑛−1𝑗=1 �∑ ∑ 𝜈�𝑙𝑚𝑇�⃗ 𝑙𝑚𝑛−1𝑚=1 × (𝑎𝑖𝑙?⃗?𝑙 − 𝑎𝑖𝑚𝜇𝑚)𝑛−2𝑙=1 ��𝑛−1𝑗=1 �   (21) 
                   
where j, l, and m indicate local amide I oscillators.  The terms within the third set of 
parentheses reflect the chirality brought about by the magnetic moment at residue l 
induced by the transition dipole moment of residue m.  As an example, the rotational 
strength of a tetrapeptide is given as (114): 
 
𝑅𝑖 = 𝐼𝑚 � 𝑎𝑖𝑗?⃗?𝑗 ��𝑎𝑖𝑗𝑚��⃗ 𝑗 − 𝑖𝜋23
𝑗=1
�𝜈�12𝑇�⃗12 × (𝑎𝑖1?⃗?1 − 𝑎𝑖2𝜇2) + 𝜈�13𝑇�⃗133
𝑗=1
× (𝑎𝑖1?⃗?1 − 𝑎𝑖3𝜇3) + 𝜈�23𝑇�⃗ 23 × (𝑎𝑖2?⃗?2 − 𝑎𝑖3𝜇3)��� 
                      (22) 
 
Here, 𝑚��⃗ 𝑗 and ?⃗?𝑗 are the magnetic and electric transition dipole moments associated with 
the local amide I mode of the jth oscillator.  The first term in the second set of 
parenthesis, namely 𝜈�12𝑇�⃗12 × (𝑎𝑖1𝜇1 − 𝑎𝑖2𝜇2) describes the chirality brought about by 
the magnetic moment at residue 1 induced by the transition dipole moment of residue 2.  
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The terms 𝜈�13𝑇�⃗13 × (𝑎𝑖1?⃗?1 − 𝑎𝑖3?⃗?3) and 𝜈�23𝑇�⃗ 23 × (𝑎𝑖2𝜇2 − 𝑎𝑖3?⃗?3) account for the 
corresponding interaction between the first and the third residue and the second and and 
third residue, respectively.  The VCD profile of the amide I can be calculated as a 
superposition of Gaussians using the expression: 
 
Δ𝜀(Ω) = 𝜈�𝑜
2.3×10−39 ∑ [𝑅𝑖 ∙ 𝑓𝑖(Ω,Ω𝑜)]𝑛−1𝑖=1  (23) 
                 
where 𝜈�𝑜 is the first moment of the entire amide I band profile. 
 
  
P a g e  | 38 
 
1.3.5 AAKA 
 
The amide I’ band profiles in the FTIR, Polarized Raman, and VCD spectra of AAKA in 
D2O were measured at acidic pD and room temperature, and are shown in Figure 8.  
Acidic conditions were chosen to allow for maximal spectral resolution and to avoid the 
instabilities (e.g. precipitation) sometimes encountered at neutral pD.  A comparison of 
the band profiles reveals a significant split between the peak positions of the isotropic 
Raman and IR band profile.  The anisotropic band has its peak between those of the IR 
and isotropic Raman band, but it is slightly closer to the IR band position.  This is typical 
for a peptide with a predominant PPII fraction (114, 123-124).  The respective VCD 
spectrum displays an asymmetric negative couplet with a large negative signal at the 
position of the lowest wavenumber amide I’ sub-band, which is predominantly assignable 
to the C-terminal peptide group (43).  This negative signal reflects, to some extent, an 
intrinsic magnetic moment of the C-terminal amide I’ oscillator, which gives rise to a 
negative Cotton effect even in the spectrum of a dipeptide.  This is illustrated by the 
amide I’ VCD spectrum of L-lysyl-L-alanine (KA) in Figure 9, which was also measured 
at acidic pD.  The 3JCαHNH coupling constants and the respective chemical shifts of 
residues 2 – 4 of AAKA are listed in Table 1.   
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Figure 8:  Amide I’ band profile (dotted) of the isotropic Raman, anisotropic Raman, IR, and VCD spectra of AAKA 
measured at pD = 1.5.  The solid line results from a simulation based on a three-state (per residue) model, 
encompassing PPII, β, and helix-like conformations derived from the coil library of Avbelj and Baldwin (125) (PPII 
and β) and the MD simulations of Duan et al. (91) (helical).  The dashed line was calculated with a two-state model 
(PPII and β).  The band of the C-terminal carbonyl stretching mode has been modeled for the sake of completeness 
by fitting a Gaussian profile to the experimental data with the wavenumber and half-width as free parameters. 
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Figure 9:  VCD spectrum of KA (pD = 1.5).  The solid line results from a fit described in the text. 
 
 
 
 
 
Residue No. 3JCαHNH (Hz) 
2 (Ala) 5.18 
3 (Lys) 6.46 
4 (Ala) 6.72 
 
Table 1:  3JCαHNH NMR coupling constants of the 2
nd, 3rd, and 4th amino acid residues of AAKA. 
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First, the VCD spectrum of KA was analyzed by using: 
 
∆𝜀(Ω) = Ω𝑜𝐼𝑚(𝜇��⃗ ∙𝑚���⃗ )
2.3×10−39𝑀∙𝑒𝑠𝑢2∙𝑐𝑚2 𝑓(Ω,Ω𝑜)                       (24) 
 
where Ω𝑜 is the peak wavenumber of the amide I’ and ?⃗? the electronic and 𝑚��⃗  the 
magnetic transition dipole moment.  𝑓(Ω,Ω𝑜) denotes the Gaussian band profile.  The 
dipole moments reported for cationic KA were utilized (108).  A magnetic dipole 
moment of 2.3 × 10−23 esu cm and an orientational angle of 10° for 𝑚��⃗  with respect to 
the NC axis of the C-terminal residue (69).  The wavenumber and half-width were 
obtained from the respective IR band profile (data not shown).  Thus, the fit of the VCD 
signal visualized by a solid line in Figure 9 was obtained. 
 The excitonic coupling model used to describe the delocalization of the amide I 
mode is described in Section 1.3.4.  In particular, it describes the amide I band profiles of 
IR, isotropic Raman, anisotropic Raman, and VCD in terms of nearest neighbor and non-
nearest neighbor excitonic coupling between the excited states of the local oscillators 
(111) and the dihedral angles φ and ψ of the residues between the interacting amide I 
modes.  The first central residue (starting at the N-terminal) is counted as I and the 
subsequent one as 2.  It should be noted that the two terminal residues are not probed by 
the amide I’ band profile. 
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The total intensity of a peptide ensemble is calculated according to eq. 19 (Section 
1.3.4).  In our analysis, three representative conformations, j, were considered, namely 
PPII (j = 1), β  (j = 2), and helical (j = 3).  The Gibbs energy of PPII was set to zero.  In a 
first step, we based our simulation on (φ, ψ)1 = (-65°, 150°) and (φ, ψ)2 = (-125°, 115°) 
for alanine, which represent their respective distributions in the coil library of Avbelj and 
Baldwin for PPII and β, respectively (125), and correspond to the 3JCαHNH coupling 
constants reported by Shi et al. (81).  For lysine, these authors reported a slightly different 
3JCαHNH value for PPII, which corresponds to φ = -68°.  Coil libraries as well as molecular 
dynamics simulations for alanine dipeptides generally exhibit helical conformations (91).  
These coordinates are closer to a 310 than to a canonical α-helical conformation (126).  In 
the following, we refer to this structural model as the “coil library model.” 
The 3JCαHNH constants of these conformations were utilized, and our 
experimentally determined coupling constants to determine the mole fraction of three 
considered conformations as follows: 
 
𝜒1,𝑘 = �𝐽𝑘−𝐽𝛽,𝑘�−𝜒3,𝑘�𝐽𝛼−𝐽𝛽,𝑘�𝐽𝑝,𝑘−𝐽𝛽,𝑘             (25a)  
𝜒2,𝑘 = 1 − 𝜒1,𝑘 − 𝜒3,𝑘             (25b) 
 
Where 𝜒𝑗,𝑘 is the mole fraction of the kth residue in the jth conformation, 𝐽𝑘 is the 
measured coupling constant of the kth residue, and 𝐽𝑝,𝑘 and 𝐽𝛽,𝑘 are the coil library 
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coupling constants of the kth residue for the PPII and β as reported by Shi et al. (81).  
𝐽𝛼 = 4.1 Hz is the representative coupling constant of the helical conformation 
mentioned above.  The mole fraction, 𝜒3,𝑘, of this conformation has been used as an 
adjustable parameter in the simulation.  The mole fractions were used to calculate the 
relative Gibbs energies of the residues: 
 
𝐺𝑗𝑘 = 𝑅𝑇𝑙𝑛 �𝜒𝑗,𝑘𝜒1,𝑘�                                     (26) 
 
which were used in eq. 21 to calculate the intensity profiles.   
 The amide I’ band profiles of AAKA were simulated assuming solely a 
coexistence of PPII and β for each residue, i.e. 𝜒3,𝑘 = 0.  Cooperativity was not 
considered, in accordance with the isolated pair hypothesis (33) and the temperature 
dependence of the UV-CD spectra reported below.  The nearest neighbor coupling 
constants (5.0 for PPII and 2.5 for β) were taken from the ab initio study on a glycine 
dipeptide by Torii and Tasumi (109).  For PPII, this is in the interval of values observed 
earlier from isotropic Raman and femtosecond IR data of tripeptides (43, 79).  The 
corresponding β-strand coupling constant is slightly lower than that obtained for trivaline 
(79).  The coupling between the N- and C-terminal amide I’ modes was calculated using 
the transition dipole coupling (TDC) formalism (see Section 1.3.4) (103).  The program 
MULTIFIT (127) was used to self-consistently decompose the IR and Raman band 
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profiles in Figure 8 into three bands as described in an earlier study (69) and used the 
respective peak positions as a basis for guessing the wavenumber positions for the 
unperturbed amide I’ modes.  The Gaussian bandwidths for the individual bands were 
also obtained from this analysis.  Moreover, we used the reported electronic transition 
dipole strengths of AA and KA (108).  This yielded band profiles which reproduced the 
IR and Raman data reasonably well (dashed line in Figure 8), though some small 
deviations between simulated and experimental IR band profiles are notable.  The VCD 
simulation, however, totally underestimates the large negative signal, which is much 
more pronounced than in the spectrum of KA.  Additionally, it overestimates the positive 
signal at higher wavenumbers.  A satisfactory simulation required a much larger 
magnetic transition dipole moment for the C-terminal amide I’ mode, i.e. 1.3⋅10-22 esu cm 
(dashed line in the lower panel of Figure 8).  In a third step, we checked for the 
possibility that a small fraction of helical conformations are present in the sample.  
Indeed, we obtained a better agreement for the IR band profile, the highly asymmetric 
shape of which was nicely reproduced with a mole fraction of 0.3 for both residues (solid 
line in Figure 8).  Larger values for χ3,k yield substantial deviations from the 
experimental data in that too much intensity is accumulated at the highest wavenumber 
position, as expected for a predominantly helical band profile (128).  We also checked the 
possibility that only one of the central residues adopts helical conformations, but that did 
not improve the profiles compared with the two-state (PPII/β) simulation.  Thus, our final 
result yields PPII fractions of χ1,1 = 0.63 for alanine and χ1,2 = 0.36 for lysine, the β-
fractions are χ2,1 = 0.07 for alanine and χ2,2 = 0.34 for lysine.  Hence, alanine has a clear 
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PPII propensity, but the values for lysine suggest a statistical coil behavior, in contrast to 
what has been observed for polylysine peptides (41, 50, 95).  
 Additionally, we considered slightly different representative structures for our 
three basic conformations.  The band profiles of a simulation based on the PPII, β and 
helix conformations in Figure 10 emerged from the MD simulation of Garcia, namely 
((φ,ψ)1 = (-60o, 120o), (φ,ψ)2 = (-150o, 120o), and (φ,ψ)3 = (-60o, 60o)), respectively (129).  
The respective 3JCαHNH constants were adjusted using the modified Karplus equation of 
Vuister and Bax (130).  The representative PPII conformation resembles more the 
structure adopted by the first residue in a type II β-turn.  The best reproduction of the 
experimental profiles was obtained with χ3,k = 0.20.  The agreement between simulated 
and experimental profiles is not bad, but small systematic differences are discernable for 
IR, isotropic and anisotropic Raman.  The respective PPII fractions are χ1,1 = 0.60 for 
alanine and χ1,2 = 0.45 for lysine, while the β-fractions are χ2,1 = 0.19 and χ2,2 = 0.35 for 
alanine and lysine, respectively.  Thus, alanine has still a clear PPII propensity.  The 
respective value for lysine is slightly larger than that obtained from the ‘coil library 
model.’ 
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Figure 10:  Amide I’ band profile (dotted) of the isotropic Raman, anisotropic Raman, IR, and VCD spectrum of 
AAKA measured at acidic pD 1.  The solid line results from a simulation based on the three-state (per residue) 
model, encompassing PPII, β, and helix-like conformations derived from MD simulations of Gnanakaran and Garcia 
(90).  The band of the C-terminal carbonyl stretching modes has been modeled for the sake of completeness by 
fitting a Gaussian profile to the experimental data with the wavenumber and half-width as free parameters. 
  
The temperature-dependent UV-CD spectra of AAKA plotted in units of M-1 cm-1 
residue-1 is depicted in Figure 11.  In contrast to what has been obtained for the heavily 
debated XAO peptide, the spectra exhibit the characteristic minimum (195 nm) and 
maximum (215 nm), which is diagnostic of a substantial PPII contribution (131).  
Compared with tetraalanine, however, both the maximum and minimum are reduced by a 
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factor of 2 and 3, respectively (69).  This is qualitatively consistent with the much larger 
PPII fraction reported earlier for tetraalanine. 
 
 
Figure 11:  Temperature-dependent UV-CD spectra of AAKA at pD = 1, measured from 20 to 80°C at 10° intervals. 
  
 
It should be emphasized that the two sets of representative structures considered 
above are most likely part of a distribution of conformations assignable to different 
basins in the Ramachandran plot.  More realistic models require the consideration of 
distributions of conformations centered about the basins of the Ramachandran map, 
whose maxima have been considered here as representative conformations.  More recent 
studies in our laboratory rely on an extension of the currently employed model which 
utilizes two-dimensional Gaussian distributions of conformations from different regions 
of Ramachandran space, instead of representative sets of dihedral angles (120, 132).   
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Different coil libraries and results from MD simulations are far away from 
agreeing with each other with respect to the corresponding mole fractions and distribution 
widths of the sampled conformations.  A classical random coil distribution of e.g. 
alanine, as it emerged from the work of Ramachandran et al. (88) and Brant and Flory 
(89) can definitely be ruled out from our experimental data.  We also considered the 
possibility of various turn conformations to contribute to the AAKA ensemble.  The 
agreement with the experimental profiles was poor at best even if only small fractions of 
e.g. β-turns were considered. 
 
1.3.6 Tetra- (A4) and Tri-alanine (A3) 
 
In the past, Schweitzer-Stenner and associates have used a somewhat less advanced 
model to determine the average structure of tri- and tetrapeptides, in that they identified 
the dihedral angles which reproduce the intensity ratios of the individual amide I’ sub-
bands derived from spectral decomposition (44, 69, 79).  The result was subsequently 
interpreted in terms of a two state model, which considered solely PPII and an extended 
β-strand conformation, which is different from the more parallel β-sheet like dihedral 
angles used in the present study.  Therefore, we felt a necessity to re-analyze both tetra- 
and trialanine by means of our statistical model.  The earlier reported band profiles of 
(cationic) tetraalanine and (zwitterionic) trialanine are depicted in Figure 12 and Figure 
13, respectively.  Additionally, we measured the 3JCαHNH coupling constants for 
tetraalanine; these values are listed in Table 2, while the coupling constant for the central 
alanine residue in AAA (i.e 5.6 Hz) was taken from a study by Graf et al. (133).  Again, 
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we used these constants to restrict the simulations of the band profiles by means of eqs. 
21 – 23.  In a first step, we considered the representative conformations of the ‘coil 
library model’ and obtained insufficient agreement with the experimental data, 
irrespective of our choice of the helical fraction.  That particularly concerned the IR and 
anisotropic Raman band profiles, for which the relatively large intensity of the lowest 
wavenumber band could not be reproduced.  For tetraalanine, however, we could obtain 
quite good agreement with the experimental profiles by using the representative 
conformation obtained in our earlier study (with φ angles of -70o and -80°), but this is not 
consistent with the observed 3JCαHNH coupling constants listed in Table 2.  Inclusion of 
any of the different types of turns in the simulation led to poorer agreement with the 
experimental data.  Subsequently, we decided to modify the coordinates of the 
representative PPII conformations and finally obtained the simulation in Figure 12 for 
tetraalanine, by assuming that the difference between the 3JCαHNH coupling constants 
reflects different PPII coordinates rather than different conformational mixtures.  The 
agreement with the experimental data can be considered as satisfactory.  The respective 
PPII conformations are (φ,ψ)11 = (-65o, 150o) and (φ,ψ)12 = (-70o, 140o).  Helical 
contributions had to be considered, and we obtained different fractions for the two 
residues, namely χ3,1 = 0.20 for the first and χ3,2 = 0.10 for the second of the non-terminal 
alanines (counted from the N-terminal).  The PPII mole fractions are χ1,1 = 0.66 and χ1,2 = 
0.73, while the β-fractions are χ2,1 = 0.14 and χ2,2 = 0.17.  With respect to PPII, this is less 
than what was estimated in our earlier study, but the result still corroborates the notion 
that alanine has a high PPII propensity, contrary to recent claims (87).  Additionally, we 
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simulated the profiles with the coordinates representing the distributions of Gnanakaran 
and Garcia (90), but this did not reproduce any of the experimental profiles.  
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Figure 12:  Amide I’ band profile of the isotropic Raman, anisotropic Raman, IR, and VCD spectrum of tetra-alanine 
(AAAA), measured at acidic pD = 1 (taken from ref(69)).  The solid line results from a simulation based on a three-
state (per residue) model, encompassing PPII, β, and helix-like conformations as described in the text.  The band of 
the C-terminal carbonyl stretching modes has been modeled for the sake of completeness by fitting a Gaussian 
profile to the experimental data with the wavenumber position and half-width as free parameters. 
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Figure 13:  Amide I’ band profile of the isotropic Raman, anisotropic Raman, IR, and VCD spectrum of AAA 
measured at neutral pD = 6 [taken from ref(79)].  The solid line results from a simulation based on a three-state 
(per residue) model, encompassing PPII, β, and helix-like conformations as described in the text.   
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Residue No. 3JCαHNH (Hz) 
2 5.50 
3 6.03 
4 6.92 
 
Table 2:  3JCαHNH NMR coupling constants of the 2
nd, 3rd, and 4th amino acid residues of tetraalanine (AAAA). 
 
 
For tetraalanine, NOESY cross-peaks are observed in the HN-Hα, HN-HMe and Hα-
HMe regions, the first one being the most relevant for conformational analysis. In fact, as 
far as the internal residues are concerned, the HN-Hα intra-residue cross-peaks are much 
less intense than the inter-residue ones, suggesting that the latter are characterized by (ϕ, 
ψ) angles in the PPII and/or in the β sheet Ramachandran region, for which  𝑑𝐻𝛼𝑖𝐻𝑁(𝑖+1) 
distances are shorter than 𝑑𝐻𝛼𝑖𝐻𝑁𝑖 (91). Moreover, the absence of measurable NOE’s in 
the amide-amide region excludes the presence of appreciable amounts of α-helix 
conformers.  These results corroborate in general terms the analysis of the vibrational 
spectra. 
With respect to trialanine, Eker et al. reported a 50:50 mixture of PPII and β (79), 
but this cannot be reconciled with the 3JCαHNH coupling constant of 5.6 Hz.  The rather 
satisfactory simulation depicted in Figure 13 was obtained with a slightly modified PPII 
conformation, namely (φ,ψ)11= (-60o, 150o), while the other coordinates of the ‘coil 
library model’ remained unchanged.  This PPII conformation is very close to the values 
reported in the early study of Woutersen and Hamm (43).  The helical fraction of χ3 = 
0.20 is a necessity.  The respective PPII and β fractions are χ1 = 0.60 and χ2 = 0.20, 
respectively.  Again, we also tried to simulate the profiles with the coordinates 
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representing the distributions of Gnanakaran and Garcia (90), but the result was less 
satisfactory. 
 It is noteworthy that the C-terminal 3JCαHNH coupling constants of AAKA and 
AAAA (6.7 and 6.9 Hz) are slightly higher than the corresponding value obtained for AA 
(6.5 Hz) (134).  All these values are higher than those of the central residues of the 
investigated peptides.  We interpret this as indicating that terminal residues are more 
likely to sample β-strand like conformations, which yield an increase of 3JCαHNH.  If one 
invokes the two-state coupling model of Shi et al. (81) and the 3JCαHNH constants of 
Avbelj and Baldwin (125), all these values are still indicative of a high percentage of 
polyproline II, as argued by Dragomir et al. (135). 
Taken together, all of these analyses demonstrate that the combination of our 
vibrational spectroscopy approach with NMR data (i.e. 3JCαHNH) is very powerful in 
identifying the conformational manifold of amino acid residues in peptides.  This strategy 
takes advantage of the site specific information provided by NMR, along with the high 
sensitivity of the amide I band profiles concerning even modest variations of the 
secondary structure.  In this context we would like to emphasize that this stems in part 
from the fact that second nearest neighbor vibrational coupling (i, i + 2) is not 
insignificant, particularly for the helical and the β-conformation. 
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1.3.7 Discussion and Comparison with Literature 
 
As mentioned above, the UV-CD spectra of various unfolded alanine based peptides 
exhibit the characteristic feature indicative of a substantial fraction of PPII (41).  The 
much discussed XAO peptide is somewhat of an exception from the rule in that its 
maximum at 216 nm is substantially reduced, which suggests the presence of other 
conformers (128).  This and other experimental data for this particular peptide led 
Makowska et al. (87) and Vila et al. (136) to the conclusion that alanine does not have a 
substantial PPII propensity.  The results of the present study strongly corroborate the 
opposite notion.  The PPII mole fraction of alanine was found to vary between 0.60 and 
0.75 for the peptides investigated.  These values are somewhat lower than those reported 
by Shi et al for XAO (45), but still large enough to consider a PPII preference of alanine.  
Our analysis also corroborates the notion that the PPII propensity depends on the number 
of alanine residues, owing to a higher PPII propensity of alanine in AAAA compared 
with that of AAA (and AA (134)), in line with theoretical predictions of Garcia (129) and 
Raman optical activity (ROA) data reported by McColl et al. (68). 
 The sampling of helical conformations by alanine in short peptides has been a 
matter of debate.  Thus far, it has been overlooked in the studies of Kallenbach, 
Schweitzer-Stenner, and their respective associates.  MD simulations, however, generally 
reveal a sampling of the helical basin of the Ramachandran plot (mostly right handed), 
but the respective fraction does depend strongly on the choice of the force field (85).  
Woutersen et al. investigated the spectral broadening of amide I of trialanine and arrived 
at the conclusion that their sample of AAA contained 20% αR and 80% PPII (137).  Our 
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own analysis for this peptide yields the same helical fraction, but a lower PPII propensity.  
The mixture reported by Woutersen et al. would be inconsistent with our amide I’ 
profiles and UV-CD data.  Mu and Stock performed MD simulations with a GROMOS 
43A1 force field and obtained χ1 = 0.41 (PPII), χ2 = 0.41 (β), and χ3 = 0.16 (helical), for 
the central residue (138).  This is close to our earlier reported 50:50 mixing of PPII and β, 
but, as argued above, inconsistent with the 3JCαHNH coupling constant.  Duan et al. (91) 
used the force field of Cornell et al. (139) to carry out a MD simulation for an alanine 
dipeptide and a blocked alanine tetrapeptide in explicit water.  For the dipeptide they 
obtained comparable populations of PPII and the (right handed) helical fraction with a 
minor population of β.  For the tetrapeptide, these three basins are nearly equally 
populated, so that their plot looks like the classical random coil distribution, which 
Ramachandran et al. (88) and Brant and Flory (89) obtained for the alanine dipeptide.  
All these results are inconsistent with our experimental data.  The discrepancy is even 
more pronounced for simulations which Hu et al. (140) and Zagrovic et al. (86) 
performed with different Amber, Charm and Gromos force fields for an alanine dipeptide 
and XAO, respectively.  Kentsis et al. used a CHARM27 force field to calculate the 
propensities of all natural amino acids in GGXGG peptides (141).  The so estimated 
alanine propensity for PPII is quite low (30%). All these simulations yield an 
overestimation of the helical fraction and an underestimation of PPII.  Tran et al. used 
their own potential function and Monte Carlo simulations to obtain a mixture of nearly 
50% PPII, 30% β (i.e. with angles of a parallel β-sheet) and approximately 18% helical 
conformations (36).  This is closer to our results, but their PPII fraction contains a 
substantial amount of a conformation termed Phyp, which exhibits lower ψ and φ values 
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than the canonical PPII.  Such conformations would exhibit a very low level of excitonic 
coupling for amide I (109) and are therefore not likely to contribute significantly to the 
observed amide I band profiles.  Gnanakaran and Garcia used a modified AMBER force 
field (A94/MOD) to simulate the sampling of polyalanine peptides of different length 
(90).  For the alanine dipeptide they observed a mixture of χ1 = 0.59 (PPII), χ2 = 0.14 (β), 
and χ3 = 0.20 (helical); for AAA they observed χ1 = 0.80 (PPII), χ2 ≈ 0.08 (β), and χ3 ≈ 
0.08 (helical).  Their result for the alanine dipeptide is very close to what we observed for 
the central residue of AAA, but even their result for AAAA is much closer to ours than 
all the other simulations discussed above.  Finally, it deserves to be mentioned that our 
results are in very good agreement with the PPII, β and helix population of alanine in the 
(reduced) coil library of Serrano (61), but are inconsistent with those in the library of 
Fiebig et al. (84). 
 We would also like to note the remarkable similarity between the dihedral angles 
which were used in the current study to simulate the vibrational spectra of tetraalanine 
and those reported recently by Pizzanelli et al. (142).  The authors performed a DFT 
calculation for tetraalanine in implicit and explicit solvent (14 water molecules).  The 
most stable conformation obtained was clearly PPII like; the respective coordinates are 
(φ,ψ)11 = (-57.6o, 145.0o) and (φ,ψ)12 = (-68.8o, 138.4o) for the central residues.  This is 
not only close to the values obtained in the present study, but also reproduces the small 
difference between the two PPII conformations of the central residues, which we inferred 
from our data.  The predominance of PPII was then confirmed by 1H NMR spectroscopy 
by measuring the dipolar couplings of tetraalanine in an oriented lyotropic liquid crystal.  
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The DFT calculations revealed a conformation with both residues in a helical 
conformation as the second one in the conformational hierarchy.    The close resemblance 
between these values and those which we report affirm the merit of our current model, as 
well as support the PPII propensity of alanine. 
The low PPII propensity observed for the lysine residue in AAKA is somewhat 
surprising since earlier studies on charged polylysine peptides of different lengths were 
all in agreement in suggesting a high PPII propensity (41, 50, 95).  That this property 
might depend on the choice of the nearest neighbors has already been indicated by Eker 
et al., who showed that K in AKA adopts β-strand like conformations at neutral pD, 
whereas PPII is preferred at acidic conditions (48).  More recently, Measey and 
Schweitzer-Stenner (143) showed that the average PPII fraction of the octa-peptide, 
(AAKA)2, is 60%, which is lower than expected based on results of previous 
spectroscopic studies of short alanine-based peptides (45, 69).  We investigated AAKA at 
acidic conditions and showed that K samples PPII, β and helical conformations.  This 
resembles the statistical coil concept of Zimmerman and Scheraga (34-35).  The reason 
for this behavior might be that lysine perturbs the order of the hydration shell which has 
been suggested to stabilize PPII in polyalanine peptides (144).  Generally, our result 
shows that nearest neighbor effects are relevant for individual propensities of amino acid 
residues and that a PPII preferring neighbor does not necessarily support the PPII 
propensity of a given residue. 
 Taken together our study provides compelling evidence for a significant PPII 
propensity of alanine in AAKA, AAAA, and AAA, while it reveals a context dependent 
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behavior of lysine, which deserves further investigations.  Furthermore, we showed that 
alanine samples, to some extent, also (right handed) helical conformations, in line with 
predictions of Gnanakaran and Garcia (90), Mu and Stock (138) and Woutersen et al 
(137).   We would like to emphasize, however, that our results do not argue in favor of a 
somewhat simplistic notion that the structure of unfolded alanine peptides is PPII, as 
suggested in a recent paper of Asher et al. (145).  If the individual PPII mole fraction of 
alanine is as high as 0.73 (as obtained for AAAA), the molar fraction of XAO with all 
alanines in PPII is 0.11.  The corresponding fractions for six, five and four residues are 
0.08, 0.095 and 0.12, respectively.  Thus, nearly 40% of the peptides exhibit PPII 
sequences of 6 and more.  This is not insignificant.  One has to take into account, 
however, that conformational fluctuations are significant on the PPII potential surface, 
i.e. a PPII segment is still a dynamic entity.  Nevertheless, it is justified to state that the 
classical random coil or even the statistical coil concept does not apply to alanine, and 
evidence exists that it does not apply to other types of residues either (61-62).   
 
1.3.8 The Hepta-Alanine-Containing XAO Peptide 
 
The amide I’ band profiles of the IR, isotropic Raman, anisotropic Raman, and VCD 
spectra of XAO in D2O (pD = 2.2) are shown in Figure 14.  We observed a clear non-
coincidence between the isotropic and IR-band profiles, which suggests that the peptide 
predominantly samples the upper left quadrant of the Ramachandran plot.  The 
anisotropic band is very broad and does not display the clearly discernable peak position 
in between the wavenumber positions of the IR and isotropic Raman bands, which has 
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been shown to be diagnostic of PPII (114, 123, 128).  The VCD spectrum displays the 
usual negative couplet of so called unfolded peptides and proteins, but it is less 
pronounced than those observed for e.g. AAA, AAAA, AAKA and (AAKA)2 (43, 48, 69, 
143, 146).  The rotational strength per residue is substantially smaller than that observed 
for the amyloid peptide fragment Aβ1-28, which has been shown to contain a substantial 
PPII content (108, 123, 128), but similar to that of salmon calcitonin, which more closely 
resembles a statistical coil (128).  All of these observations suggest that XAO has much 
less PPII content than suggested by Kallenbach and associates (45). This notion is 
corroborated by the UV-CD spectra of XAO at 20°C, as shown in Figure 15. As already 
argued by Vila et al. (136), the spectra show the minimum at 195 nm, which is associated 
with PPII, but do not display the maximum at 216 nm, which is diagnostic of this 
structure.  With respect to the minimum, the corresponding ∆ε value (per residue) is 
much less pronounced than that observed for AAAA (triangles in Figure 2) (See Section 
1.3.6), and slightly smaller than that obtained for Aβ(1-28) (123, 146). 
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Figure 14:  Experimental isotropic and anisotropic Raman, FTIR, and VCD spectra of the amide I’ band region of 
XAO, pD = 2.2 (dotted), and band profiles simulated by using the two-state per residue model (PPII/β), in line with 
the results of Shi et al. (45). 
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Figure 15:  Temperature-dependent UV-CD spectra of XAO (pD = 2.2) at 20°C (solid), 40°C (dotted), 60°C (dash), and 
80°C (dash dot dot dash).  For comparison, the spectrum of tetraalanine (pD = 1) at 20°C is also shown (triangles).  
The inset shows the difference spectrum of XAO obtained by subtracting the spectrum at 20°C from that measured 
at 80°C. 
 
 
We performed a detailed analysis of the amide I’ band profiles based on a 
statistical model which assumes a blend of different conformations per residue.  This 
approach is a substantial refinement of more crude models which were used previously to 
analyze the profiles of longer peptides (95, 123), and an extension of a recently applied 
simple statistical model (146).  The model is based on the following representative 
conformations: (a) PPII with (φ,ψ) = (-68o, 150°), (b) β-strand with (φ,ψ) = (-119o, 113o), 
(c) various β-turn conformations, i.e. type I’ ((φ,ψ)i  = (60o, 30o), (φ,ψ)i+1 = (90o, 0o)), type 
II  ((φ,ψ)i = (-60o, 100o), (φ,ψ)i+1 = (80o, -10o)), type III  ((φ,ψ)i  = (-60o, -30o), (φ,ψ)i+1 = (-
60o, -30o)), type III’  ((φ,ψ)i  = (60o, 30o), (φ,ψ)i+1 = (60o, 30o)), type V ((φ,ψ)i = (80o, -
80o), (φ,ψ)i+1 = (-80o, 80o)) and a conformation representing the bridge region between 
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the upper left quadrant and the helical region of the Ramachandran plot  ((φ,ψ)i = (-
20o,20o), (φ,ψ)i+1 = (20o,20o)), which emerged from the simulations of Makowska et al. as 
part of the heterogeneous manifold of so called type IV turns (87).  The coordinates for 
PPII, β-strand, and 310 (type III) correspond to maxima of distributions inferred from coil 
libraries (125).  The turn structures represent the structural manifolds sampled by MD 
simulations of Makowska et al. (87).   
 The total intensity of an amide I’ band profile at a given wavenumber is written in 
terms of the above considered statistical ensemble, and calculated according to eq. 19 
(Section 1.3.4).  In our analysis we considered PPII (j=1) and β-strand (j=2) for all 
residues.  For residues 3, 4, 7, and 8 (all alanines), we additionally considered type IV 
(j=3), type III (j=4) (type III’ for residue 3), type V (j=5), type II (j=6), and type I’ (j=7).    
For residues 2 (X), 5, 6, and 9 (all Ala) we allowed type III’ and type IV turns as 
additional conformations.  This blend represents, more or less, different clusters which 
emerged from the MD simulations of Makowska et al. (87). Their results suggest a 
limited sampling of conformations involving intrapeptide hydrogen bonding, hence this 
possibility was disregarded for the sake of simplicity. These authors did not obtain 
substantial fractions of right handed helix-like conformations for alanine residues, but 
some coil libraries and many MD simulations indicate that alanine significantly samples 
helix like conformations (136).  We used the 3JCαHNH coupling constants reported by Shi 
et al. (45) to restrict the choice of possible conformational mixtures by calculating: 
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𝐽3 𝑘 = ∑ 𝜒𝑗𝑘 ∙ 𝐽𝑗𝑘𝑛𝑐𝑘𝑗𝑘                (27) 
 
where 3Jk is the experimental coupling constant obtained for the k-th residue, 
kjχ is the 
mole fraction of the j-th conformation of the k-th residue and 3
kjJ is the respective 
coupling constant. 
For the simulation of the band profiles, we used the nearest neighbor coupling 
∆i,i+1 constants which Torii and Tasumi obtained from ab initio calculations on a glycine 
dipeptide (109).  These coupling constants have been shown to agree well with 
experimentally derived values for short peptides (43, 111).  The non-nearest neighbor 
coupling constants δi,j were calculated by using the transition-dipole-coupling (TDC) 
formalism. We used the intrinsic amide I’ wavenumber position of the central alanine 
residue of tetraalanine in water as a reference for the PPII conformation of alanine (69).  
For the two charged residues, X and O, we estimated the respective intrinsic 
wavenumbers by utilizing the wavenumber difference between K and A obtained from 
the anionic dipeptides AA and KA (108).  The intrinsic wavenumbers for the other 
conformations considered in this study were obtained by considering their conformational 
dependence obtained by DFT studies on alanine dipeptides (112).  The intrinsic dipole 
strengths of the individual amide I’ modes were obtained from the dipeptide study of 
Measey et al. (108).  Here, we used K as a model for X and O. Thus, we calculated the IR 
absorption and the vibrational circular dichroism in absolute units.  Finally, we utilized 
the earlier obtained (relative) Raman tensors for AA (for A) and KA (for X, O) to 
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calculate the ratio of anisotropic and isotropic Raman scattering.  Parameters used in the 
simulation can be found in Table 3. 
 
 
Parameter Value 
Alaµ  19 -12.7 10  esu cm−×  
Lysµ  19 -13.0 10  esu cm−×  
 Alaν  -11658 cm  
 Lysν  -11664 cm  
α∆  -112.0 cm  
103
∆  -13.1 cm  
PPII∆  -110.0 cm  
sβ
∆  -12.6 cm  
TypeI∆  
-1 -17.0 cm ,  2.0 cm  
TypeII∆  
-1 -1-3.0 cm ,  -2.0 cm  
TypeIII∆  
-1 -18.0 cm ,  8.0 cm  
TypeIV∆  -1-10.0 cm  
TypeV∆  
-1 -1-1.0 cm ,  20.0 cm  
 
 
Table 3:  Parameters used in the simulation of XAO, including dipole moments (µ), wavenumber positions (𝝂�), and 
nearest-neighbor coupling constants (∆).  The two coupling constant values listed for the turn conformations, i.e. 
types I-V, are for residues i and i + 1 of the turn, respectively. 
 
 
We started the analysis by first testing the model of Shi et al. (45), which invokes 
a two-state model per residue, namely PPII and β-strand.  In this case the measured 
3JCαHNH coupling constants determine the respective molar fractions. The result of this 
simulation is depicted in Figure 14.  Apparently neither the asymmetry of the IR nor that 
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of the isotropic Raman band profile is reproduced. The width of the anisotropic band 
profile is also not accounted for.  Only the VCD signal is close to the experimentally 
obtained couplet.  This simulation provides compelling evidence for the above 
formulated supposition that the two-state model of Shi et al. (45), which yields very high 
PPII fractions for the alanine residues (between 0.65 and 0.95), is not in agreement with 
our data.  We calculated the corresponding average end to end distance by utilizing: 
 
𝑅 = ∑ ∑ �𝑟𝐶𝑁,𝑘,𝑚 + 𝑟𝐶𝐶𝛼,𝑘,𝑚 + 𝑟𝐶𝛼𝐶,𝑘,𝑚�𝑓𝑚10𝑘=1𝑄𝑚=1                       (28) 
 
where m labels a given sequence of PPII and β-strand residues, and fm is the fraction of 
the sequence m. The total number of sequences for the two-state model is Q = 1024.  The 
vectors denote the length and orientations of the CN, NCα, and CαC bonds with respect to 
a coordinate system defined in Section 1.3.4.  Eq. (26) neglects the C-terminal residue 
for which we do not have any data. For the two-state model we obtained 30 Å, which far 
exceeds that of 18.1 Å, derived from the radius of gyration of 7.4 Å, as obtained from 
SAXS data (86). 
 In a second step, we performed a simulation which considered the entire above 
mentioned conformational manifold, containing representatives of all the local turn 
structures which emerged from the MD simulations of Makowska et al. (87).  We used 
the result of these simulations to initially guess the mole fractions of the respective 
residue conformations and subsequently varied them to optimize the simulations with 
respect to the measured profiles. This yielded a reasonable reproduction of the IR band 
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profile, but the asymmetry of the isotropic band profile, the band profile of anisotropic 
scattering, and the observed non-coincidence between isotropic Raman scattering and IR 
absorption, were all not accounted for.  Moreover, the VCD signal was nearly eliminated 
in all of these simulations. This is per se an important result in that it indicates that a 
pronounced amide I’ VCD signal is inconsistent with a statistical coil sampling, in 
agreement with arguments by Dukor and Keiderling (59). 
 In the third and final step, we somewhat reduced the number of sampled 
conformations for all residues. Table 4 lists the (representative) conformations and the 
respective optimized mole fractions considered for this simulation. With respect to the 
turn structures, we confined ourselves to β-turn type III’ for residues 2 and 3 (XA), type 
III for residue 4 (A), type IV for residues 2-9 (X2A7O2), and type V for residues 2 and 3 
(XA).  PPII and β-strand conformations were considered for all residues.  Altogether, we 
thus considered 142,884 different peptide conformations.  Figure 16 shows the best set 
of profiles obtained from simulations based on this structural model. The two Raman 
profiles are nearly perfectly reproduced. The simulated IR-band profile is slightly broader 
than the experimental one and the negative part of the VCD couplet is somewhat 
underestimated. Nevertheless, the agreement between experiment and simulation is more 
than satisfactory, particularly in view of the fact that the utilized structural model is still 
crude, since it considers only representative conformations rather than distributions.     
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Residue PPII β-strand β-turn  
type III 
β-turn  
type III’ 
β-turn  
type IV 
β-turn  
type V 
β-turn 
type II 
β-turn 
type I 
1 0.64 0.35       
2 0.46 0.29   0.25    
3 0.21 0.09  0.20 0.25 0.15 0.05 0.05 
4 0.03 0.32 0.15  0.25 0.15 0.05 0.05 
5 0.68 0.12   0.2    
6 0.66 0.14   0.2    
7 0.57 0.18   0.25    
8 0.46 0.29   0.25    
9 0.77 0.12   0.11    
10 0.55 0.35       
 
Table 4:  Molar fractions of different residue conformations used to simulate the amide I’ band profiles of XAO. 
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Figure 16:  Experimental isotropic and anisotropic Raman, FTIR, and VCD spectra of the amide I’ band region of XAO 
(pD = 2.2) (dotted) and the band profiles simulated by using the conformations listed in Table 4. 
 
   
We used eq. (26) to calculate the end to end distance associated with the 
considered conformational blend, and obtained a value of 19.1 Å.  This is in excellent 
agreement with the values derived from the SAXS experiment (86), and underscores the 
suitability of our analysis.  
 The temperature dependence of the UV-CD spectra (Figure 15), and of the 
3JCαHNH coupling constants, as observed by Shi et al. (45), has been interpreted as 
indicating a larger fraction of β-strand at higher temperatures.  Figure 17 compares the 
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IR, Raman, and VCD band profiles measured at 25o (black) and 65o C (red). In order to 
compare these profiles, we have to consider a wavenumber upshift of amide I’ of 4 cm-1 
for this temperature interval, which is due to anharmonic coupling to a low frequency 
mode involving the hydrogen bonds to water molecules (67), which was accounted for by 
downshifting the profiles measured at 65o C by this amount. The remaining difference 
between the experimental profiles at 25° and 65° should result from changes of the 
equilibrium between different conformations. Apparently, the first moments of the 
experimentally observed anisotropic Raman and IR band profiles, and to a lesser extent 
also that of the isotropic Raman band profile, are at lower wavenumbers than those of the 
respective solid line profiles in Figure 17. For IR, the high temperature band profile is 
more asymmetric. The non-coincidence between the peak positions of the IR and 
isotropic Raman profiles is reduced from 20 cm-1 (at 25o C), to 14 cm-1 (at 65o C). The 
VCD couplet is reduced at high temperatures.  All these observations are consistent with 
the notion that a β-strand conformation is more populated at higher temperatures.  This 
conformation gives rise to a reduced nearest neighbor coupling, which leads to the 
observed reduction of the IR/isotropic Raman non-coincidence and also of the VCD 
signal.  The reduced wavenumber shift at high temperature is consistent with the results 
of DFT calculations, which predict that amide I’ exhibits a slightly lower wavenumber 
position in the β-strand conformation than in PPII (147).  
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Figure 17:  Comparison of the experimental isotropic and anisotropic Raman, FTIR, and VCD amide I’ band profiles 
of XAO (pD = 2.2) at 25°C (solid line) and 65°C (dotted line).  For comparison, the spectra at 65°C were downshifted 
by 4 cm-1. 
 
 
The result of their MD simulations led Makowska et al. to the conclusion that 
polyproline II is only one of many possible conformations sampled by alanine residues, 
and that the notion of a PPII propensity for alanine has to be rejected (87).  This finding 
is at variance with results obtained from experimental investigations on short peptides 
(48, 69, 95), which are clearly indicative of a PPII propensity for alanine, in accordance 
with recent MD simulations of Garcia and coworkers (85, 90). On the other hand, it was 
clear that the radius of gyration value obtained from SAXS experiments was inconsistent 
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with a predominant PPII population for all alanine residues of the XAO peptide. Our 
results strongly indicate that the truth lies between the extremes invoked in the studies of 
Shi et al. (45) and Makowska et al. (87).  The blend used for the simulation depicted in 
Figure 16 still exhibits a substantial PPII fraction for residues 1 and 5-10.  As a matter of 
fact, this is the only way to explain the significant non-coincidence between IR and 
isotropic Raman peak positions, which reflect the average nearest neighbor coupling. 
This can only be achieved by a substantive fraction of PPII like conformations (124, 
143).  In particular, in the PPII conformation the amide I transition dipole moments are 
oriented nearly perpendicular to the helix axis, giving rise to strong IR intensity in the 
low-wavenumber amide I mode, E1 (109).  The high wavenumber in-phase amide I 
component, A, however, has a strong intensity in the Raman spectrum, resulting in a non-
coincidence between the peaks of the amide I bands in the IR and isotropic Raman 
spectra (109).   
Our results also agree to some extent with Makowska et al., in that the 
consideration of turn-like conformations is necessary to explain our experimental results 
(87). We invoked the results of these authors in assuming that type III’ and V turn 
structures predominantly involve residues 2, 3 and 4, but we would have obtained similar 
results if we had selected another pair of residues.  Makowska et al. obtained substantial 
type IV β-like conformations for residues 3-10 (87).  In principle, this is a rather 
heterogeneous class of conformations, containing all turn like structures which are 
different from types I, II, III, and V, or their stereo-isomers. From the center of this 
region, we selected a representative conformation, i.e. (φ, ψ) = (-20o, 20o), which allows 
negative nearest neighbor coupling between amide I oscillators. The consideration of 
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negative coupling is absolutely necessary for reproducing the asymmetry of the isotropic 
Raman band. 
 Taken together, our results suggest that longer alanine peptides can be more 
heterogeneous than one would expect based on the analysis of short peptide fragments. A 
re-investigation of tri- and tetraalanine (see Section 1.3.6) suggested that a substantial 
population of turn structures is inconsistent with our spectroscopic data (146).  The 
reason for the local turn propensity of alanine in XAO still needs to be explored. That the 
properties of XAO might reflect some general properties of unfolded alanine based 
peptides is underscored by a recent, very elegant ESR study on the unfolded state of  
P2HG3WP(A4K)2CA4KA by Jun et al. (93), which also indicates a much smaller end to 
end distance than expected for an extended molecule.  The results of the present study 
might indicate that alanine shows a propensity for turn conformations in the vicinity of 
charged residues (e.g. X). The possibility of turn formations as initiation of protein 
folding had been discussed in detail by Wright et al. (148), in view of their NMR studies 
on unfolded peptides and proteins.  The undeniable occurrence of turn structures, 
however, cannot obscure the fact that alanine still exhibits a substantial PPII propensity in 
longer peptides, which is in full accordance with findings derived from the coil libraries 
of Serrano (61) and Jha et al. (80), but at variance with the more ‘disordered’ library 
reported by Dobson and coworkers (84).   
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1.4 Materials and Methods 
 
1.4.1 Materials 
 
H-(Ala-Ala-Lys-Ala)-OH (AAKA) was custom synthesized by Celtek Peptides 
(Nashville, TN), with a purity of > 98%.  The peptide contained a small amount of TFA, 
which was removed by dialysis in a Spectra/Por CE Float-A-Lyzer bag, and the peptide 
was lyophilized overnight.  For IR, VCD, and Raman measurements, the peptide was 
dissolved at a concentration of 0.1 M, in 0.025 M NaClO4 in D2O (pD = 1), where the 
ClO4- Raman peak at 934 cm-1 was used as an internal standard (149), and the D2O was 
made acidic by addition of DCl.  Both D2O and DCl were obtained from Sigma-Aldrich.  
After addition of the peptide, the solution had pD = 1.5.  The pD values were determined 
by utilizing the method of Glasoe and Long to correct the values obtained from pH 
electrode measurements (150).  
 L-lysyl-L-alanine (KA) was purchased from Bachem Bioscience, Inc (> 96 % 
purity).  The peptide was dissolved in D2O at a concentration of 0.2 M (pD = 1.1). 
Ac-(Daba)2-(Ala)7-(Orn)2-NH2 (XAO) was obtained as a gift from the laboratory 
of Dr. Pandé at Stanford University.  In order to remove residual TFA, which absorbs in 
the vicinity of the amide I region, the peptide was dialyzed in a 1 mL Spectra/Por CE 
Float-A-lyzer dialysis bag , with a MWCO of 500, and lyophilized overnight.  For 
Raman, FTIR, and VCD experiments, the peptide was dissolved at a concentration of 
25.1 mg/mL in acidified D2O.  The pD of the resulting peptide solution was 2.2.  For UV-
CD measurements, the peptide solution was diluted 10-fold, with acidified D2O. 
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1.4.2 Polarized Raman Spectroscopy 
 
The polarized Raman spectra were obtained with the 442 nm (32 mW) excitation from a 
HeCd laser (Model IK 4601R-E, Kimmon Electric US).  The laser beam was directed 
into a RM 100 Renishaw confocal Raman microscope, and focused onto a 1.0 mm Q 
Silica cell with a thin glass cover slip using a x50 objective.  The scattered light was 
filtered with a 442 nm notch filter, dispersed by a single-grating 2400 l/mm grating and 
imaged onto a back-thinned Wright Instrument CCD.  It was polarized by a combination 
of a linear polarizer and a λ/2 plate.  The latter rotates the y-polarized light 
(perpendicular to the laser polarization) into the x-direction to achieve an optimal 
spectrometer transmission.  All spectra were recorded in the ‘continuous’ mode.  At least 
5 scans were measured for each peptide sample for both polarization directions.  All 
spectra were averaged for each polarization direction in order to eliminate some of the 
noise.  The reference spectra were appropriately subtracted from the sample spectra.  
High temperature Raman measurements were carried out using an LTS-350 temperature 
controlled microscope slide holder from Linkam (UK).  
 
1.4.3 FTIR/VCD Spectroscopy 
 
The FTIR and VCD spectra were recorded with a Chiral IRTM Fourier Transform VCD 
spectrometer from Bio Tools.  The respective peptide samples were placed into a cell 
with a pathlength of 42.5 µm.  The spectral resolution was 8 cm-1 for measurements of 
AAKA and 4 cm-1 for measurements of XAO.  The VCD and IR were both collected as 
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one measurement for a combined total time of 720 minutes (648 min. for VCD, 72 min. 
for IR).  The appropriate background spectrum was manually subtracted from each 
peptide spectrum using the program MULTIFIT (127).  For XAO, the IR and VCD 
spectra were also obtained at 65°C, using a temperature controlled cell. 
 
1.4.4 Spectral Analysis 
 
All IR and Raman spectra were treated by using the program MULTIFIT (127).  The 
calibration of the Raman spectrum was checked by using the NaClO4 band at 934 cm-1.  
To eliminate solvent contributions, we measured the solvent reference spectra for both 
polarizations, which were then subtracted from the corresponding peptide spectra.  The 
isotropic and anisotropic Raman intensities were calculated as: 
 
4
3iso x y
aniso y
I I I
I I
= −
=           (29)
 
where Ix and Iy denote the Raman scattering polarized parallel and perpendicular to the 
polarization of the exciting laser light. 
 
1.4.5 UV-CD Spectroscopy 
 
Temperature dependent UV-CD spectra of AAKA were obtained using an OLIS DSM-10 
UV/Vis CD spectrophotometer, located in the laboratory of Prof. Kai Griebenow, at the 
University of Puerto Rico, San Juan.  A 1.0 mm pathlength quartz cell was used, and the 
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spectra were collected at 2 nm resolution.  A peptide concentration of 1.0 mM in D2O 
(pD = 1) was used.  The sample was placed in a nitrogen purged OLIS CD module.  The 
sample temperature was controlled by means of a Peltier-type heating system (accuracy 
± 1oC).  Spectra were recorded from 20° – 80° C at 10° intervals, averaging 5 scans at 
each temperature.  The sample was allowed to equilibrate for 5 minutes at a given 
temperature.  The spectra were collected as milliabsorbance as a function of wavelength 
and converted to molar absorptivities via Beer’s Law. 
The temperature-dependent UV-CD spectra of XAO in the wavelength range of 
190 – 240 nm of XAO were obtained using a JASCO J-810 spectrapolarimeter in a 0.1 
mm quartz cell.  Spectra were acquired with a resolution of 0.05 nm and a scan speed of 
500 nm/min.  The measurements were performed in D2O rather than in H2O in order to 
allow a direct comparison with structural data obtained by vibrational spectroscopies.  
For each measurement, the sample was allowed to equilibrate for 5 minutes at the 
adjusted temperature prior to acquisition.  The spectra were obtained by averaging ten 
scans and were collected as ellipticity as a function of wavelength and converted to molar 
absorptivity per residue using the following relationship: 
 
∆𝜀 = 𝜃
32980∙𝑐∙𝑙∙(𝑛−1) (30) 
 
where 𝜃 is the ellipticity in [mdeg], c is the concentration in [M], l is the pathlength in 
[cm], and n is the number of residues.  
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1.4.6 NMR Spectroscopy 
 
NMR samples of AAKA were prepared by dissolving the peptide at ca. 5 mM 
concentration in either D2O (99.8 atom % D; Cambridge Isotope Laboratories) or a 
mixture of 90% H2O/10% D2O. One- and two-dimensional proton NMR spectra were 
acquired at 25 °C using a Varian INOVA NMR spectrometer (Varian Inc., Palo Alto, 
CA) operating at a proton frequency of 499.9 MHz and equipped with a 5 mm dual 
broad-band z-gradient probe.  
Two-dimensional proton correlation spectroscopy (COSY) (151-152) and NOE 
spectroscopy (NOESY) (153-154) experiments were measured in Department of 
Chemistry at Rutgers University (Newark, NJ).  Spectra were recorded in the pure 
absorption mode by employing the TPPI improvement (155-156) of the States-
Haberkorn-Ruben hypercomplex method (157). Selection of desirable coherences and 
artifact suppression were accomplished by z-gradients (COSY) and phase cycles of 4 
(COSY) or 32 (NOESY) steps. The NOESY data set was acquired using a 600 ms mixing 
time. Typically, 256  t1 increments of 2K complex data points over a 6 kHz spectral width 
were collected with 4 (COSY) or 32 (NOESY) scans per t1 increment, preceded by 4 or 
32 dummy scans, and a relaxation delay of 1.5 s. All spectra were acquired with the 
carrier offset placed on the water resonance, which was reduced by either solvent 
presaturation (158) or tailored excitation, using WATERGATE (159-160). The peptide 
NH resonances must not be in fast exchange with water since they were readily observed 
in 90% H2O.  
Data sets were processed on a Sun Blade 100 workstation (Sun Microsystems 
Inc., Palo Alto, CA) using the VNMR software package (Varian Inc., Palo Alto, CA). In 
P a g e  | 79 
 
order to decrease t1 ridges arising from incorrect treatment of the first data point in the 
discrete Fourier transform (FT) algorithm, the spectrum corresponding to the first t1 value 
was divided by 2 prior to FT along t1 (161).  Shifted (COSY) or unshifted (NOESY) 
Gaussian window functions were used in both dimensions.  Data sets were zero-filled in 
the t1 dimension, yielding 1K x 1K final matrices that have not been symmetrized. 
Spectra were referenced to the HDO resonance of the D2O sample [4.76 ppm vs 4,4-
dimethylsilapentanesulfonic acid (deuterated at carbons 2 and 3) at 0.00 ppm].  
The amino acid spin systems of AAKA were identified from the COSY spectra in 
D2O and 90% H2O/10% D2O (162). The sequential assignments were made from the R 
CHi-NHi+1 cross-peaks of the NOESY spectrum in 90% H2O/10% D2O. The 3JCαHNH 
values were obtained from one-dimensional spectra of 32K complex data points over a 6 
kHz spectral width.  
1H NMR experiments on AAAA (>98% purity; Bachem Bioscience Inc.) in 
aqueous solution (0.025 M) were measured at the Instituto per I Processi Chimico-Fisici, 
Consiglio Nazionale della Richerche Area della Ricerca di Pisa via G. Moruzzi (Pisa, 
Italy), and were performed at room temperature on a Bruker AMX-300 WB spectrometer 
equipped with a 5 mm reverse probe, using standard Bruker pulse programs. The π/2 
pulse was 5.7 µs, and the relaxation delay was set to 4 s. The water signal was 
presaturated using a 4 s soft pulse (B1 = 25 Hz). The assignment of the signals (Table 5) 
was performed through the cross-peaks of the 1H DQF-COSY and NOESY experiments 
in the amide-Hα proton region (162), the former yielding the J connectivity’s and the 
latter allowing the identification of adjacent residues from the Hα and the amide proton of 
the subsequent residue cross-peak. The signal from the protons bound to the terminal 
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nitrogen could not be identified because of their rapid exchange with water. The 3JCαHNH 
coupling constants were obtained from the DQF-COSY experiment.  NOESY 
experiments with mixing times ranging from 200 to 400 ms were acquired. 
 
 
Residue No. NH CHα CHβ 
1 --- 4.01 1.46 
2 8.53 4.27 1.34 
3 8.36 4.22 1.32 
4 7.88 4.04 1.26 
 
Table 5:  1H chemical shifts (ppm) of AAAA in aqueous solution at 0.025 M and room temperature.  The proton 
chemical shifts are referenced to the water signal, which was set at 4.75 ppm. 
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CHAPTER 2 
Misfolding and Fibril Formation of a Short Alanine-Rich Peptide 
Probed by Vibrational Circular Dichroism (VCD) Spectroscopy 
 
2.1 Synopsis 
 
The aggregation of various misfolded peptides and proteins into well-ordered fibrils is 
linked to a number of debilitating human ailments.  In addition to such disease-related 
proteins, short peptides with no pathological affiliations can form similar structures.  
Herein is presented a spectroscopic characterization of the misfolding and fibril 
formation of a short alanine-rich peptide, namely Ac-(AAAAKAAY)-NH2 (AKY8).  A 
detailed understanding of the interactions involved in peptide and protein misfolding is of 
utmost biomedical importance, so that short peptides such as AKY8 present convenient 
model systems for studying the mechanism of fibril formation.   
The propensity of AKY8 to aggregate is found to be promoted by the C-terminal 
tyrosine residue, consistent with suggestions that aromatic interactions can play important 
roles in peptide and protein aggregation.  Moreover, AKY8 fibrils exhibit an enhanced 
VCD couplet in the amide I’ region.  This chapter provides insight into the interactions 
involved in the misfolding and aggregation of short peptides, and highlights the use of 
vibrational circular dichroism (VCD) as a novel means to probe the kinetics of 
aggregation, which has the potential to provide information on the local structure 
formation during fibrillogenesis. 
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2.2 Background Information 
2.2.1 Protein Misfolding 
 
As the typical protein energy landscape is now considered heterogeneous and highly 
complex (see Figure 2, section 1.2.4), a polypeptide chain may inhabit various local 
minima along its journey down the energy funnel.  Misfolded states are representative of 
these various local minima located along the pathway to the correctly folded state of a 
protein (4).  Owing to the complexity of the protein energy landscape, various states are 
often accessible in the biological environment, which depend on specific conditions and 
various kinetic and thermodynamic factors (4, 163).  These various accessible states of a 
protein molecule, as illustrated in Figure 18, include, in addition to the unfolded and 
native states, aggregated states such as fibrils, which are affiliated with various human 
pathologies.   A complete and detailed description of the protein energy landscape 
requires an understanding of the energetics accompanying the interconversion between 
the assortment of accessible states, not only for understanding amyloid formation for 
disease treatment and prevention, but also for the exploitation of the peptide self-
assembly process for various biotechnological applications. 
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Figure 18:  Various states accessible to a protein molecule, including the unfolded (U), intermediate (I), and folded 
(F) states.  Adapted from ref(4). 
   
 
2.2.2 Misfolding and Human Disease 
 
The ability of a protein to achieve its native 3-D structure is important for maintaining 
proper biological function.  It is not surprising, therefore, that the inability to achieve or 
maintain a native fold is linked to various debilitating human ailments (164).  In 
particular, aggregation of misfolded peptides and proteins is affiliated with common 
neurodegenerative diseases such as Alzheimer’s, Huntington’s, Parkinson’s, and the 
prion diseases, as well as the systemic amyloidoses (164-166).  The largest class of 
‘protein misfolding’ or ‘conformational’ diseases, as they are often referred, result from 
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the aggregation of specific misfolded or intrinsically disordered proteins (IDP’s) into 
insoluble filamentous structures termed ‘amyloid fibrils’ (4, 164-165, 167-168).  The 
number of conformational diseases currently known is quickly approaching 50.  A list of 
some conformational diseases associated with amyloid deposition, including the culprit 
protein believed to result in the formation of insoluble cellular deposits is listed in Table 
6, for the various neurodegenerative diseases, and systemic and localized amyloidoses. 
 
 
Disease Aggregating 
protein or 
peptide 
Number of 
residuesa 
Native structure of protein or 
peptideb 
Neurodegenerative 
diseases 
   
Alzheimer's disease Amyloid β 
peptide 
40 or 42 Natively unfolded 
Spongiform 
encephalopathies 
Prion protein or 
fragments thereof 
253 Natively unfolded (residues 1-120) 
and α-helical (residues 121-230) 
Parkinson's disease α-Synuclein 140 Natively unfolded 
Dementia with Lewy 
bodies 
α-Synuclein 140 Natively unfolded 
Frontontemporal 
dementia with 
Parkinsonism 
Tau 352-441 Natively unfolded 
Amyotrophic lateral 
sclerosis 
Superoxide 
dismutase 1 
153 All-β, Ig like 
Huntington's disease Huntingtin with 
polyQ expansion 
3144 Largely natively unfolded 
Spinocerebellar ataxias Ataxins with 
polyQ expansion 
816 All-β, AXH domain (residues 562-
694); the rest are unknown 
Spinocerebellar ataxia 17 TATA box-
binding protein 
with polyQ 
expansion 
339 α+β, TBP like (residues 159-339); 
unknown (residues 1-158) 
Spinal and bulbar 
muscular atrophy 
Androgen 
receptor with 
polyQ expansion 
919 All-α, nuclear receptor ligand-binding 
domain (residues 669-919); the rest 
are unknown 
Hereditary dentatorubral-
pallidoluysian atrophy 
Atrophin-1 with 
polyQ expansion 
1185 Unknown 
Familial British dementia ABri 23 Natively unfolded 
Familial Danish dementia ADan 23 Natively unfolded 
Nonneuropathic systemic 
amyloidoses 
   
AL amyloidosis Immunoglobulin 
light chains or 
»90 All-β, Ig like 
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fragments 
AA amyloidosis Fragments of 
serum amyloid A 
protein 
76-104 All-α, unknown fold 
Familial Mediterranean 
fever 
Fragments of 
serum amyloid A 
protein 
76-104 All-α, unknown fold 
Senile systemic 
amyloidosis 
Wild-type 
transthyretin 
127 All-β, prealbuminn like 
Familial amyloidotic 
polyneuropathy 
Mutants of 
transthyretin 
127 All-β, prealbuminn like 
Hemodialysis-related 
amyloidosis 
β2-microglobulin 99 All-β, Ig like 
ApoAI amyloidosis N-terminal 
fragments of 
apolipoprotein 
AI 
80-93 Natively unfolded 
ApoAIV amyloidosis N-terminal 
fragment of 
apolipoprotein 
AII 
98 Unknown 
ApoAIV amyloidosis N-terminal 
fragment of 
apolipoprotein 
AIV 
»70 Unknown 
Finnish hereditary 
amyloidosis 
Fragments of 
gelsolin mutants 
71 Natively unfolded 
Lysozyme amyloidosis Mutants of 
lysozyme 
130 α+β, lysozyme fold 
Fibrinogen amyloidosis Variants of 
fibrinogen α-
chain 
27-81 Unknown 
Icelandic hereditary 
cerebral amyloid 
angiopathy 
Mutant of 
cystatin C 
120 α+β, cystatin like 
Nonneuropathic localized 
diseases 
   
Type II diabetes Amylin, also 
called islet 
amyloid 
polypeptide 
(IAPP) 
37 Natively unfolded 
Medullary carinoma of 
the thyroid 
Calcitonin 32 Natively unfolded 
Atrial amyloidosis Atrial natriuretic 
factor 
28 Natively unfolded 
Hereditary cerebal 
haemorrhage with 
amyloidosis 
Mutants of 
amyloid β 
peptide 
40 or 42 Natively unfolded 
Pituitary prolactinoma Prolactin 199 All-α, 4-helical cytokines 
Injection-localized 
amyloidosis 
Insulin 21 + 30 All-α, insulin like 
Aortic medial amyloidosis Medin 50 Unknown 
Hereditary lattice corneal 
dystrophy 
Mainly C-
terminal 
fragments of 
kerato-epithelin 
50-200 Unknown 
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Corneal amyloidosis 
associated with trichasis 
Lactoerrin 692 α+β, periplasmic-biding protein like 
II 
Cataract γ-Crystallins Variable All-β, g-crystallin like 
Calcifying epithelial 
odontogenic tumors 
Unknown ~46 Unknown 
Pulmonary alveolar 
proteinosis 
Lung surfactant 
protein C 
35 Unknown 
Inclusion-body myositis Amyloid β 
peptide 
40 or 42 Natively unfolded 
Cutaneous lichen 
amyloidosis 
Keratins Variable Unknown 
 
Table 6:  Human diseases associated with formation of extracellular amyloid deposits or intracellular inclusions 
with amyloid-like characteristics.  Adapted from ref(165). 
   
 
A defining feature of the various pathologically diverse diseases which arise from 
the misfolding and subsequent aggregation of specific proteins is the accumulation of 
intra- or extra-cellular proteinaceous deposits, consisting primarily of fibrillar species.  In 
particular, the brains of patients with Alzheimer’s disease contain deposits of the Aβ 
protein known as amyloid plaques (169), while Parkinson’s patients develop Lewy bodies 
within neurons consisting predominantly of the α-synuclein protein (170).   It is typically 
believed that, e.g. amyloid plaque build-up inhibits proper neuronal signal transmission, 
thus causing neurodegeneration (171).  A recent study, however, suggests that the 
deposits, instead, seek to protect neurons from stressful conditions which often result in 
pathogenesis (172).  
Amyloid-like plaques and Lewy bodies are formed from the accumulation of 
unbranched fibrils which adopt a characteristic cross-β core, where so-called 
protofilaments intertwine with their constituent β-strands aligned perpendicular to the 
fibril axis, as shown in Figure 19 (173).  The thickness of the fibrils is determined by the 
number of protofilaments.   Typical amyloid-like fibrils are 6-12 nm in diameter and 
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usually consist of 2-6 protofilaments (3).  These fibrils show well-defined diffraction 
patterns, and specifically bind dyes such as Congo red and Thioflavin T.  Despite the 
sequence diversity of the many known fibril-forming polypeptides and proteins, and their 
associated diseases, the architecture of the resulting fibrils is remarkably similar in all 
cases.  Even short peptides and globular proteins not affiliated with any known disease 
can form amyloid-like fibrils under certain conditions.  These results have led to the 
suggestion that amyloid fibril formation is a general feature of all polypeptides (4, 164-
165).  
It is now of current belief that the conformational disorder inherent in misfolded 
proteins is a prerequisite for aggregation and fibril formation.  Disordered regions result 
in the exposure of non-native hydrophobic segments, which would otherwise be buried 
within the globular protein fold  (164, 174).    Disordered regions of a protein, by nature, 
are more solvated, allowing for aberrant interactions of exposed hydrophobic regions, 
such as non-native interactions which are believed to play a role in promoting 
aggregation of the diverse assortment of disease-related peptides and proteins (175). 
Peptide and protein misfolding can be envisaged to result from two scenarios 
which produce partial conformational disorder, namely the partial unfolding of natively 
structured peptides and proteins, or the partial folding of intrinsically disordered/unfolded 
peptides and proteins (164-165, 168, 176).  Large amounts of experimental data suggest 
that globular proteins require partial unfolding prior to aggregation (166, 177-178).   
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2.2.3 Functional Fibrils 
 
In addition to the formation of toxic protein fibrils implemented in various human 
diseases, there are increasing reports of these structures being exploited by living systems 
to carry out important biological functions (165).  A list of proteins from various bacteria 
which can form nonpathological amyloid-like fibrils exhibiting specific functions can be 
found in Table 7.  For example, amyloid-like fibrils formed by the protein spidroin are 
the major constituent of spider silk (179).  Other examples include the fibril-forming 
bacterial proteins which are deposited at the bacterial surface and promote binding to 
inert substrates (e.g. epithelial cells).  In particular, the E. coli protein curlin forms 
amyloid-like fibrils which promote cell adhesion to the epithelial surface and favors 
colonization (180).  Thus, if regulated under well-controlled conditions, fibril formation 
can be advantageous and exploited in living systems to carry out specific biological 
functions. 
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Figure 19:  Cross-β structure of amyloid fibrils.  Individual β-strands are arranged perpendicular to the fibril axis.  
Figure was adapted from ref(181). 
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Protein Organism Function of the resulting amyloid-like fybrils 
Curlin Escherichia coli (bacterium) To colonize inert surfaces and mediate binding to host proteins 
Chaplins Streptomyces coelicolor 
(bacterium) 
To lower the water surface tension and allow the development of aerial 
hypae 
Hydrophobin EAS Neurospora crassa (fungus) To lower the water surface tension and allow the development of aerial 
hypae 
Proteins of the chorion 
of the eggshell 
Bombyx mori (silkworm) To protect the oocyte and the developing embryo from a wide range of 
environmental hazards 
Spidroin Nephila edulis (spider) To form the silk fibers of the web 
Intralumenal domain 
of Pmel17 
Homo sapiens To form , inside melanosomes, fibrous striations upon which melanin 
granules form 
Ure2p (prion) Saccharomyces cervisiae 
(yeast) 
To promote the uptake of poor nitrogen sources ([URE3]) 
Sup35p (prion) Saccharomyces cervisiae 
(yeast) 
To confer new phenotypes ([PSI+]) by facilitating the readthrough of stop 
codons on mRNA 
Rnq1p (prion) Saccharomyces cervisiae 
(yeast) 
Not well understood ([RNQ+]), also known as [PIN+], phenotype 
HET-s (prion) Podospora anserina 
(fungus) 
To trigger a complex programmed cell death phenomenon (heterokaryon 
incompatibility) 
Neuron-specific 
isoform of CPEB 
(prion) 
Aplisia californica (marine 
snail) 
To promote long-term maintenance of synaptic changes associated with 
memory storage 
 
Table 7:  Proteins forming naturally nonpathological amyloid-like fibrils with specific functional roles.  Adapted 
from ref(165). 
 
 
 
2.2.4 Fibril Formation       
 
Fibril formation, or fibrillogenesis, is believed to be pathogenic (177, 182).  Therefore, 
uncovering ways to inhibit the unwanted processes is necessary to combat various 
amyloid diseases (183).  In this regard, elucidation of the mechanism of the self-assembly 
of polypeptides is of fundamental importance in structural biology (164), and of utmost 
biomedical significance.  A complete understanding of fibril formation requires a detailed 
structural and dynamic characterization of the various prefibrillar species (e.g. oligomers 
and protofibrils), and the principles which govern their transition into amyloid fibrils 
(165).  These prefibrillar species are believed to be in equilibrium with both the 
monomeric and fibrillar states, as illustrated in Figure 20.  Moreover, identification of 
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specific residues and regions in the primary amino acid sequence of amyloidogenic 
peptides and proteins is necessary (165).  
 
Figure 20:  Various protein species which can be populated and co-exist during protein  aggregation/fibril 
formation.  Adapted from ref(184). 
 
 
Amyloid formation usually proceeds via a “nucleation growth mechanism,” in 
which a lag phase is typically observed prior to an exponential growth phase (165, 185-
186), as shown in Figure 21.  The lag phase is believed to harbor the formation of 
oligomeric species, which act the ‘nuclei’ for fibril formation.  Many studies now 
indicate that it is the soluble oligomeric species that are pathogenic, and not the insoluble 
fibrils (3, 166, 187-188).  In such cases, the formation of fibrils of such toxic species 
might be considered as a cell defense mechanism. 
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Figure 21:  (A) Two stages of protein aggregation, i.e. nucleation and aggregate/fibril growth (B) Typical aggregation 
curve of nucleated aggregation, depicting turbidity of solution as a function of time, where turbidity is proportional 
to the formation of insoluble fibril aggregates.  The dotted red line indicates the maximal growth rate.  Figure was 
taken from ref(186) and adapted. 
 
 
2.2.5 Cellular Control of Misfolded Species 
 
In vivo, misfolded peptides and proteins often result from either amino acid mutations or 
improper translation (3, 165).  Mutated proteins are not always able to adopt their native 
fold.  Since structure often dictates function, such improperly folded species usually only 
exhibit a fraction of their ability to carry out their proper functions.   Pathological states 
resulting from folding inefficiency, for example in cystic fibrosis, ensue from the 
reduction in the amount of correctly folded protein necessary for normal functioning, due 
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to an increased amount of misfolded species which are targeted for degradation in vivo 
(3, 165).   
Since adoption of a correct 3-D fold is often necessary for proper biological 
functioning, living systems have evolved ways in which to prevent the proliferation of 
incompletely or improperly folded proteins, which can favor inappropriate interactions 
and increase the likeliness of aggregation (164).  These cellular control processes are a 
driving force of protein evolution (189), and include the ‘unfolded protein response’ 
(UPR) in the endoplasmic reticulum (ER) (190) and the heat shock response (HSR) in the 
cytoplasm (164).  These regulatory processes typically rely on the performance of 
chaperones to guide rogue protein species to proper locations for their ultimate 
degradation and disposal (164, 190).  The duties of protein chaperones include the 
oversight of correct folding of nascent polypeptide chains and refolding of misfolded 
chains to guide various later stages of folding, and to protect incompletely folded proteins 
from participating in inappropriate interactions which might favor aggregation (3, 191).  
In particular, some chaperones interact with nascent chains as they are being synthesized 
on the ribosome, while others work by interact with proteins at later stages of the folding 
process (192-193).   Figure 22 shows a schematic illustrating the cellular balance 
between proper folding vs. misfolding/disposal in the ER.  
Despite the attempts made by a cell’s regulatory machinery to properly dispose of 
misfolded and partially folded proteins, such aberrant species do thrive.    The regulatory 
processes are not fool-proof, and rogue species often elude these quality-control checks.  
Some estimates have suggested that nearly half of newly synthesized polypeptides are 
targeted for disposal (4).  It has been speculated that perhaps cells expend such large 
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quantities of energy by synthesizing and then destroying proteins for as yet unrecognized 
purposes (4). 
 
 
Figure 22:  Regulation of protein folding in the endoplasmic reticulum.  This figure illustrates two distinct pathways 
that a newly synthesized polypeptide chain may take after translation from the ribosome.  These are: (1) proper 
folding, where the protein is sent further downstream to carry out its normal function in its destined are, or (2) 
degradation, where a mutated or improperly folded protein is ultimately chaperoned to the ubiquitin machinery.  
This figure was taken from ref(164) and modified. 
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2.2.6 Intrinsically Disordered Proteins (IDP’s) 
 
In addition to the misfolded species of globular proteins which expose various buried 
hydrophobic regions, or those mutated species which elude cellular regulatory processes 
in vivo, there also exist ‘intrinsically disordered’ or ‘natively unfolded’ peptides and 
proteins, which, owing to their inherent disorder, are also linked to various human 
diseases (168).  The existence of intrinsic disorder challenges the well-established 
structure/function dogma of protein science, namely that the 3-dimensional fold of a 
protein dictates its function.  The discovery of IDP’s with specific and important 
functions clearly contradicts such a notion (168).   
The term natively unfolded was introduced in 1994 to describe the nature of the 
tau protein, which has been linked to Alzheimer’s disease (176).  In contrast to molten 
globule proteins, which, although somewhat flexible, are still rather compact and contain 
elements of secondary structure, IDP’s are flexible and non-compact, and exhibit very 
little secondary structure under physiological conditions (176). Although lacking in any 
major elements of secondary structure, most of these IDP’s carry out important functions, 
such as molecular recognition and protein modification (98, 174, 176).  A few examples 
of disordered proteins and their respective functions are listed in Table 8 (82).  From this 
point on, the term intrinsically disordered proteins (IDP’s) will be employed when 
referred to those proteins lacking in any of the major structural content (α-helix, β-strand, 
β-sheet, β-turn, γ-turn, or PPII). 
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Protein Function 
fd Phage Membrane penetration 
Histone octamer DNA replication, Transcription, Chromosome 
remodeling 
Clusterin Protein detergent 
Calcineurin Display of calmodulin target 
Calsequestrin Ca++ binding 
 
Table 8:  Examples of disordered proteins with well-defined biological functions.  This table was adapted from 
ref(82). 
 
Both misfolded and IDP’s result in the exposure of residues and regions that 
promote aggregation.  The distinction between the two classes is attributed to the fact that 
while misfolding often results in partial unfolding, IDP’s typically undergo partial 
folding.    In particular, transformations that result in favorable non-native interactions, 
including hydrogen and hydrophobic bonding, and favorable electrostatic interactions, 
can promote the aggregation and fibril formation of such disordered segments (176).  
 
 
2.2.7 Fibril Formation is A General Feature of all Polypeptides 
 
Owing to the similarity of structural features of amyloid-like fibrils formed by various 
disease- and non-disease-related peptides and proteins, it has been suggested that 
aggregation and fibril formation is an inherent property of all polypeptides and proteins 
(3, 164, 166, 191).  Fibril formation is not restricted only to those peptides and proteins 
which are linked with various diseases.  In fact, many studies have demonstrated the 
potential of various peptides and proteins that are not affiliated with any known disease to 
form amyloid-like fibrils in vitro (191, 194).  Even myoglobin can form fibrils under 
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well-defined conditions (195).  A list of non-disease related amyloidogenic peptides and 
proteins is given in Table 9.   
 
 
Table 9:  Non-disease-associated amyloidogenic proteins or peptides.  Adapted from ref(3). 
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This generic feature of amyloid-like fibrils, and the aggregated protein state in 
general, affords the extension of the typical protein energy landscape (see Section 1.2.4) 
to include such species, as shown in Figure 23.  It was even suggested by Gazit (186) 
that the aggregated state may be the most stable proteins structure, consistent with the 
energy funnel depicted in Figure 23.  From a fundamental viewpoint, the generic ability 
to form fibrils is intriguing, as it suggests that the many seemingly unrelated protein 
misfolding diseases share common molecular principles, so that therapeutic means to 
treat or prevent such diseases could result from common targets (196). 
 
 
 
Figure 23:  Extended protein energy landscape, exhibiting the amyloid fibril state  as the lowest energy state of the 
landscape extension.  This figure was adapted from ref(197). 
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2.2.8 Techniques Used to Probe Amyloid Fibril Formation 
 
The most commonly used technique to confirm the presence of amyloid fibrils is the 
detection of a distinct green birefringence when viewed under crossed polarizers, after 
staining the fibrils with the diazo dye Congo red, but the reliability of this method of 
detection has been questioned (198).  In particular, Kurana et al. recently suggested that 
Congo red does not bind only to amyloid fibrils (198).  Various biophysical techniques 
are now commonly used to detect the presence of amyloid fibrils and probe fibril 
formation.  These include x-ray crystallography (199-200) and x-ray diffraction, dynamic 
light scattering (DLS) (201-203), staining and fluorescence assays (204-205), solid-state 
NMR (206-208), and electron and atomic force microscopy (EM and AFM, respectively) 
(209-210).  Vibrational spectroscopic techniques such as FTIR (211) and Raman (212), 
as well as UV-CD (3, 26) can also be used to monitor the increase in β-sheet marker 
bands, which occurs concomitantly with fibril formation.  
While amyloid-like fibrils are not amenable to single crystal x-ray diffraction, a 
few studies have reported that some short amyloidogenic peptides can also form nano- 
and micro-crystals, which exhibit structural characteristics similar to those of the non-
crystalline fibril species (199-200).  The first such peptide found to form microcystals 
amenable to x-ray crystallographic techniques was the heptameric motif from the N-
terminal region of the yeast prion protein (Sup35), namely GNNQQNY (200).  Results 
from this study indicate that GNNQQNY microcrystals have a cross-β spine, consisting 
of a double β-sheet, with the side chains of each sheet protruding in such as way so as to 
form a tightly packed steric zipper.    Also, the de novo designed 12-mer 
KFFEAAAKKFFE (AAAK) was found to form amyloid fibril-like crystals, composed of 
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antiparallel β-sheets which form a cross-β arrangement, characteristic of amyloid fibrils 
(199).  A higher degree of inter-sheet order relative to the less rigid fibrils is 
characteristic of these so-called fibrous crystals (199-200).   
More recently, VCD spectroscopy has shown sensitivity to amyloid fibrils, and 
was used to probe fibrillogenesis (213).  In particular, fibrils formed from lysozyme and 
insulin were shown to exhibit enhanced VCD signals in the amide I band.  Ma et al. 
suggested that the origin of the intensity enhancement might be due to coupling between 
neighboring β-sheets or from the twisting of individual sheets or braiding of multiple 
protofibrils (213).  Since VCD can provide information on local structure, the use of this 
technique offers a novel and convenient approach to obtain information on local 
secondary structure of the amyloid fibrils as they form, especially when combined with 
other complementary techniques such as FTIR and Raman spectroscopy. 
 
 
2.2.9 The Role of PPII in Misfolding and Aggregation 
 
Conformational disorder is believed to be a prerequisite for fibril formation.  Disordered 
regions of a protein are more solvent-accessible allowing for interactions of exposed 
hydrophobic regions, which can favor aggregation via non-native interactions.  The PPII 
conformation (see Section 1.2.10), which is known to be prevalent in short, unfolded 
alanine-based polypeptides, has been dubbed the ‘killer’ conformation by Blanch et al. 
(214).  These authors demonstrated that the prefibrillar species of lysozyme at low pH 
and a temperature of 57°C, exhibits characteristics of a PPII conformation in its Raman 
optical activity (ROA) spectrum (214).  The PPII conformation is well-suited to act as a 
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‘transitional’ conformation to the β-sheet-rich aggregated state, due to its flexibility and 
extended and fully hydrated structure, lacking in intra-molecular hydrogen bonds.  
Another study illustrated the population of PPII-like conformations by PLK prior to β-
sheet formation (215).  Moreover, many disease-related peptides and proteins, such as tau 
(Alzheimer’s) (60), Aβ (Alzheimer’s) (123), and α-synuclein (Parkinson’s) (60) have 
been shown to adopt elements of PPII structure in their monomeric states.   
In contrast to the suggested precursor role for the PPII conformation in fibril 
formation, other studies suggest that the presence of PPII conformations inhibits fibril 
formation.  In the huntington protein, for instance, which is affiliated with the disease of 
the same name, tracts of poly-L-glumatine (PLQ) residues are often found flanked by 
tracts of PLP residues.  Darnell et al. have provided conclusive evidence which suggest 
that the flanking PLP residues promote the PLQ tracts to form PPII helices, which 
prevent β-sheet and thus fibril formation (216).  Moreover, these authors have 
demonstrated that when the central PLQ tracts exceeds a certain threshold number of 
glutamine residues, the flanking PLP tracts can no longer stabilize PPII helices of the 
central glutamine residues, which then form β-sheet conformations, ultimately leading to 
the formation of toxic fibrils.  In addition, a more recent study by these authors on short 
tandem PLQ-PLP peptides, which are too short to form fibrils, instead form small soluble 
oligomers with a predominantly PPII structure (217).   
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2.2.10 Self-Recognition Elements (SRE’s)  
 
Short peptide motifs (usually containing 5 – 15 amino acid residues) of various 
amyloidogenic proteins can also yield fibrillar structures, which are nearly 
indistinguishable from those formed from the full-length parent protein (218).  These 
findings suggest that such short segments contain all the necessary elements for fibril 
formation, and possibly form the core of the resulting fibrils produced from the full-
length proteins.  Such short peptide segments have been dubbed “self-recognition 
elements” (SRE’s) (218).  Some examples of SRE’s from various amyloidogenic proteins 
are listed in Table 10.  Studies of the fibril formation of short peptides and proteins and, 
in particular, those which are fragments of disease-related proteins, have provided insight 
into the molecular interactions which promote aggregation, as well as those which 
stabilize β-sheet packing of such motifs (219-221).  In addition to the SRE’s of disease-
related peptides and proteins, numerous short peptides with no disease affiliation have 
also been reported to form amyloid-like fibrils.   
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Protein Amyloidogenic Sequence(s)/Peptide(s) Location in Native 
Mature Protein 
Sequence 
α-Synuclein (68)GAVVTGVTAVA(78) 
(51)GVATVA(56) 
(66)VGGAVVTVG(74) 
(86)GSIAAAT(92) 
(71)VTGVTAVAQKTV(82) 
(77) VAQKTV 
68 – 78 
51 – 56 
66 – 74 
86 – 92 
71 – 82 
77 - 82 
β-Lactoglobulin (11)DIQKVAGTWY(20) 
(101)KYLLFCMENS(110) 
(116)SLVCQCLVRTP(126) 
(146)HIRLSFN(152) 
11 – 20 
101 – 110 
116 – 126 
146 - 152 
Lysozyme, Human (56)IFQINS(61) 56 – 61 
Myoglobin, Horse Heart (1)GLSDGEWQQVLNVWGKVEADIAGHGQEVL(29) 1 - 29 
Prion Protein, Human, 
hPrP 
(113)AGAAAAGAVVGGLGG(127) 113 - 127 
 
Table 10:  Proteins of which peptide fragments have been shown to form amyloid fibrils in vitro.  Adapted from 
ref(218). 
 
 
 
2.2.11 Role of Aromatic Residues in Peptide and Protein Aggregation 
 
In addition to the many extrinsic factors that can favor protein and peptide aggregation, 
such as elevated temperature, high concentration, and exposure of hydrophobic patches, 
physicochemical properties such as hydrophobicity and net charge can also stabilize the 
aggregated state (222).  Moreover, a growing number of experimental studies have 
highlighted the importance of aromatic residues in promoting peptide and protein self-
assembly and fibril formation (199, 223-227).   Many short sequences which are believed 
to be active in the fibril formation of various disease-related proteins contain aromatic 
residues (228), and the importance of aromatic interactions in inducing peptide self-
assembly to form supramolecular hydrogels has also been documented (225, 229-230).  
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 The SRE of the amyloid-β (Aβ) peptide associated with Alzheimer’s disease 
constitutes residues 16 – 21, namely KLVFFA.  This segment ultimately forms the core 
of Aβ fibrils, but can also form fibrils with an antiparallel β-sheet arrangement.  The 
diphenylalanine (FF) motif has also been shown to self-assemble into nanorods under 
very well-defined conditions.  Moreover, π-π interactions resulting from the terminal Tyr 
residue of the active motif of the yeast prion protein Sup35, namely GNNQQNY has 
been suggested to promote the parallel arrangement of β-sheets, (224).  Computational 
studies have indicated that the polypeptide backbone favor an antiparallel arrangement, 
so that the π-π interactions stabilizing the parallel arrangement of GNNQQNY is 
significant (231). 
 Despite the bounty of evidence pointing to the significance of aromatic 
interactions in stabilizing peptide and protein aggregation and fibril formation, there are 
reports which indicate that aromatic residues do not promote aggregation and fibril 
formation (232-233).  In particular, Bemporad et al. recently suggested that the β-sheet 
propensity and not the aromaticity of the bulky aromatic amino acid residues promotes 
polypeptide aggregation (233).  
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Name of Parent 
Protein 
 
Pathological or 
Physiological 
Condition 
 
 
Short Active Sequence 
 
Islet Amyloid 
Polypeptide 
 
Type II Diabetes 
 
1. FGAIL 
2. TNVGSNTY* 
3. QRLANFLVH* 
 
 
β-Amyloid 
Peptide 
 
Alzheimer’s 
Disease 
 
1. KLVFF (inhibitor) 
2. LVFFA (inhibitor) 
3. LPFFD (inhibitor) 
4. KLVFFAE* 
 
 
Lactadherin 
 
Aortic Medial 
Amyloid 
 
      
NFGSVQFV* 
 
Gelsolin 
 
Finnish Hereditary 
Amyloidosis 
 
              
SFNNGDCCFILD* 
 
Serum Amyloid 
A 
 
Chronic 
Inflammation 
Amyloidosis 
 
           
SFFSFLGEAFD* 
 
PrP 
 
Creutzfeldt-Jakob 
Disease (CJD) 
 
      
PHGGGWGQ 
 
Sup35p 
 
Yeast Prion 
Protein 
 
1. PQGGYQQYN 
2. GNNQQNY 
 
 
Table 11:  Functional amyloid-related sequences that contain aromatic residues.  The aromatic residues are 
underlined.  * indicates that the minimal active fragment may actually be shorter. 
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2.3 Misfolding and Fibril Formation of a Short Alanine-Rich Peptide 
 
 
2.3.1 Introduction 
 
Self-assembly of polypeptides and proteins has become the subject of intense research 
activity for various reasons. First, an understanding of the underlying mechanism is 
necessary for the development of diagnostic and therapeutic strategies for a variety of 
diseases, including Alzheimer’s, Huntington’s, Creutzfeldt-Jakob’s, and Parkinson’s 
disease (164-166).  These diseases are believed to result from misfolding and subsequent 
aggregation of specific proteins and peptides to form rigid insoluble fibrils.  These fibrils 
then deposit in tissues to form insoluble plaques, e.g. amyloid plaques (169).  Second, 
polypeptide/protein self-aggregation results in the formation of novel supramolecular 
structures (e.g., hydrogels) that are of biomedical and biotechnological relevance (26, 
234-235).   
Elucidating the mechanism of the self-assembly of peptides and proteins is of 
fundamental importance (164).  The rules governing self-aggregation are still debated, 
however.  Strong experimental evidence suggests that the aggregation process does not 
primarily reflect the conformational propensities of a peptide’s amino acid residues (236).  
The pivotal role of aliphatic and aromatic residues in the aggregation of even small 
peptides suggests that aggregation is strongly driven by hydrophobic forces (228, 236).  
Gazit demonstrated the importance of aromatic residues for self-aggregation, but it is 
unclear whether this is due to aromaticity or the propensity of these peptides to adopt β-
sheet-favoring conformations (225).  In this regard, conformational disorder has been 
suggested to be a prerequisite for fibrillation (164-165, 237). 
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Herein is reported the fibril formation of an eight residue alanine-based 
oligopeptide, namely, Ac-A4KA2Y-NH2 (AKY8).  Alanine-rich peptides of this size are 
typically used as model systems for studying the unfolded state of peptides and proteins 
(see Chapter 1), and often adopt an ensemble of conformations in aqueous solution, with 
a predominant sampling of PPII-like conformations (133).  Owing to the intrinsic 
disorder of short peptides, however, along with the currently accepted notion that β-sheet 
formation is general feature of the polypeptide backbone, it is not surprising that short 
alanine-based peptides can also form fibrils under well-defined conditions.  In addition, 
PPII has been hypothesized to be a prerequisite for polypeptide/protein aggregation, and 
has even been dubbed the ‘killer’ conformation by Blanch et al. (214).  This stems mainly 
from its flexibility and extended structural features, as well as its close location to the β 
basin in Ramachandran space.    
Incubation in acidic media results in the spontaneous aggregation of AKY8, 
where an exponential fibril growth period is preceded by a lag phase, consistent with 
typical amyloid fibril formation (165, 185-186).  AKY8 fibrils give rise to an enhanced 
couplet in the amide I’ region of the corresponding VCD spectrum, and a much less 
intense band in the amide II’ region, both of which can be utilized to probe the kinetics of 
fibril formation.  Such enhanced amide I’ VCD signals are hypothesized to originate from 
favorable stacking interactions between side chains of neighboring strands, as well as 
close inter-sheet packing (213).  VCD can yield local secondary structural information, 
and can thus be considered a novel probe of fibril formation, especially when coupled 
with complementary methods, such as IR, UV-CD, fluorescence spectroscopies. 
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  Promotion of AKY8 fibril formation is attributed to the C-terminal tyrosine 
residue of AKY8.  This is suggested to be due to cation – π interactions between the 
lysine and tyrosine residues which stabilize the final aggregated structure.  The role of 
aromatic residues in amyloid-fibril formation is becoming increasingly important, and the 
fibril formation of other short peptides has also been suggested to be at least stabilized by 
aromatic interactions (220, 225), as well as C-terminal aromatic residues (224). 
The results presented in this chapter reinforce the link between the flexible PPII 
conformation and fibril formation, and offer further support for generality of amyloid 
fibril formation and the role of aromatic residues in promoting fibril formation, at least in 
short peptides.  Moreover, the use of VCD as a novel probe of fibrillogensis is 
highlighted, which, when combined with other experimental and computational methods, 
may be able to yield local structural information about the fibril architecture. 
 
 
2.3.2 Monomeric AKY8 
 
Upon dissolution in deuterated water (D2O), and in the absence of any added ions, AKY8 
behaves as expected for such a short alanine-rich peptide (48, 69, 146, 238).   The UV-
CD spectrum exhibits a negative maximum at 196 nm, and a much less-pronounced 
shoulder at 218 nm, as shown in Figure 24.  These spectral features are typical for short 
alanine-rich peptides and are indicative of an ensemble of conformations being populated 
with a predominance of PPII-like conformations admixed with β-strand and turn-like 
conformations (146, 238).   
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The temperature-dependent UV-CD spectra of AKY8 show a loss of intensity at 
both the negative and positive maxima at 198 and 220 nm, respectively, at higher 
temperatures.  The difference spectrum between that measured at 85ºC and that measured 
at 25ºC, as shown in the inset of Figure 24, is indicative of an increase in β-strand 
conformations.  Such temperature-dependent spectra have also been observed for the 
controversial XAO peptide (see Figure 15) (238). 
 
 
Figure 24:  Temperature-dependent UV-CD spectra of 2 mM AKY8 in D2O (pD = 1).  Inset:  difference spectrum 
between that measured at 85° and that measured at 5°C, reflecting the increase in β-strand structures at higher 
temperatures. 
 
 
The amide I’ band in the FTIR spectrum of monomeric AKY8 shows a single band at 
1645 cm-1, while the respective VCD spectrum in this region shows a negative couplet.  
Both the FTIR and VCD spectra are indicative of a predominance of PPII-like 
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conformations (124), consistent with results reported for other short alanine-rich peptides 
(see Chapter 1)  (59, 124).   
 
 
Figure 25:  VCD (top panel) and FTIR (lower panel) spectra of 20 mM AKY8 in D2O.   These spectra are typical of 
short alanine-based peptides, and are attributed to an ensemble of conformations, with a predominate sampling of 
PPII-like conformations. 
 
 
 
2.3.3 AKY8 Fibril Formation 
 
In contrast to peptides of similar length and composition, (e.g. Ac-(AAKA)2-NH2 (143)), 
incubation of AKY8 at room temperature and in the presence of a small amount of 
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deuterium chloride (DCl) results in the slow and spontaneous aggregation into insoluble 
amyloid-like fibrils.  The resulting fibrils are long, rigid, and un-branched, as indicated 
by atomic force microscopy (AFM) images shown in Figure 26.  The fibrils consist of a 
mixture of rod-like and fibrillar structures, where the latter display a left-handed helical 
twist, consistent with amyloid-like fibrils (183).  Moreover, the AKY8 fibrils are found to 
bind the amyloid-specific dye Congo red (239), as indicated by a red-shift of the visible 
absorption band at 498 nm, as shown in the lower panel of Figure 27.  This, combined 
with the spectroscopic results and AFM images suggests that AKY8 aggregates are of the 
amyloid-fibril type. 
 
 
 
Figure 26:  Amplitude AFM images of AKY8 fibrils.  A mixture of twisted amyloid-like fibrils and more crystalline 
species can be discerned.  Scale bar represents 1 µM in each image. 
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Figure 27:  Visible absorption spectra of the amyloid-specific dye Congo red in the absence (red) and presence 
(black) of AKY8 fibrils. 
 
 
 
Relative to the IR spectrum of the monomeric state, the amide I’ band in IR 
spectrum of the AKY8 fibril solution is downshifted to 1616 cm-1, as shown in Figure 
28.  This is indicative of a β-sheet-like structure, where the presence of a much less 
intense peak at ~1695 cm-1 is consistent with an anti-parallel sheet arrangement (103, 
240).  The broad IR band centered at ~1650 cm-1 in the AKY8 fibril solution is blue-
shifted by ~7 cm-1 with respect to the amide I’ band of the monomer, and coincides with 
the amide I’ bands in the isotropic and anisotropic Raman spectra of AKY8, which are 
shown in Figure 29.  This suggests that both IR and Raman bands should be assigned to 
a distorted β-sheet conformation, in which the two Raman active modes become IR 
active.  That is, in an ideal anti-parallel β-sheet with 4 amide I modes, two of the modes 
are IR active and the other two are Raman active (103).  The Raman active bands in an 
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ideal anti-parallel β-sheet occur at wavenumber positions just in between those which are 
IR active (103).  Symmetry lowering via a sheet distortion results in the Raman active 
modes becoming IR active.  
 
Figure 28:  VCD (top panel) and FTIR (bottom panel) of AKY8 fibril (20 mM) solution, resulting from the overnight 
incubation at room temperature after the addition of a small amount of DCl. 
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Figure 29: Amide I’ profile in the isotropic and anisotropic Raman spectra of the AKY8 fibril solution. 
 
Interestingly, the VCD spectrum of the AKY8 fibril solution shows an enhanced 
couplet in the amide I’ region, with an inflection point coinciding with the peak in the 
amide I’ peak IR spectrum (Figure 28).  The VCD couplet is nearly 2 orders of 
magnitude larger than signals observed for typical peptides and proteins.  Enhanced VCD 
signals of this magnitude were recently reported for fibrils of lysozyme and insulin, 
where it was suggested that the intensity enhancement could be the result of either inter-
sheet coupling, fibril braiding, or fibril twisting (213).  The origin of the enhancement has 
yet to be confirmed, however. 
It should be noted that the less intense, high-frequency shoulders of the enhanced 
VCD couplet of the AKY8 fibril solution coincide with peaks in the corresponding IR 
P a g e  | 115 
 
band profile.  These spectral features suggest a heterogeneous population of β-sheets of 
various lengths (240).  
 
 
2.3.4 VCD as a probe of fibril formation 
 
To illustrate the potential of VCD as a means to probe fibril formation kinetics, both the 
IR and VCD spectra were monitored as a function of time for different concentrations of 
AKY8.  A small amount of DCl was added to each peptide solution, which was then 
immediately placed into the spectrometer for measurement.  After a period of time (lag 
phase), features in the amide I’ and amide II’ regions of the VCD spectra begin to 
develop, which reflect the formation of β-sheet-rich fibrils.  In particular, a negative band 
appears in the amide II’ region, as shown in Figure 30, while the symmetric couplet 
observed for the AKY8 fibril solution (Figure 28) emerges in the amide I’ region.   
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Figure 30:  Time dependent VCD spectra of a 30 mM AKY8 solution, illustrating the increase in signals in the amide 
I’ and amide II’ regions attributed to AKY8 fibril formation.  These are representative spectra obtained from the 
kinetic experiment described in the Methods section (Section 2.5.3).  Starting with the spectrum displaying the 
least intensity in the amide I’ couplet, these spectra were acquired at times of approx. 17, 18.5, 20, 22, 24, 26.5, 
28.5, 30.5, 33.5, 37.5, and 44.5 hours, respectively. 
 
 
Figure 31 displays the kinetics of various marker bands in the VCD spectra, 
which emerge during the incubation at room temperature of a 20 mM solution of AKY8 
in acidic media.  As shown in Figure 31, the various normalized marker bands, including 
a negative VCD maximum at 1469 cm-1 in the amide II’ region, all overlap nearly 
perfectly.  To our best knowledge, this is the first time that VCD signals have been 
observed in the amide II’ region for amyloid-like fibrils, and thus suggest that this band 
may prove useful for delineating structural information of the resulting fibrils.  Moreover, 
the sigmoidal shape of the kinetic curves, which include both a lag phase and an 
exponential growth phase, is consistent with amyloid fibril formation (165, 185-186).  
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Figure 31:  Kinetics of AKY8 fibril formation probed by various marker bands in the time-dependent VCD spectra. 
 
 
The kinetics of fibril formation probed by the increase of the VCD couplet intensity in 
the amide I’ region were measured for various AKY8 concentrations.  Two representative 
sets of data are depicted in Figure 32 for 20 and 30 mM AKY8 solutions. 
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Figure 32:  Kinetics of AKY8 fibril formation probed by the increase in the couplet intensity at 1604 cm1 in the VCD 
spectrum of AKY8 at two different concentrations, namely 20 and 30 mM. 
 
 
As expected for aggregation via a nucleation mechanism, both the lag time and 
maximal rate of growth depend on the peptide concentration.  In particular, the lag time 
decreases, while the maximal growth rate, kmax, increases upon increasing the peptide 
concentration from 20 to 30 mM.  This is consistent with the aggregation of other 
peptides and proteins in vitro (241-243), which ultimately form un-branched, amyloid-
like fibrils.  Such behavior is typical of nucleated aggregation processes such as 
crystallization and amyloid fibril formation, where the lag phase can be eliminated by the 
addition of preformed aggregates to fresh solutions, a process known as seeding (165, 
185).   While the sequence of AKY8 is not linked with any particular disease, other non-
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disease related protein aggregates have shown cytotoxic effects (244).  Such systems can 
even form such toxic fibrils under the exact incubation conditions.   
 
2.3.5 PPII Structure of Oligomers 
 
During the lag phase, AKY8 maintains a PPII-like conformation, as indicated by VCD 
spectra acquired throughout this nucleation period shown in Figure 33.  As mentioned in 
Section 2.3.2, a negative couplet in the amide I’ region of the VCD spectrum is indicative 
of a predominant sampling of PPII-like conformations.  The VCD spectra acquired after 
20 min and 13 hours for a 20 mM AKY8 solution both reflect significant amounts of 
PPII-like structure is present during the nucleation phase.  These results reinforce the 
hypothesis proposed by Blanch et al. that PPII may be the so-called ‘killer’ conformation, 
which precedes the conformational switch to β-sheet secondary structure and subsequent 
fibril formation (214). 
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Figure 33:  (a.) VCD kinetic data of 20 and 30 mM AKY8 solutions from Figure 32.  (b.) Representative VCD spectra 
acquired during the nucleation phase of the 30 mM AKY8 solution after 20 min (blue, left) and 13 hour (red, right). 
 
 
 
2.3.6 C-Terminal Tyrosine Promotes AKY8 Aggregation 
 
The UV-CD spectrum of the AKY8 fibril solution is shown in Figure 34, along with that 
of monomeric AKY8.  The spectrum exhibits a negative maximum at ~220 nm, 
indicative of a β-sheet conformation (24, 245).  Moreover, the presence of some CD 
intensity in the near-UV region suggests that the C-terminal tyrosine residue of AKY8 is 
in a chiral environment.  Some scattering effects are also visible, attributed to negative 
sloping intensity extending from > 300 nm, where neither the peptide backbone nor the 
tyrosine side chain absorbs.  It is plausible that the intensity in the region of the tyrosine 
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side chain absorption is due to π – π interactions between tyrosine residues of molecules 
arranged in a parallel β-sheet conformation.  In fact, the N-terminal fragment of the yeast 
prion protein Sup35p, GNNQQNY, has been reported to form fibrils and microcrystals 
with the constituent molecules arranged as closely packed, dehydrated parallel β-sheets, 
stabilized by π – π interactions of neighboring strands (200, 224).  
 
 
Figure 34:  UV-CD spectra of a 2 mM AKY8 solution (black) and the AKY8 fibril solution (red).  
 
 
Since the IR spectrum in the amide I’ region clearly indicates an antiparallel 
conformation, interactions between the tyrosine residues in adjacent strands of the same 
sheet can be ruled out.  Instead, it is proposed that sheet formation is caused by cation - π 
interactions between the lysine and tyrosine side chains that yield the following out-of-
register arrangement: 
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     AAAAKAAY 
      YAAKAAAA                    (Scheme I) 
     AAAAKAAY 
      YAAKAAAA 
 
 
It has been shown that cation - π interactions, particularly those between a 
tyrosine and charged lysine, can be important for the stabilization of protein structures 
(246).  The role of such an interaction in peptide aggregation, however, has not been 
proposed to date.  The fibrils revealed by AFM images are consistent with the stacking of 
β-sheet tapes or protofibrils, which could be stabilized by π stacking between tyrosine 
residues or by addition cation – π interactions.  First simulations of the IR and VCD 
profiles of the amide I band for a very simple two-dimensional model of amide I 
oscillators in which a one-dimensional chain represents a sheet indicate that efficient 
packing rather than tilting of the sheet structure might yield the observed enhancement of 
the VCD signal (247).  
Intensity in the region of the UV-CD spectrum of AKY8 associated with tyrosine 
absorption prompted us to investigate the tyrosine-free peptide, namely Ac-
(AAAAKAA)-NH2 (AK7).  In a first step, we measured the amide I’ band profile of AK7 
of the IR and VCD spectra in D2O and in the absence of any added acid.  Figure 35 
shows a comparison of the IR and VCD amide I’ band profiles of monomeric AK7 and 
AKY8, prior to incubation in acidic media.  Clearly, the spectra normalized with respect 
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to concentration, pathlength, and number of amino acid residues, indicate very little 
structural difference between the two peptides in the monomeric state.   
 
 
Figure 35:  VCD (top) and FTIR (bottom) spectra of 30 mM AKY8 (black) and 50 mM AK7 (red) solution. 
 
 
We also measured the UV-CD spectrum of AK7, which is depicted in Figure 36, along 
with the monomeric spectrum of AKY8 for comparison.  These spectra offer further 
support for the notion that the monomeric states of both AK7 and AKY8 contain very 
similar structural characteristics. 
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Figure 36:  UV-CD spectra of monomeric solutions of AKY8 (2 mM) and AK7 (5 mM) in D2O. 
  
 
In contrast to AKY8, however, incubation of AK7 under conditions which 
promote the fibril formation of AKY8, does not result in any changes in the IR or VCD 
spectra (data not shown).  That is, AK7 does not aggregate into the fibrillar structures 
observed for AKY8.  Attempts were made to increase both the peptide and acid 
concentrations, as well as the incubation time, however, under no circumstance did AK7 
aggregate.  These results, in conjunction with the IR, VCD, and UV-CD spectra of AKY8 
suggest that the C-terminal tyrosine residue of AKY8 promotes aggregation and fibril 
formation.  These results thus provide insight into the mechanism of fibril formation by 
short segments of amyloidogenic proteins, such as Sup35p and Aβ, where in the former, 
the fibril formation of the N-terminal 7-residues motif, namely GNNQQNY has been 
suggested to be stabilized by π - π interactions involving the tyrosine residues from 
neighboring β-strands .  In the latter, the SRE of Aβ comprising residues 16 – 21 (248), 
consists of an aromatic residue, F (residue 19), which is separated from a lysine residue 
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(residue 16), by two amino acids, and are therefore positioned in the primary sequence so 
as to allow for possible cation - π interactions, similar to those proposed herein for 
AKY8.      
   
2.3.7 Yeast Sup35 Fragment 
 
The fibril-forming motif from the N-terminal region of the yeast prion protein, Sup35p, 
namely GNNQQNY, has been shown to form fibrils with an underlying parallel β-sheet 
arrangement (200).  The close packing of these ‘dehydrated’ sheets has been suggested to 
allow for aromatic interactions between the C-terminal tyrosine residues of consecutive 
strands (249).  To further investigate the enhanced VCD phenomena and the significance 
of C-terminal aromatic residue, we measured the IR and VCD spectra in the amide I’ 
band of the N-terminal fragment of the yeast prion protein.  This fragment has been 
shown to form both amyloid-like fibrils and fibrous microcrystals (200, 250).  More 
importantly, recent studies indicate a possible role of the C-terminal tyrosine residue in 
stabilizing the ‘dehydrated’ parallel β-sheets adopted by the fragment in fibrils (224).  
AFM images of the GNNQQNY aggregates reveal structures which more closely 
resemble microcrystals rather than typical amyloid-like fibrils (200, 224). 
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 The IR and VCD spectra of the amide I’ band of a saturated solution of 
GNNQQNY in D2O are shown in Figure 37.  The IR shows a maximum at 1630 cm-1, 
consistent with previous studies and indicative of a β-sheet conformation.  The 
corresponding VCD spectrum in this region shows a negative couplet, with an inflection 
point coinciding with the maximum of the IR band.  The negative couplet is in contrast to 
the positive couplet observed for AKY8 fibrils, but the magnitude of the enhanced VCD 
signal is even larger than that observed for AKY8 fibrils.  Moreover, AFM images of the 
corresponding GNNQQNY solution reveal aggregates which are more crystalline, and 
similar to those previously reported, as shown in Figure 38 (200, 224). 
 
 
Figure 37:  Amide I' band profiles of the FTIR (top) and VCD (bottom) spectra of aggregated GNNQQNY. 
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Figure 38:  AFM amplitude images of GNNQQNY.  The scale bar in each panel represents 1 μM. 
 
 
 
The UV-CD spectrum of the GNNQQNY fibril solution exhibits a negative at ~ 220 nm, 
consistent with a β-sheet structure.  Moreover, intensity in the near-UV region suggests 
that the C-terminal tyrosine residue is in a chiral environment.  These results are 
consistent with earlier reports that GNNQQNY forms fibrils with an underlying parallel 
β-sheet secondary structure (200).  The sheets are closely packed and stabilized by π - π 
interactions between the terminal tyrosine residues (224).  These results might suggest 
that the arrangement of AKY8 fibrils is actually parallel, in contrast to the IR results 
reported above.  In such a case, shielding of the positively charged lysine residue at acid 
pH by the Cl- would be required.   
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Figure 39:  Comparison of the UV-CD spectra of monomeric AKY8 and AK7 with the UV-CD spectra of the fibril 
solution of AKY8 and GNNQQNY. 
 
 
 
2.3.8 Conclusions 
 
The fibril formation of a short alanine-rich peptide, namely AKY8, has been reported.  
AKY8 forms amyloid-like fibrils upon incubation at room temperature in the presence of 
a small amount of acid.  Prior to aggregation, AKY8 adopts an ensemble of 
conformations in aqueous solution, with a predominance of PPII-like conformations, 
consistent with other short alanine-based peptides (e.g. see Chapter 1), as indicated by 
FTIR, VCD, and UV-CD spectra (69, 146, 238). 
The formation of AKY8 fibrils results in a downshift of the amide I’ peak in the 
amide I’ band of the IR spectrum as well as an enhanced couplet in this region of the 
VCD spectrum.  The increase in intensity of the amide I’ couplet, as well as a smaller 
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band in the amide II’ region of the VCD spectra can be used to probe the kinetics of fibril 
formation.  These results suggest that VCD can complement typical aggregation studies 
using, e.g.  IR spectroscopy, which can be employed to monitor the increase in the amide 
I’ aggregation band.  Thus, VCD spectroscopy is a convenient and novel probe of the 
fibril formation kinetics and structure of peptide fibrils.  When coupled with 
computational results and simulations, the use of VCD for protein aggregation studies 
may be able to provide local structural information of fibrils.  The progression of 
monomeric AKY8, containing a predominant fraction of PPII-like structure, into β-sheet-
rich fibrils reinforces the hypothesis of Blanch et al. that PPII may serve as a transitional 
conformation between the unaggregated species and the toxic fibrillar aggregates linked 
to various human pathologies (214-215).  
The C-terminal tyrosine residue plays a pivotal role in the aggregation of AKY8, 
as the heptameric analogue AK7 remains monomeric under conditions that promote 
AKY8 aggregation.  Such terminal tyrosine residues have also been suggested to provide 
stabilization of other short fibril forming motifs contained in many disease related 
proteins (224-225).  Results presented here further highlight the role of aromatic residues 
and aromatic interactions in promoting/stabilizing amyloid fibril formation of short 
peptides.   
  Taken together, these results reaffirm the notion that short peptides not affiliated 
with any known debilitating human ailments can be used as models for studying the 
mechanistic principles which govern the self-assembly of disease-related proteins.  
Moreover, these results offer further support for the hypothesis that fibril formation is an 
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inherent feature of the polypeptide backbone, so that a detailed understanding of the 
process will yield information which can be applied to developing therapeutic means for 
treating various seemingly unrelated diseases.   
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2.4 Materials and Methods 
 
2.4.1 Peptide Synthesis and Purification 
 
AKY8 and AK7 were synthesized in the laboratory of Sean Decatur at Mt. Holyoke 
College (South Hadley, MA), via Fmoc solid-phase peptide synthesis using a CEM 
Liberty microwave accelerated peptide synthesizer.  An acetyl group was added to the N-
terminus after the final deprotection.  Cleavage of the peptide product from the resin was 
carried out in a cocktail consisting of 95% trifluoroacetic acid (TFA), 2.5% H2O, and 
2.5% isopropanol.  Crude peptide was precipitated from the cleavage cocktail using cold 
t-butyl methyl ether, collected by centrifugation, and lyophilized.  The crude peptide was 
purified using reverse phase high-performance liquid chromatography (RP-HPLC) on an 
AKTA system (Amersham Pharmacia Biotech) equipped with a C18 prep column 
(Vydac).   The peptide was eluted using a linear gradient of acetonitrile, with 0.85% 
TFA.  Electrospray mass spectrometry (performed at the University of Massachusetts at 
Amherst Mass Spectrometry Facility) was used to confirm the peptide identity and 
purity.  Prior to use, all samples were dialyzed in a Spectra-Por Float-A-Lyzer Dialysis 
Bag, with a molecular weight cut-off of 500 Da (Spectrum Labs), to remove residual 
trifluoroacetic acid (TFA), which overlaps with the amide I’ band in the FTIR spectrum.   
The peptides were then lyophilized overnight, and re-dissolved in D2O.  For AKY8, the 
exact peptide concentration was determined from the tyrosine absorption at 275 nm, 
which has an extinction coefficient of 1450 M-1 cm-1, for experiments involving the 
monomeric, non-aggregated state.  To form the fibril solution of AKY8, the peptide was 
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incubated overnight at room temperatures in the presence of deuterium chloride (DCl).  
This procedure resulted in a gelatinous solution, containing AKY8 fibrils.   
 The 7-residue peptide motif from the N-terminal region of the yeast prion protein, 
Sup35, namely GNNQQNY, was purchased from AnaSpec (Fremont, CA), and used 
without further purification.  The peptide was dissolved in D2O at a concentration of 25 
mg/mL, which results in aggregation of GNNQQNY into amyloid-like fibrils and 
microcrystals (224, 251). 
 
2.4.2 Congo Red Binding 
 
Congo red was obtained from Fluka (> 97% purity).  To determine if the fibrils formed 
by AKY8 were of the amyloid type, a previously prepared 100 µM Congo red in D2O 
solution was added to the resulting gelatinous AKY8 solution (20 mM), and the 
subsequent UV/visible absorption spectrum was measured.  Upon binding of Congo red 
to amyloid fibrils, a red-shift of the Congo red absorption band at ca. 498 nm is observed.  
 
2.4.3 FTIR/VCD Spectroscopic Methods 
 
Vibrational Circular Dichroism (VCD) and FTIR spectra were measured with a 
ChiralIRTM spectrometer with a single PEM from BioTools (Jupiter, FL).  The peptide 
solutions were placed in a 20 um CaF2 BioCellTM obtained from BioTools.  The VCD and 
IR spectra of the unaggregated AKY8 and AK7 peptide were collected using the ChiralIR 
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software implemented in GRAMS/AI software v. 7.00 (Thermo Galactic), for 324 and 36 
minutes respectively, to improve signal-to-noise ratio, while the VCD and IR spectra of 
the supernatant fibril solutions of both AKY8 and GNNQQNY were obtained for 18 and 
2 minutes, respectively.  Both VCD and IR spectra were collected using 8 cm-1 
resolution. 
 Kinetic VCD and IR experiments were carried out using the features of the 
ChiralIRTM software, which allowed for arrayed or ‘blocked’ experiments.  For all VCD 
and IR kinetic experiments, 20 minute blocks were measured, where, for each block, the 
VCD and IR spectra were acquired for 18 and 2 minutes, respectively. 
 
2.4.4 Polarized Raman Spectroscopy 
 
The polarized Raman spectra were obtained with the 514 nm excitation from a mixed-gas 
ArKr laser (Stabilite 2018-RM).  The laser beam was directed into a RM 100 Renishaw 
confocal Raman microscope, and focused onto a 1.0 mm Q Silica cell with a thin glass 
cover slip using a x50 objective.  The scattered light was filtered with a 514 nm notch 
filter, dispersed by a single-grating 2400 l/mm grating and imaged onto a back-thinned 
Wright Instrument CCD.  It was polarized by a combination of a linear polarizer and a 
λ/2 plate.  The latter rotates the y-polarized light (perpendicular to the laser polarization) 
into the x-direction to achieve an optimal spectrometer transmission.  All spectra were 
recorded in the ‘continuous’ mode.  2 scans were measured for the AKY8 fibril solution 
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for both polarizations, and the spectra were averaged for each polarization direction in 
order to eliminate some of the noise.  
 
 
2.4.5 Atomic Force Microscopy (AFM)   
 
All AFM experiments were performed at room temperature, using a multimode atomic 
force microscope (Nanoscope IIIa; Digital Instruments, Santa Barbara, CA), equipped 
with an E-type piezoscanner.  5 µL of peptide solutions were applied to a freshly-cleaved 
mica surface for approx. 15 sec., at which point it was washed with 300 µL of deionized 
water and subsequently dried with a stream of N2 gas. Tapping-mode imaging was 
carried out with a silicon probe (TESP) from Veeco (Camarillo, CA). Height and 
deflection images of the gelled and non-gelled samples were obtained with a scan rate of 
1.0 Hz, 512 samples/line, an integral gain of 0.4, a proportional gain of 0.6, an amplitude 
setpoint of 0.8175, a drive amplitude of 10.53 V, and a lock-in BW of 1500Hz. 
 
 
2.4.6 Ultraviolet Circular Dichroism (UV-CD) Spectroscopy 
 
All UV-CD spectra were obtained on a Jasco J-810 spectropolarimeter,  using a data 
pitch of 0.05 nm, a response time of 1 second, a bandwidth of 5 nm, a scan speed of 500 
nm/min, and a wavelength window of either 180 – 300 or 180 – 500 nm.  The instrument 
was purged with N2 during the course of the measurements. For all UV-CD 
measurements, peptide stock solutions were diluted 10-fold with D2O, and were placed in 
a 50 um Q Silica UV-Grade demountable cell (International Crystal Laboratories).  
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CHAPTER 3 
Unexpected Aggregation and Hydrogel Formation of an Alanine-
Rich Oligopeptide 
 
3.1 Synopsis 
 
A detailed understanding of the mechanistic principles which govern peptide and protein 
self-assembly is of considerable biomedical and biotechnological importance.  Owing to 
the diversity of peptide and protein sequences which have been shown to aggregate, the 
ability to self-assemble is now recognized as an inherent feature of the polypeptide 
backbone.  It is therefore of utmost importance to elucidate the rules governing the self-
assembly process.  De novo designed oligopeptides, based on alternating hydrophobic 
and hydrophilic sequences exhibiting repetitive complimentary charge distributions have 
shown the potential to self-assembly into hydrogels rich in β-sheet structure.  Herein is 
presented the unexpected self-assembly of an alanine-rich oligopeptide containing only 
positively charged lysine residues, namely Ac-(AAKA)4-NH2 (AK-16).  Such a sequence 
does not abide by typical rules which allow for peptide self-organization.  AK-16 rapidly 
forms soluble thermodynamically unstable β-sheet structures in deuterated water at room 
temperature.  These β-sheet-rich aggregates can be stabilized by salt addition to yield a 
self-supporting macroscopic hydrogel, exhibiting the ability to encapsulate and slowly 
release a model protein.  The ability of AK-16 to self-assemble is attributed to the length 
of the lysine side chains, which allow for inter- and possibly intra-molecular hydrogen 
bonding to the peptide backbone.  This one-charge-type system with the ability to adopt 
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unstable β-sheet structures prior to hydrogelation belongs to a novel class of self-
assembling oligopeptides in which the conformational instability can be exploited to tune 
the viscosity of the resultant hydrogel.  This study provides insight into the de novo 
design of self-assembling oligopeptide systems. 
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3.2 Background Information 
 
3.2.1 Self-Assembly of Polypeptides 
 
“Molecular self-assembly is the spontaneous association of molecules under equilibrium 
conditions into stable, structurally well-defined aggregates joined by non-covalent bonds 
(252).”  Self-Assembly is ubiquitous throughout nature and technology, and results from 
the autonomous formation of non-covalent bonds, such as ionic and hydrogen bonds, as 
well as hydrophobic interactions (253-254).  While such non-covalent interactions are 
inherently weak, they collectively govern the self-assembly process (254).  A defining 
feature of all living systems is the precise organization of their constituent components 
(164).  On the biomolecular level, self-assembly manifests itself as the characteristic 
tertiary fold of a protein, the intricate architecture of a cell membrane, and the 
organization of extra-cellular matrix proteins such as elastin and collagen, which are 
responsible for imparting elasticity and flexibility to various tissues and organs (255).   
While the above-mentioned manifestations of biological self-assembly are 
necessary for the sustainability of living systems, other self-assembly processes are 
believed to be toxic.  In particular, the formation of amyloid-like fibrils from the 
aggregation of  misfolded or intrinsically disordered proteins and peptides (see Chapter 2) 
is believed to be responsible for the onset of various neurodegenerative diseases as well 
as the systemic amyloidoses (4, 164-165).  Clearly, biological self-assembly results in 
diverse architectures displaying various and often complex functions (253). 
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3.2.2 Hydrogels 
 
In addition to the biomedical relevance, peptide self-assembly has been exploited in 
recent years to create materials with inherent biofunctionality, such as hydrogels (26, 
235).  Hydrogels are defined as a hydrophilic polymeric network exhibiting the unique 
ability to swell in the presence of water (256-257), and are thus able retain large amounts 
of fluids in their swollen states, which can affect different mechanical and surface 
properties, as well as permeability and biocompatibility (257). 
Hydrogels were first discovered in 1960 by Wicherle and Lim (258), who realized 
the potential of poly(2-hydroxyethyl methacrylate) (PHEMA) gels as soft contact lens 
materials (256-257).  All hydrogels have in common that they can trap water, and are 
amphiphilic, consisting of both hydrophilic and hydrophobic parts (259).  Hydrogels are 
typically comprised of an underlying nanofiber scaffold, which allows for the entrapment 
of small clusters of water, such that convection and flow are reduced (259).  Such 
properties are unique to nanoscale fibers, so that synthetic and biological polymeric gels 
which exhibit microcavities result in reduced surface area and entrapment of significantly 
less water (259). 
While most synthetic hydrogels require the addition of chemical cross-linkers, 
peptide-based hydrogels rely on more physical cross-links, such as entanglements or 
weak intermolecular interactions (e.g. hydrogen bonds or van der Waals interactions) 
(256).  This attribute makes peptide-based hydrogels appealing for biological use, owing 
to their inherent lower toxicity, due to the absence of any added chemical cross-linkers.  
The bioactivity of peptide-based hydrogels arises from their “living tissue”-like 
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properties.  It has even been hypothesized that life began in a hydrogel environment, 
enabling pre-cells to form and carry out functions (260).  
So-called responsive peptide-based hydrogels have shown sensitivity to various 
physiological and biological environments, such as external pH and temperature, which 
highlight their usefulness in various biological applications.  Controlling/tailoring the 
primary amino acid sequence and environmental conditions may yield various novel 
biomaterials for specific biomedical and biotechnological uses (256). 
 
 
3.2.3 Hydrogel Formation by Oligopeptides 
 
De novo designed synthetic oligopeptides have shown the potential to self-assemble into 
macroscopic hydrogels with an underlying fibril-like network, rich in β-sheet content (26, 
183, 261-265).  Such oligopeptide-based hydrogels have been demonstrated to be useful 
as controlled release devices (261, 264)  and as tissue-engineering scaffolds (266-267).  
Oligopeptides offer themselves as convenient systems to exploit the hydrogel formation 
as they can easily be fine-tuned to allow for specific functionality and conformational 
preference.  In addition, large scale production of such oligo-systems has clear processing 
advantages over the production of longer poly-systems (183).  
Certain general guidelines exist for the formation of oligopeptide hydrogels (235).  
In particular, oligopeptide-based hydrogels are typically formed from de novo-designed 
sequences with alternating hydrophobic and hydrophilic residues, often containing 
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complementary charge distributions recurring throughout (235, 261, 264).  Charge 
complementarity provides for favorable electrostatic interactions which can stabilize both 
intermolecular and intramolecular hydrogen bonding, ultimately resulting in hydrogel 
formation with an underlying filamentous architecture, rich in β-sheet secondary 
structure (261, 264, 268-270).   
A few examples self-assembling oligopeptides that were designed under the 
consideration of the above-mentioned guidelines include KLD-12 (AcN-(KLDL)4-CNH2) 
(268), MAX-1 ((VK)4VDPPT(KV)4 -NH2) (271), RADA-16 (AcN-(RARADADA)2-
CNH2) (261, 264), EAK-16 ((AEAEAKAKA)2) (269), and EMK16-II 
((MEMEMKMK)2) (270).  Each of these sequences possesses the ability to form a 
polymeric network of nanofibers under well-defined conditions, e.g. pH, temperature, etc, 
rich in β-sheet secondary structures.  Most of these self-assembling oligopeptides form 
macroscopic hydrogels in the presence of added salt (235).   
In particular, the oligopeptides KLD-12, RADA-16, EAK-16 and EMK-16 all 
possess charged side chains under neutral conditions, which are positioned in the 
sequence so as to allow for favorable electrostatic interactions which can stabilize β-sheet 
secondary structures.  Recently, however, a comparison of the self-aggregation of 
EMK16-II and EAK-16 led to the conclusion that hydrophobicity rather than electrostatic 
interactions are the driving force of aggregation (270).  To advance the exploitation of 
peptide self-assembly in the creation of novel biomaterials, it is necessary to have a 
complete and detailed understanding of the rules which govern the self-assembly process. 
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Viscoelastic properties of peptide-based hydrogels and the density of the 
underlying nanofiber scaffold can be controlled by varying both peptide and salt 
concentrations (235, 262, 271).  Self-assembled gels typically exhibit shear thinning 
behavior, and are often quick in recovering their elastic properties once shearing has 
ceased (271).  Shear thinning is defined as the drop in viscosity as a function of the rate 
of the applied shear.  Such behavior results from breaking of physical cross-links, e.g. 
hydrogen bonds, by the applied strain (271).  
 
3.2.4 MAX1 
 
While polypeptides containing sequences of alternating hydrophobic and hydrophilic 
residues typically result in precipitation (263), the 20-residue-containing peptide 
(VK)4VDPPT(KV)4 is known to form hydrogels at alkaline pH values.  In this case, the 
short VDPPT motif allows for the formation of a turn between the (Val-Lys)n repeating 
units of the amphiphilic segments, which are then driven to adopt an antiparallel β-sheet 
arrangement by hydrophobic interactions, as shown in Figure 40  (271).  While at pH 
values below the pKa of the lysine side chains the peptide is monomeric, the presence of 
the turn motif allows for the stabilization of the amphiphillicty of (VKVKVK) at pH 
values where the lysine side chains are deprotonated.  In fact, UV-CD spectra indicate 
that upon increasing the pH, the peptide’s secondary structure shows transition from a 
statistical-coil-like conformation to one with a predominance of β-sheet structure in the 
hydrogel phase (245). 
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Figure 40:  Sequence and antiparallel β-sheet formation by the de novo designed MAX1 oligopeptide.  Figure was 
adapted from ref(271). 
 
 
3.2.5 KLD-12 
 
The oligopeptide AcN-(KLDL)3-CHN2 (KLD-12), designed by Kisiday et al., consists of 
alternating hydrophilic (K and D) and hydrophobic residues (L), and can form a 
macroscopic hydrogel under conditions providing favorable electrostatic interactions 
between the positively charged lysine residues and the negatively charged aspartic acid 
residues (267-268).  As shown in Figure 41, the charged residues of a single charge type 
all reside on the same face of an extended β-sheet.  Sheet stacking on one side via 
favorable electrostatic interactions between the negatively and positively charged faces of 
the sheet, and favorable hydrophobic interactions of the other side, results in the 
formation of a filamentous network, and ultimately hydrogelation. 
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Figure 41:  Representation of KLD-12 in a β-sheet conformation, illustrating the hydrophobic face containing all 
leucine residues and the hydrophilic face containing side chains with alternating charges (at neutral pH values). 
Adapted from ref(268). 
 
 
3.2.6 RADA-16 and Controlled Delivery  
 
The alternating complementary charges of the designed alanine-rich oligopeptide AcN-
(RARADADA)2-CNH2 (RADA-16) allow for the stabilization of β-sheet structures, and 
the formation of a macroscopic hydrogel (261, 264).  These ‘responsive’ peptides form 
hydrogels under neutral conditions, which allow for favorable electrostatic interactions 
between the oppositely charged side chain residues, as in the case of KLD-12 (see 
preceding section).  The resulting RADA-16 hydrogels have been shown to act as 
controlled release devices (261, 264).   
In particular, by tailoring the peptide concentration, Nagai et al. demonstrated the 
slow release of model dyes from the RADA-16 hydrogel matrix (264).  The authors 
found that the diffusivity of the various dyes decreased with increasing hydrogel peptide 
concentration, and were thus able to tailor the release profile of dyes by controlling the 
molecular interactions between the peptide nanofiber scaffold and the diffusant (264).  
Koutsopoulos et al. incorporated various proteins of differing hydrodynamic radii into the 
RADA-16 hydrogels, and monitored the slow release of the proteins from the hydrogel 
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matrix using fluorescence correlation spectroscopy (FCS) (261).  Using a variation of 
Fick’s second law of diffusion, the authors were able to determine the diffusion 
coefficient of the various proteins encapsulated in the RADA-16 hydrogel matrix, which 
are reported in Table 12. 
 
 
 
Protein Mol Mass [kDa] rH [nm] Diffusivity [10-10 m2/s] 
Lysozyme 14.3 1.9 0.50 ± 0.02 
Trypsin Inhibitor 20.1 2.4 0.32 ± 0.01 
BSA 66.0 5.3 0.24 ± 0.02 
IgG ≈ 150.0 ≈ 7.2 0.07 ± 0.01 
 
Table 12:  Molecular mass, radii of hydration (rH) , and diffusivities of various proteins released from RADA-16, as 
reported in ref(261). 
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3.3 AK-16 
 
3.3.1 Introduction  
 
Molecular self-assembly is ubiquitous throughout nature and technology, and is governed 
by noncovalent interactions (235, 252).  The onset of a variety of human diseases such as 
Alzheimer’s, Huntington’s, Parkinson’s, and type II diabetes, is directly associated with 
the spontaneous aggregation of specific proteins into unbranched, filamentous structures, 
termed amyloid fibrils (3-4, 165, 172). Despite the sequence diversity of the disease-
related proteins, the resultant fibril architectures are remarkably similar, consisting of a 
‘cross-β’ core, with individual β-strands aligned perpendicular to the fibril axis (173, 
200).  The formation of these fibrils has recently been shown to be causative in at least 
one type of amyloidosis, suggesting that inhibition or prevention of fibril growth offers a 
therapeutic means to combat many amyloidoses (272).  In this regard, elucidation of the 
mechanistic principles and contributing interactions which govern the fibril formation 
process is of utmost importance.   
In addition to the biomedical relevance, peptide self-assembly has been exploited 
in recent years to create materials with inherent biofunctionality and biocompatibility.  In 
particular, peptide hydrogels have shown potential to act as drug delivery systems (261, 
264), tissue engineering scaffolds (263, 269), and to accelerate hemostasis (262).  De 
novo-designed oligopeptide systems typically rely on a sequence of alternating 
hydrophobic and hydrophilic residues, often containing complimentary charge 
distributions alternating recurring throughout (235).  A few examples self-assembling 
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oligopeptides include KLD-12 (AcN-(KLDL)4-CNH2) (268) (see Section 3.2.5), RADA-
16 (AcN-(RARADADA)2-CNH2) (261, 264) (see Section 3.2.6), EAK-16 
((AEAEAKAKA)2) (269), EMK16-II ((MEMEMKMK)2) (270), and MAX-1 
((VK)4VDPPT(KV)4 -NH2) (271) (see Section 3.2.4).  Each of these peptides can form a 
polymeric network of nanofibers rich in β-sheet secondary structures, under well-defined 
conditions, e.g. pH, temperature, etc.  
In particular, the peptides KLD-12, RADA-16, EAK-16 and EMK-16 all posses 
charged side chains under neutral conditions, which are positioned in the sequence so as 
to allow for favorable electrostatic interactions which can stabilize β-sheet secondary 
structures.  Recently, however, a comparison of the self-aggreagation of EMK16-II and 
EAK-16 led to the conclusion that hydrophobicity rather than electrostatic interactions is 
the driving force of aggregation (270).  To advance the exploitation of peptide self-
assembly in the creation of novel biomaterials, it is necessary to have a complete and 
detailed understanding of the rules which govern the self-assembly process.      
In contrast to de novo designed oligopeptide sequences containing alternating 
complimentary charges, our group has recently reported the surprising ability of an 
alanine-based peptide, namely Ac-(AAKA)4-NH2 (AK-16) to form a hydrogel rich in β-
sheet structures (273).  This came as a surprise since alanine-rich peptides of similar 
length and amino acid composition typically adopt α-helical conformations in aqueous 
solutions (65, 274) and the positively charged lysine residues were expected to prevent 
self-aggregation.  Instead, AK-16 forms thermodynamically unstable β-sheet structures, 
which decay into PPII- and turn-like conformations.  Stabilization of the initial AK-16 β-
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sheet structures via salt addition yields a macroscopic hydrogel which can slowly release 
encapsulated molecules. The viscosity and physicochemical properties of the AK-16 
hydrogels can by tuned by varying the type of salt, the salt and peptide concentrations, 
and more importantly by exploiting the conformational instability of the β-sheet 
aggregates. These unique properties are, in part, promoted by the length of the side chain 
of the lysine side chains. Our results illustrate the unique properties of a novel class of 
self-assembling peptides, and provide insight into considerations for de novo design of 
self-assembling oligopeptides.   
 
3.3.2 Time-Dependent UV-CD Reflects Conformational Instability of AK-16  
 
Upon dissolution in deuterated water, AK-16 forms a thermodynamically unstable 
population of β-sheet-rich structures.  This is observed even at concentrations as low as 
7µM.  These β-sheet rich aggregates organize into a filamentous network of structures, as 
shown in Figure 42. These filamentous aggregates exhibit the ability to bind the 
amyloid-specific dye Congo Red, as shown by the shift in the 498 absorption band of 
Congo red to approx. 541 nm (Figure 43) (239).   This is consistent with other 
oligopeptide aggregates (270), and indicative of structures very similar to those of 
amyloid fibrils.   
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Figure 42:  AFM Height Images of various samples deposited onto freshly cleaved mica. (a.) 10 mg/mL AK-16 
solution, showing a filamentous network (b.)  AK-16 hydrogel, prepared with AK-16 and NaCl concentrations of 10 
mg/mL and 1.0 M, respectively, displaying a nanoweb-like network.  
 
 
 
Figure 43:  UV absorption spectra illustrating the binding of Congo red to AK-16 aggregates in a 5 mg/mL peptide 
solution in the absence (black) and presence (blue) of 1 M NaCl.  Congo red (red) shows an absorption band at 498 
nm.  This is shifted when bound to amyloid-like fibrils, such as those formed by AK-16. 
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AK-16 forms filaments rich in β-sheet secondary structure, even at concentrations as low 
as 35 μM, where bundles of tangled fibers are observed, as shown in the AFM image in 
Figure 44. 
 
 
Figure 44:  AFM image (height) of 35 μM AK-16, showing a bundle of tangled filaments. 
 
 
In contrast to amyloid-like fibrils, however, the AK-16 aggregates are soluble and 
conformationally unstable.  Figure 45 exhibits the time-dependence of the UV-circular 
dichroism (UV-CD) spectra of AK-16 at various peptide concentrations.  For each 
concentration, the spectrum measured after 5 minutes of sample preparation exhibits a 
negative maximum at ca. 215 nm, indicative of a β-sheet-conformation (23-24).  As time 
progresses, this band slowly looses intensity at the expense of a negative maximum 
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appearing at approximately 198 nm and a negative shoulder near 220 nm, for 
concentrations ≤  5 mg/mL (3.5 mM).  These spectral changes reflect a conformational 
transition into more PPII- and possible turn-like conformations (238, 270). The difference 
spectra between those measured at 300 min. and 5 min. exhibit a characteristic positive 
maximum at 218 nm and a negative maximum at 198 nm (see Figure 46), both of which 
are consistent with a predominance of PPII-like conformations being populated (275). 
 
 
Figure 45:  Time-dependent UV-CD spectra of AK-16 at various concentrations.  For clarity, only those spectra 
acquired at 5 (short dash), 150 (dash dot dash), and 300 (solid) minutes after dissolution in deuterated water are 
shown.  The spectral changes reflect a decrease in β-sheet secondary structure, while the increase in the negative 
maximum at 198 nm reflects an increase in more flexible PPII- and turn-like conformations as described in the text. 
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Figure 46:  Time-dependent UV-CD spectra of AK-16 at various concentrations.  For clarity, only those spectra 
acquired at 5 (short dash), 150 (dash dot dash), and 300 (solid) minutes after dissolution in deuterated water are 
shown.  The spectral changes reflect a decrease in β-sheet secondary structure, while the increase in the negative 
maximum at 198 nm reflects an increase in more flexible PPII- and turn-like conformations as described in the text. 
 
 
3.3.3 UV-CD Kinetics 
 
Figure 47 displays the kinetics of the time-dependent UV-CD spectra of Figure 
47, at three different peptide concentrations, namely 1.0, 5.0, and 10.0 mg/mL.  The 
kinetics of the conformational transitions probed by recording the dichroism, ∆ε, as a 
function of time at 215 nm exhibit a biphasic behavior.     The fast phase is concentration 
independent and has a time constant of 18 ± 1 min., while the second phase proceeds an 
order of magnitude slower and yields a rate constant which is linearly proportional to the 
peptide concentration, as depicted in the inset of Figure 47.  As will be discussed, the 
fast phase reflects the slow hydration of the AK-16 aggregates. 
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Figure 47: Kinetic Analysis of AK-16 at three different peptide concentrations, namely 1, 5, and 10 mg/mL, probed 
at 215 nm.  The decay of the 215 nm signal reflects the loss of β-sheet structure.  Analysis revealed biphasic 
kinetics, consisting of a concentration-independent fast phase with a time constant of 18 ± 1 min. attributed to the 
slow hydration kinetics of AK-16 β-sheet aggregates.  The second phase proceeds an order of magnitude slower 
that the first, with the rate constant, k2, exhibiting a linear correlation with the concentration of AK-16, as shown in 
the inset. 
 
 
 
3.3.4 Time-Dependent FTIR Confirms Slow Hydration Kinetics of AK-16  
 
To further elucidate structural characteristics of the unstable AK-16 aggregates, we 
measured the time-dependent FTIR spectra of AK-16 in the amide I’ band region.  The 
amide I’ band is the most structurally sensitive IR band, resulting predominantly from 
backbone carbonyl stretching (103).  The FTIR spectra of the amide I’ band region of 
AK-16 (10 mg/mL), measured at 5 min. and 300 min. after dissolution are shown in 
Figure 48(a.).  An intense band at 1616 cm-1 and a much weaker band at 1693 cm-1 are 
consistent with an antiparallel β-sheet conformation (103, 240).  Further support for an 
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antiparallel arrangement has been confirmed by molecular dynamics (MD) simulations of 
AK-16 dimers and trimers (276).   
Interestingly, the FTIR spectrum of AK-16 initially shows some intensity in the 
amide II band region (Figure 48(a)).  This band typically occurs between 1500 and 1600 
cm-1, and results from a combination of C-N (s), C-C (s) (s = stretching mode), and N-H 
in-plane bending (103).  Deuteration results in a downshift of the amide II band (termed 
amide II’) by approx. 100 cm-1, owing to the lower frequency of the N-D bending (102).  
This initial intensity in the amide II region of the initial AK-16 spectrum indicates a 
significant amount of amide protons involved in hydrogen bonds.  These amide protons 
slowly exchange with deuterons of the solvent, resulting in a decrease in intensity of the 
amide II band and a concomitant increase in intensity of the amide II’ band.  A linear 
correlation exists between the amide II’ and amide II peak intensities, suggesting a slow 
H-D exchange process, as show in the inset to Figure 48(b.)  Interestingly, the kinetics of 
both the amide II’ and amide II peak intensities Figure 48(b.) can be fit with a single 
exponential function with the time constant determined for the fast phase of the UV-CD 
kinetic analysis, namely 18 ± 1 min.  This value is indicative of somewhat buried, 
immobile amide protons (277).  
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Figure 48:  Top Panel:  FTIR Spectra of a 10 mg/mL AK-16 solution measured at both 5 min. (red) and 5 hour (black) 
after dissolving the peptide in D2O.  Bottom Panel:  Kinetics of the amide II’ (blue triangles) and amide II (black 
circles) bands probed at 1469 cm-1 and 1535 cm-1, respectively, both of which can be fit with a single exponential 
function using the time constant reported for the fast phase of the UV-CD kinetic analysis, namely 18 min.  Inset:  a 
plot of amide II versus amide II’ peak intensities.  The negative linear correlation reflects H-D exchange of backbone 
amide protons. 
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3.3.5 Temperature Dependence of AK-16 
 
In addition to the time-dependent instability of the AK-16 β-sheet aggregates, these 
species also decay with increasing temperatures into conformations similar to those 
which form over time.  Figure 49 shows the temperature dependent UV-CD spectra of 
AK-16, which reflect a β-sheet to PPII conformational transition as the temperature is 
increased.  Moreover, temperature-depending FTIR spectra are shown in Figure 50.  The 
decrease in intensity of the band at 1616 cm-1 is also consistent with a loss of anti-parallel 
β-sheet secondary structure.      
 
 
Figure 49:  Temperature-dependent UV-CD spectra of a 5 mg/mL AK-16.  The arrows indicate the direction of 
temperature increase.  The inset displays the change of the molar absorptivity, ∆ε, at 214.5 nm as a function of 
temperature.   
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Figure 50:  Temperature-dependent FTIR spectra of a 5 mg/mL AK-16 solution, reflecting the decay of the β-sheet 
secondary structure at increasing temperatures. 
 
 
 
3.3.6 Side Chain Length Promotes Conformational Instability 
 
In an attempt to elucidate the stabilizing elements of AK-16 β-sheet aggregates, we 
looked at various lysine side chain mutations.  In particular, the four lysine residues in 
AK-16 were substituted by either glutamic acid (E), arginine (R), or ornithine (O), 
resulting in the following sequences:  Ac-(AAEA)4-NH2 (AE-16), Ac-(AARA)4-NH2 
(AR-16), and Ac-(AAOA)4-NH4 (AO-16), respectively.  Ornithine is essentially a 
truncated lysine residue, with one less methylene (–CH2) group.  In addition, we also 
investigated Ac-(AAKA)3-NH2 (AK-12), to see if sequence length played a role in the 
aggregation propensity of AK-16.  Figure 51 shows the UV-CD spectra of AO-16, AE-
16, and AK-12 in deuterated water at different pH values, all of which are at peptide 
concentrations of 5 mg/mL.  It is clear that each of these peptides adopts a mixture of α-
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helical and PPII conformations, depending on whether the side chains are uncharged or 
charged, respectively (24).  This observation is consistent with homopolypeptides of 
amino acids containing ionizable side chains (41).  AFM images show no indication of 
AO-16, AE-16, or AK-12 aggregation (not shown).  In contrast to these results, AR-16 
behaves in a way similar to that of AK-16 in solution.  In particular, AR-16 forms 
soluble, thermodynamically unstable β-sheet-rich aggregates upon dissolution in 
deuterated water.  AFM images of AR-16 depict a filamentous network similar to that 
which is observed for AK-16 (Figure 52).  
 
 
Figure 51:  UV-CD spectra of AO-16 (dash dash), AE-16 (solid), and AK-12 (dash dot dash), measured at 25°C, at two 
indicated pH values.  The negative maxima at 208 nm and 222 nm reflect α-helical conformation, while the positive 
and negative maxima at 220 and 198 nm, respectively, are indicative of PPII- like conformations.    
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Figure 52:  AFM image (height) of 5 mg/mL AR-16. 
 
3.3.7 AK-16 Hydrogel Formation as a Function of Salt and Secondary Structure  
 
Upon salt addition, AK-16 solutions instantaneously form macroscopic hydrogels at 
concentrations > approx. 5 mg/mL (Figure 53).  This is consistent with hydrogel 
formation observed for other self-assembling oligopeptides (235).  The AK-16 hydrogel 
shows a nanoweb-like architecture, as seen in the AFM image shown in Figure 42(b).  
To study the salt dependence of the physicochemical properties of the AK-16 hydrogels, 
we measured the the UV-CD spectra of AK-16 in the presence of various salts, including 
NaCl, CsCl, MgCl2, and Na3PO4.  As shown in Figure 54(a.), salt addition stabilizes the 
underlying β-sheet secondary structure, resulting in a narrowing of the negative 
maximum at 215 nm in the UV-CD spectrum.  The valency of salt ions can have a large 
effect on the types of aggregates formed by oligopeptides (270).  We found that the 
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position of the negative maximum in the UV-CD spectra is blue-shifted when multivalent 
salts are added, relative to the position in the presence of monovalent salts.  Similar 
results have recently been observed for EMK16-II, where the blue-shift of the negative 
UV-CD band is attributed to the formation of more compact and amorphous aggregates 
observed in the presence of multivalent ions.  The FTIR spectra of AK-16 as a function 
of the various salts (Figure 54(b.)), shows a downshift of the amide I’ band from 1618 
cm-1 in the absence of salt, to 1616 cm-1 in the presence of the monovalent salts NaCl and 
CsCl, at concentrations of 1 M, to 1614 cm-1 in the presence of the multivalent salts, 
MgCl2 and Na3PO4.  The amide I’ downshift results from stronger coupling of the 
backbone carbonyl stretching vibrations (240), and is consistent with the formation of 
more compact β-sheet-rich aggregates (270).  
 
 
Figure 53:  Self-suporting AK-16 hydrogel, prepared by adding NaCl to a 5 mg/mL solution of AK-16 to yield a 2 M 
NaCl AK-16 hydrogel. 
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Figure 54:  (a.) UV-CD and (b.) FTIR spectra of 5 mg/mL AK-16 solution with various salts (all salt concentrations 
were 1 M).  The multivalent salts result in more compact β-sheet secondary structures,  as reflected by the (a.) red-
shift and narrowing of the UV-CD negative maximum (between 215 – 220 nm), and (b.) the downshift of the amide 
I’ peak position. 
 
 
 
To elucidate the rheological properties of AK-16 hydogels, we measured the 
viscosity as a function of shear rate for AK-16 hydrogels prepared with varying NaCl 
concentrations.  At peptide concentrations of 5 and 10 mg/mL and NaCl concentrations 
ranging from 1 – 2 M, shear-thinning behavior is observed, in which the viscosity of the 
hydrogel decreases as a function of shear rate, as shown in Figure 55.  Such behavior is a 
defining characteristic of oligopeptide hydrogels (see Section 3.2.3) (271).  Higher salt 
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and peptide concentrations yield more viscous hydrogels.  Based on the prerequisite of β-
sheet structures being necessary for the formation of stable hydrogels, we attempted to 
exploit the conformational instability of the AK-16 β-sheets to essentially tune the 
viscosity of the resulting hydrogel.  We prepared 2 separate AK-16 hydrogels from the 
same 5 mg/mL peptide stock solution, one of which was prepared with the fresh stock 
solution; the other from a portion of the solution which was allowed to incubate overnight 
at room temperature.  As shown in Figure 55, the hydrogel prepared from the incubated 
solution exhibited a much lower viscosity than that which was prepared with a fresh 
sample, yet still resulted in shear-thinning behavior. 
 
 
Figure 55:  Viscosity of AK-16 hydrogels as a function of shear rate.  Hydrogels were prepared with 5 mg/mL AK-16 
and 1 M NaCl (black) and 10 mg/mL AK-16 and 1 M NaCl (red).  To illustrate how β-sheet structure effects the 
viscosity of the resulting hydrogel, NaCl was added to both a freshly prepared portion of a 5 mg/mL AK-16 solution 
(blue, solid), and to a portion which was allowed to incubate overnight at room temperature (blue, dash), to yield 
as resulting salt concentration of 2 M.  All samples were measured a total of three times.  The decrease in viscosity 
vs. shear rate is indicative of shear-thinning behavior, and characteristic of peptide-based hydrogels. 
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3.3.8 Slow Release of a Model Protein from AK-16 Hydrogels 
 
Capitalizing on the inherent biocompatibility and wide range of pH values at which the 
system should be operable (i.e. below the pKa of the Lys side chain), we illustrated the 
application of AK-16 hydrogels as potential drug delivery systems by incorporating a 
model protein, namely cytochrome c, into the AK-16 matrix, and monitored the release of 
the protein from the hydrogel via UV absorption spectroscopy.  The release profiles are 
shown in Figure 56. for different AK-16 and protein concentrations.  The diffusion 
coefficient of cytochrome c was determined using the method of Koutsopoulos et al. 
(261), as described in Section 3.4.5.  The diffusivity was found to be nearly independent 
of the protein concentration, and slightly dependent on the concentration of AK-16 in the 
hydrogel.  In particular, we obtained a diffusion coefficient of 0.61 ± 0.05 x 10-10 m2/s for 
cytochrome c released from the 10 mg/mL AK-16 hydrogel and 0.52 ± 0.05 x 10-10 m2/s 
for cytochrome c released from the 5 mg/mL AK-16 hydrogel.  The magnitude of these 
values is consistent with those of proteins of similar size and radii of hydration (278) 
released from RADA-16 hydrogels (261).  The similarity of the UV-CD spectrum of 
cytochrome c released from the AK-16 hydrogel with that in aqueous solution (Figure 
57) suggests that AK-16 hydrogels can be used to encapsulate and release model proteins 
while maintaining their native secondary structure. 
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Figure 56:  Slow release experiments of cytochrome c (cyt. c) encapsulated in AK-16 hydrogels (prepared w 1 M 
NaCl) with the following peptide and protein concentrations:  10 mgmL AK-16 + 65 µM cyt. c (blue), 10 mg/mL AK-
16 + 130 µM cyt. c (black), and 5 mg/mL AK-16 + 65 µM cyt. c (red).  Cytochrome c release was monitored via the 
absorption at 275 nm.  Inset:  Plot of [𝑪𝒚𝒕𝒄]𝒕[𝑪𝒚𝒕𝒄]∞  vs. √𝒕𝒊𝒎𝒆.  The slope of the linear portion is used to calculate the 
protein diffusion coefficient as described in Section 3.4.5. 
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Figure 57:  Comparison of UV-CD spectra of cytochrome c (equine) in D2O (solid), at a concentration of 130 µM, and 
after release from the AK-16 hydrogel (dashed line).  Both samples had pH values between 7 and 8.  The slight 
negative intensity bias at 208 nm in the spectrum of the cytochrome c released from the peptide hydrogel is most 
likely due to the presence of a small amount of AK-16, which may have become dislodged from the hydrogel matrix 
either during the addition of the top D2O layer (see Materials and Methods) or during the course of the release 
experiment. 
 
 
  
3.3.9 Discussion   
 
The ability of AK-16 to form aggregates rich in β-sheet secondary structures comes as a 
surprise since alanine-rich peptides of similar length and amino acid composition 
typically adopt α-helical conformations in aqueous solutions (65, 279).  The sequence 
positions of the positively charged lysine residues should prevent the formation of sheet 
structures via electrostatic repulsion.  In contrast to these expectations, the time-
dependent UV-CD and FTIR spectroscopic measurements suggest that AK-16 forms 
thermodynamically unstable β-sheet structures in water which spontaneously decay into 
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more flexible, PPII-like conformations.  Biphasic kinetics are observed for the 
conformational decay, as probed by the UV-CD spectra, where the fast phase reflects the 
slow hydration of AK-16 aggregates, as confirmed by the H-D exchange process 
observed by the temporally resolved FTIR spectra.   
These results suggest that preformed β-sheet aggregates in the solid state, which 
would be expected to dissociate upon dissolution in water, are somewhat stabilized and 
exhibit slow hydration kinetics.  Indeed, the attenuated total reflectance (ATR) spectrum 
of AK-16 powder confirms the predominance of an antiparallel β-sheet conformation in 
the solid state (Figure 58).  This behavior is different from what is generally reported in 
the literature about more conventional self-aggregating peptides, including both those 
which dissolve quickly into monomers in aqueous solution and recombine into 
aggregates only after a nucleation process has taken place (280), and those which 
assemble under well-defined and controlled conditions (235).  
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Figure 58:  ATR spectrum of solid AK-16 measured on a Perkin Elmer Spectrum One FTIR Spectrometer equipped 
with a universal ATR sampling accessory, and acquired using the Spectrum software (v. 5.3, Perkin Elmer). 
 
 
 
The percentage of PPII-like conformations present 5 hours after dissolution 
(relative to the initial 5 min. spectra) can be gauged by the intensity of the positive 
maximum at 220 nm (275).  As shown in Figure 46, the PPII percentage exhibits a 
negative linear correlation with the AK-16 concentration.  The decay of the AK-16 β-
sheet conformation into PPII-like conformations suggests a link between these two 
conformations.  This finding offers support for the hypothesis put forward by Blanch et 
al. suggesting that PPII may be the ‘killer’ conformation in the various ‘conformational’ 
diseases, since PPII conformations appear to precede the β-sheet conformational switch, 
which is concurrent with fibril formation (see Section 2.2.9) (214).   
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In addition to the spontaneous decay of the AK-16 β-sheets over time, these 
aggregated structures also decay with increasing temperature, as reflected by the 
temperature-dependent UV-CD and FTIR spectra shown in Figure 49 and Figure 50, 
respectively.   As the temperature is increased, both UV-CD and FTIR spectral changes 
reflect a melting of the β-sheet structures into more PPII-like conformations.  Molecular 
dynamics simulations are also consistent with thermodynamically unstable AK-16 β-
sheets (276).  In particular, REMD simulations of the dimerization and trimerization of 
AK-16 were carried out for 64 nm, using 16 replicas with temperatures ranging from 
290.5 to 527.5 K.  Results of this study confirm that the population of the oligomer 
species drops sharply as the temperature is increased above approx. 320 K (276). 
The ability of AR-16 to self-assemble into well-ordered structures similar to those 
of AK-16, together with the fact that neither AO-16 nor AE-16 aggregate under similar 
conditions suggests that the length of the side chains are defining features of (AAxA)4 β-
sheet aggregates.  The side chains of both Lys and Arg are of similar lengths, while Orn 
and Glu are slightly shorter.  Owing to the similar functionality of the Lys and Orn side 
chains, this finding provides strong evidence that inter- and possibly intra-molecular 
hydrogen bonds are initially formed between the Lys side chains and the peptide 
backbone, which can stabilize β-sheet structures.  Without the addition of stabilizing 
elements, e.g. salt, electrostatic repulsion of the Lys/Arg side chains results in the 
spontaneous decay of the β-sheet structures, with the concurrent hydration of the 
backbone, until a slow-approaching equilibrium is reached.  β-sheet stabilization and thus 
hydrogel formation results from the shielding of the lysine side chain charges, which can 
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then allow for such an extended structure, with the lysine side chains all residing on the 
same face of the sheet. 
Sequence length is important for self-assembly and β-sheet formation.  This is 
evidenced by the fact that AK-12 does not aggregate under conditions similar to those 
promoting AK-16 self-assembly, even at concentrations five times larger than those used 
for AK-16 and AR-16 (not shown).  It is plausible that only the two central AAKA 
segments of AK-16 are involved in the β-sheet formation, so that end effects dominating 
in the case of AK-12, prevent such behavior.  In fact, the aggregation and β-sheet 
formation of many disease-related peptides and proteins is thought to be initiated by short 
motifs, or “self-recognition elements” (SRE’s), which contain only a few amino acid 
residues (218, 250).  
β-sheet structure is a prerequisite for hydrogel formation by AK-16.  Stabilization 
of AK-16 β-sheet aggregates can be achieved via the addition of various salts to yield a 
self-supporting hydrogel with an underlying nanoweb-like architecture.  The viscosity 
and physicochemical properties of the hydrogel depend on the type of salt used, the salt 
and peptide concentrations, as well as the amount of β-sheet secondary structure present.  
The underlying fibrillar network of AK-16 hydrogels allows for the encapsulation and 
slow release of a model protein, illustrating the potential of such a system for drug 
delivery.  Since β-sheet structure is a prerequisite for AK-16 hydrogel formation, the 
initial conformational instability of such structures presents AK-16 as a unique class of 
hydrogel-forming oligopeptides, where the conformational instability can exploited as a 
means to tune the viscosity and physicochemical properties of the resultant hydrogel.  In 
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contrast to other de novo designed oligopeptides which rely on stabilization by opposing 
charges present at neutral pH values, AK-16 hydrogels should, in principle, be stable at a 
wide range of pH values below the pKa of the lysine side chains.   
 
3.3.10 Conclusions 
 
The 16-residue alanine rich peptide Ac-(AAKA)4-NH2 was found to form 
thermodynamically unstable β-sheet-rich aggregates in water. AK-16 disobeys typical 
sequence requirements that allow for peptide self-assembly.  In particular, the presence of 
only positively-charged lysine residues spaced every three residues in the sequence, 
would be expected to disfavor β-sheet formation by electrostatic repulsion.  The 
thermodynamically unstable AK-16 β-sheet aggregates decay as a function of both time 
and temperature, to yield a more heterogeneous population with a predominance of PPII-
like conformations. 
 The kinetics of the temporal decay of the β-sheet aggregates indicates a biphasic 
behavior where the fast phase is independent of peptide concentration, yielding a value of 
18 ± 1 min.  This phase is attributed to the slow hydration kinetics of pre-formed β-sheet-
rich aggregates in the solid state.  The aggregation propensity of AK-16 is attributed to 
the length of the lysine side chain, which can allow for the formation of inter- and 
possibly intra-molecular hydrogen bonding to the peptide backbone upon dissolution.  
Stabilization of the unstable AK-16 β-sheet structures via salt addition results in the 
formation of a hydrogel for potential biotechnological and biomedical applications.  The 
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viscosity and physicochemical properties of the resulting hydrogel can be tuned by 
factors such as salt type and concentration, peptide concentration, and β-sheet content.  
Taken together, these results illustrate the unique conformational properties of a novel 
class of self-assembling oligopeptides, and offer insight into de novo design of self-
assembling peptides for the creation of novel biomaterials.   
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3.4  Materials and Methods 
 
3.4.1 Materials 
 
Ac-(AAKA)4-NH2 (AK-16, > 98 % purity), Ac-(AAEA)4-NH2 (AE-16, > 98 % purity), 
Ac-(AARA)4-NH2 (AR-16, > 98 % purity), Ac-(AAOA)4-NH2 (AO-16, > 98 % purity), 
and Ac-(AAKA)3-NH2 were synthesized by Celtek Peptides (Nashville, TN), and used 
without further purification.  D2O, CsCl, Na3PO4, and MgCl2 were purchased from 
Sigma.  NaCl was purchased from Acros Organics.  Equine cytochrome c was purchased 
from Sigma and used without further purification.  Peptide solutions for the UV-CD and 
FTIR spectroscopic time-dependent measurements were prepared as follows.  A pre-
weighed amount of solid peptide was dissolved in D2O, and sample was vortexed for 
approximately 1 min.  This resulted in non-turbid, homogenous samples.  The peptide 
solution was added to an appropriate cell, and placed into the sample chamber of the 
instrument.  All kinetic measurements were started approximately 5 minutes after sample 
preparation.  Samples of AK-16 with varying salt concentrations were prepared by 
adding a freshly prepared solution of 5 mg/mL AK-16 to a pre-weighed amount of salt.   
     
3.4.2 UV-CD Spectroscopy 
 
All UV-CD spectra were measured using a Jasco J-810 spectropolarimenter, using a data 
pitch of 0.05 nm, a response time of 1 second, a bandwidth of 5 nm, a scan speed of 500 
nm/min, and a wavelength window of 180 – 300 nm.  The instrument was purged with N2 
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during the course of the measurements.  For all UV-CD measurements, peptide stock 
solutions were diluted 10-fold with D2O, and were placed in a 50 um Q Silica UV-Grade 
demountable cell (International Crystal Laboratories).  Temperature was controlled inside 
the chamber using a Peltier temperature controller (Jasco). 
 
3.4.3 FTIR Spectroscopy 
 
FTIR spectra were measured with a ChiralIRTM spectrometer BioTools (Jupiter, FL).  All 
peptide solutions containing various peptide and salt concentrtaions were placed in a 100 
µm CaF2 circular BioCellTM obtained from BioTools.  For kinetic FITR measurements, 
spectra were collected at 5 minute intervals over a course of 5 hours, using 8 cm-1 
resolution, and were solvent corrected.  3 scans were averaged at each time interval.  The 
instrument was purged with N2 during the course of the measurements, and all spectra 
were collected using the GRAMS/AI software v. 7.00 (Thermo Galactic).   
 
3.4.4 AFM 
 
All AFM experiments were performed at room temperature, using a multimode atomic 
force microscope (Nanoscope IIIa; Digital Instruments, Santa Barbara, CA), equipped 
with an E-type piezoscanner.  Peptide samples were applied to a freshly-cleaved mica 
surface for approx. 15 sec., and subsequently dried with a stream of N2 gas. Tapping-
mode imaging was carried out with a silicon probe (TESP) from Veeco (Camarillo, CA). 
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Height and deflection images of the gelled and non-gelled samples were obtained with a 
scan rate of 1 Hz. 
 
3.4.5 Controlled Release Expeirments 
 
Cytochrome c encapsulated AK-16 hydrogels were prepared as follows.  A pre-weighed 
amount of AK-16 was dissolved in cytochrome c in D2O solution with a protein 
concentration of either 1 or 2 mg/mL.  This solution was transferred to a 10 mm quartz 
cell (Hellma), and a saturated NaCl solution (in D2O) was added dropwise to yield a final 
AK-16 of either 5 mg/mL or 10 mg/mL, and a final NaCl concentration of 1.0 M.  Due to 
dilution with the saturated NaCl solution, this procedure yielded an encapsulated 
cytochrome c concentration of either 65 or 130 µM, depending on the initial protein stock 
solution used.  500 µL of D2O was carefully placed on top of the AK-16 hydrogel 
containing cytochrome c, and the system was placed into the nitrogen-purged sample 
chamber of a Jasco J-810 spectropolarimeter.  Cytochrome c diffusion into the upper 
water layer was monitored via absorbance at 275 nm, resulting from the aromatic 
residues in the protein.  A control experiment, containing no cytochrome c, was 
performed to establish a baseline for the release profiles.   
The diffusion coefficient of cytochrome c was determined via the method 
reported in ref(261), using Fick’s second law of diffusion, given as: 
[𝐶𝑦𝑡𝑐]𝑡[𝐶𝑦𝑡𝑐]∞ = �16∙𝐷𝑎𝑝𝑝.∙𝑡𝜋∙𝐻2 �0.5              (31) 
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Where Dapp. is the apparent diffusion coefficient, t is time, and [𝐶𝑦𝑡𝑐]𝑡 and [𝐶𝑦𝑡𝑐]∞ are 
the concentration of cytochrome c released at time, t, and infinite time, respectively.  H is 
the height of the hydrogel, which was determined using the dimensions of the employed 
cuvette and the volume of the hydrogel.  Dapp. was obtained from the slope of the linear 
portion of a plot of [𝐶𝑦𝑡𝑐]𝑡[𝐶𝑦𝑡𝑐]∞ vs. 𝑡0.5. 
 
3.4.6 Rheological Measurements 
 
AK-16 hydrogel samples for rheological measurements were prepared by adding a 
freshly prepared AK-16 in D2O solution to a pre-weighed amount of salt.  Additionally, a 
sample of 5 mg/mL AK-16 was left to sit overnight prior to hydrogelation, to investigate 
the effect of conformational relaxation, and in particular, β-sheet decay on the hydrogel 
viscosity.   
Viscosity measurements of the AK-16 hydrogel samples were measured in the 
laboratory of Prof. Konstantin Kornev at the School of Materials Science and 
Engineering, Clemson University (Clemson, SC) using a Brookfield DV-III Ultra 
Viscometer/Rheometer using a Wells-Brookfield CPE-42 cone spindle.  The absolute 
viscosity of the small amount (~1 mL) of the peptide hydrogel was obtained via ‘cone-
plate’-like method, with a cone angle of 1.5° and a spindle radius of 2.4 cm.  Data was 
obtained using the Rheocalc software (Brookfield Engineering Laboratories), and 
automatically acquired over RS232. 
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After zeroing the instrument, approx. 1 mL of the peptide hydrogel sample was 
allowed to equilibrate on the plate at room temperature for 15 – 20 minutes.  The shear 
rate was then varied from 1 s-1 to 5 s-1 and then back to 1 s-1, at intervals of 1 s-1.  The 
shear stress [Dyne/cm2] was measured after 3 minutes at each speed to ensure that data 
were collected at equilibrium.  Viscosity was determined via: 
 
𝑉 = 100 ∙ �𝑆ℎ𝑒𝑎𝑟 𝑆𝑡𝑟𝑒𝑠𝑠
𝑆ℎ𝑒𝑎𝑟 𝑅𝑎𝑡𝑒 �              (32) 
 
where V is the viscosity [cP], and the shear stress and shear rate have units of [Dyne cm-
2] and [s-1], respectively.  A total of three trials were performed for each sample, and the 
results were averaged. 
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